lojgaomexmbmxktmuooqjgvotcckqommtcmiyiia length 6 242505 page 242505 <!DOCTYPE html>
<html xmlns="https://www.w3.org/1999/xhtml" lang="en" xml:lang="en">
<HEAD><!--ccm   -->
				<script id="cookieConsentScript" async src="https://img.lb.wbmdstatic.com/webmd_static_vue/file-explorer/webmd/consumer_assets/site_images/webmd-ccm/ccm_oo.min.js"></script>
<meta charset="UTF-8">
<script>
    // Flag set to know we are using the newest Global Ads coded
    var globalAsyncAdsCode = false;
</script>
<link rel="preconnect" href="https://securepubads.g.doubleclick.net" crossorigin>
<link rel="preconnect" href="https://assets.adobedtm.com" crossorigin>
<link rel="preconnect" href="https://img.webmd.com" crossorigin>

<link rel="shortcut icon" href="https://www.rxlist.com/images/fav/rx.ico" />
<link rel="apple-touch-icon" href="https://www.rxlist.com/images/mobile/rxlist-icon.png" />

<link rel="preconnect" href="https://images.rxlist.com">
<link rel="preload" href="https://images.rxlist.com/fonts/open-sans-v20-latin/open-sans-v20-latin-regular.woff2" as="font" type="font/woff2" crossorigin>
<link rel="preload" href="https://images.rxlist.com/fonts/open-sans-v20-latin/open-sans-v20-latin-600.woff2" as="font" type="font/woff2" crossorigin>
<link rel="preload" href="//assets.adobedtm.com/2c8c1e17b98c/bd8b7ed95b8d/launch-a2e2197ecad5.min.js" as="script" />
<link rel="preload" href="https://img.wbmdstatic.com/webmd_static_vue/webmd-share-static-files/webmd/PageBuilder_Assets/JS/api/oo_shim_head.min.js" as="script">
<link rel="preload" href="https://img.wbmdstatic.com/webmd_static_vue/webmd-share-static-files/webmd/PageBuilder_Assets/JS/api/oo_shim_body.min.js" as="script">
<link rel="preload" href="https://img.webmd.com/bi_common/bi_oocommon.js" as="script">
<style>/*** Icomoon ***/@font-face {font-family: 'icomoon';src: url(data:application/x-font-ttf;charset=utf-8;base64,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)format('truetype');font-weight: normal;font-style: normal;font-display: block}[class^="icon-"],[class*=" icon-"] {font-family: 'icomoon' !important;speak: never;font-style: normal;font-weight: normal;font-variant: normal;text-transform: none;line-height: 1;-webkit-font-smoothing: antialiased;-moz-osx-font-smoothing: grayscale}.icon-facebook:before {content: "\e608"}.icon-twitter:before {content: "\e607"}.icon-shield:before {content: "\e906"}.icon-search:before {content: "\e612"}.icon-menu:before {content: "\e613"}.icon-close:before {content: "\e624"}.icon-arrow-right2:before {content: "\e605"}.icon-slide:before,.icon-slideshow:before,#artPromoCunk .slide:before {content: "\e604"}.icon-image:before,#artPromoCunk .image:before {content: "\e623"}.icon-quiz:before,#artPromoCunk .quiz:before {content: "\e602"}.icon-right:before {content: "\e628"}.icon-wrong:before {content: "\e629"}.icon-start-over:before {content: "\e630"}.icon-pro:before {content: "\e901"}.icon-consumer:before {content: "\e902"}.icon-side-effect:before {content: "\e903"}.icon-drug-interaction:before {content: "\e905"}.icon-pill-id:before {content: "\e907"}.icon-drug-class:before {content: "\e908"}.icon-drug-cf:before {content: "\e900"}.icon-vit:before {content: "\e904"}.icon-map:before {content: "\e600"}.icon-toc-arrow:before {content: "\e909"}/*** Font ***/@font-face {font-family: 'Open Sans';font-style: normal;font-display: swap;font-weight: 400;src: local(''), url('https://images.rxlist.com/fonts/open-sans-v20-latin/open-sans-v20-latin-regular.woff2') format('woff2'), url('https://images.rxlist.com/fonts/open-sans-v20-latin/open-sans-v20-latin-regular.woff') format('woff')}@font-face {font-family: 'Open Sans';font-style: normal;font-display: swap;font-weight: 600;src: local(''), url('https://images.rxlist.com/fonts/open-sans-v20-latin/open-sans-v20-latin-600.woff2') format('woff2'), url('https://images.rxlist.com/fonts/open-sans-v20-latin/open-sans-v20-latin-600.woff') format('woff')}/*** Normalize ***/html {line-height: 1.15;-webkit-text-size-adjust: 100%}body {margin: 0}main {display: block;max-width:1250px;width: calc(100vw - 80px);margin: 0 auto;}h1 {font-size: 2em;margin: 0.67em 0}hr {box-sizing: content-box;height: 0;overflow: visible}pre {font-size: 1em}a {background-color: transparent}abbr[title] {border-bottom: none;text-decoration: underline;text-decoration: underline dotted}b,strong {font-weight: bolder}code,kbd,samp {font-size: 1em}small {font-size: 80%}sub,sup {font-size: 75%;line-height: 0;position: relative;vertical-align: baseline}sub {bottom: -0.25em}sup {top: -0.5em}img {border-style: none}button,input,optgroup,select,textarea {font-size: 100%;line-height: 1.15;margin: 0}button,input {overflow: visible}button,select {text-transform: none}button,[type="button"],[type="reset"],[type="submit"] {-webkit-appearance: button}button::-moz-focus-inner,[type="button"]::-moz-focus-inner,[type="reset"]::-moz-focus-inner,[type="submit"]::-moz-focus-inner {border-style: none;padding: 0}button:-moz-focusring,[type="button"]:-moz-focusring,[type="reset"]:-moz-focusring,[type="submit"]:-moz-focusring {outline: 1px dotted ButtonText}fieldset {padding: 0.35em 0.75em 0.625em}legend {box-sizing: border-box;color: inherit;display: table;max-width: 100%;padding: 0;white-space: normal}progress {vertical-align: baseline}textarea {overflow: auto}[type="checkbox"],[type="radio"] {box-sizing: border-box;padding: 0}[type="number"]::-webkit-inner-spin-button,[type="number"]::-webkit-outer-spin-button {height: auto}[type="search"] {-webkit-appearance: textfield;outline-offset: -2px}[type="search"]::-webkit-search-decoration {-webkit-appearance: none}::-webkit-file-upload-button {-webkit-appearance: button;font: inherit}details {display: block}summary {display: list-item}template {display: none}[hidden] {display: none}/*** Owl Carousel (core) ***/.owl-carousel {display: none;width: 100%;-webkit-tap-highlight-color: transparent;position: relative;z-index: 1}.owl-carousel .owl-stage {position: relative;-ms-touch-action: pan-Y;touch-action: manipulation;-moz-backface-visibility: hidden}.owl-carousel .owl-stage:after {content: ".";display: block;clear: both;visibility: hidden;line-height: 0;height: 0}.owl-carousel .owl-stage-outer {position: relative;overflow: hidden;-webkit-transform: translate3d(0px, 0px, 0px)}.owl-carousel .owl-wrapper,.owl-carousel .owl-item {-webkit-backface-visibility: hidden;-moz-backface-visibility: hidden;-ms-backface-visibility: hidden;-webkit-transform: translate3d(0, 0, 0);-moz-transform: translate3d(0, 0, 0);-ms-transform: translate3d(0, 0, 0)}.owl-carousel .owl-item {position: relative;min-height: 1px;float: left;-webkit-backface-visibility: hidden;-webkit-tap-highlight-color: transparent;-webkit-touch-callout: none}.owl-carousel .owl-item img {display: block;width: 100%}.owl-carousel .owl-nav.disabled,.owl-carousel .owl-dots.disabled {display: none}.owl-carousel .owl-nav .owl-prev,.owl-carousel .owl-nav .owl-next,.owl-carousel .owl-dot {cursor: pointer;-webkit-user-select: none;-khtml-user-select: none;-moz-user-select: none;-ms-user-select: none;user-select: none}.owl-carousel .owl-nav button.owl-prev,.owl-carousel .owl-nav button.owl-next,.owl-carousel button.owl-dot {background: none;color: inherit;border: none;padding: 0 !important;font: inherit}.owl-carousel.owl-loaded {display: block}.owl-carousel.owl-loading {opacity: 0;display: block}.owl-carousel.owl-hidden {opacity: 0}.owl-carousel.owl-refresh .owl-item {visibility: hidden}.owl-carousel.owl-drag .owl-item {-ms-touch-action: none;touch-action: none;-webkit-user-select: none;-moz-user-select: none;-ms-user-select: none;user-select: none}.owl-carousel.owl-grab {cursor: move;cursor: grab}.owl-carousel.owl-rtl {direction: rtl}.owl-carousel.owl-rtl .owl-item {float: right}.no-js .owl-carousel {display: block}.owl-carousel .owl-item .owl-lazy {opacity: 0;transition: opacity 400ms ease}.owl-carousel .owl-item img.owl-lazy {transform-style: preserve-3d}/*** Common ***/html {font-family: 'Open Sans', sans-serif;font-size: 17px;font-weight: 400;color:#232323;}b,strong,optgroup,h1,h2,h3,h4,h5,h6 {font-weight: 600;}h1{font-size:55px;line-height:57px;}h2{font-size:26px;line-height:30px;}h3{font-size:20px;line-height:30px;}h4{font-size:20px;line-height:30px;margin:5px 0px;}p{line-height:25.5px;font-size:17px;margin:5px 0px;}a {color: #2196f3;text-decoration: none;cursor: pointer}a:hover {text-decoration: underline}::-moz-selection {background: #000;text-shadow: none;color: #fff}::selection {background: #000;text-shadow: none;color: #fff}a[data-title]:hover:before {content: attr(data-title);padding: 4px 8px;color: #fff;position: absolute;z-index: 9999;border-radius: 3px;background: #333;font-size: 12px;margin: 35px 15px 0 0;line-height: normal}.apPage h2, #apPage h2 {border-left: 5px solid #2196f3;padding: 5px 10px;}#backTop {display: none;position: fixed;right: 20px;top: calc(100vh - 60px);z-index: 49}#backTop .icon-arrow-right2:before{background: #2196F3;    border-radius: 50px;    box-shadow: 0px 4px 4px rgb(0 0 0 / 25%);color:#fafafa;padding:7px;} #backTop span {color: #232323;font-size: 36px;padding: 3px;transform: rotate(-90deg);display: block;transition: all 250ms}#backTop span:hover {cursor: pointer;color: #fff;}main ::-webkit-scrollbar-track {-webkit-box-shadow: inset 0 0 5px rgba(0, 0, 0, 0.3);background: #f4f4f4}main ::-webkit-scrollbar {width: 5px;background: #f4f4f4}main ::-webkit-scrollbar-thumb {background: #000}.sc-modal button {color: #fff;font-size: 14px;font-weight: normal;line-height: normal;text-decoration: none;text-transform: uppercase;text-align: center;padding: 17px;margin: 15px 0;background: #2196f3;width: 250px;border: none;outline: none;display: inline-block;position: relative;z-index: 1;overflow: hidden}.sc-modal button:hover {text-decoration: none;cursor: pointer}.sc-modal button:after {content: "";background: #000;position: absolute;z-index: -1;left: 0;right: 0;top: -100%;bottom: 100%;transition: all 250ms}.sc-modal button:hover:after {left: 0;right: 0;top: 0;bottom: 0}.stickyColLeft {display: none}.icon-arrow-left2:before {content: "\e605";display: inline-block;transform: rotate(180deg)}.w-full {width: 100%}/*** AD ***/body>header.fixed {margin-top: 100px}.adTopWrapper {border-bottom: #e2e2e2 solid 1px;width: 100%;min-height: 100px;z-index: 1;position: relative;background-color: #fff;position: sticky;top: 68px;}.adTopWrapper #bannerAd_rdr,.ad-slot.content-ads {background: url(https://images.rxlist.com/images/ads/1atopbannerside.gif) no-repeat 0 center;margin: 0 auto;padding: 5px 10px;position: relative;display: table}.adTopWrapper #bannerAd_fmt {padding: 4px;border: 1px solid #ccc;min-width: 738px;min-height: 90px}#rightAd_rdr:after,#leftAd_rdr:after {content: '';background: url(https://images.medicinenet.com/images/ads/rightad_toptransparent.gif) no-repeat center 0;height: 10px;display: block}.rightAd_BG_fmt {width: 300px;min-height: 250px;padding: 0px;border: 1px solid #ddd}.leftAd_BG_fmt {width: 160px;min-height: 600px;padding: 4px;border: 1px solid #ddd}.leaderboard_fmt {background: url(https://images.medicinenet.com/images/ads/1atopbannerside.gif) no-repeat 0 20px;width: 738px;margin: 30px auto;padding: 16px 10px;clear: both}.leaderboard_fmt>div {padding: 4px;border: 1px solid #ddd;width: 728px;height: 90px}.ad-slot.content-ads {min-height: 90px;min-width: 748px;}/*** Modal ***/.innerBox iframe {position: absolute;top: 0;left: 0;padding: 0;margin: 0;border: 0}.modalBox .logo {text-indent: -9999px;margin-top: -33px;background: url(https://images.rxlist.com/images/mobile/rxlist/logo-rxl-reverse.png) no-repeat 0 2px/130px 24px}.modalClose:after {content: "\e624";font-family: 'icomoon';font-size: 28px;right: 0;top: -38px;z-index: 1;position: absolute;color: #FFF;padding: 4px 6px;line-height: 30px}.modalClose:hover:after {color: #47638D}.modalBox {border-top: 38px solid #6896DA;box-shadow: 0 0 15px #000;background: #fff;z-index: 99999999;position: absolute}.modalBox>a {text-decoration: none}.blockPage {position: absolute;top: 0;left: 0;background: rgba(0, 0, 0, 0.6);z-index: 99999998}.innerBox a {background: #47638D !important}.innerBox a:hover {background: #000 !important}.sc-modal {text-align: center;position: fixed;top: 0;right: 0;bottom: 0;left: 0;background: rgba(0, 0, 0, .8);overflow: auto;overscroll-behavior: contain;z-index: 1000000}.sc-modal-dialog {max-height: 80vh;max-width: 80vw;min-width: 300px;background: #fff;padding: 30px;position: absolute;top: 50%;left: 50%;transform: translate(-50%, -50%)}.sc-modal-title {display: none}.sc-modal .close {color: #232323;font-size: 26px;line-height: 20px;text-decoration: none;padding: 5px;border: 1px solid #ccc;background: rgba(255, 255, 255, .9);right: 10px;top: 10px;position: absolute;transition: all 250ms}.sc-modal .close:hover {cursor: pointer;color: #fff;background: #000;border-color: #000;text-decoration: none}.sc-modal h3 {font-size: 17px;font-weight: 400;line-height: 24px}/*** Module ***/.extra .from_webmd {width: 65%}.from_webmd {margin: 40px auto;border-collapse: separate;border-spacing: 5px;border-radius: 10px;background: #E4F3FA;padding: 20px;}.from_webmd h2, .from_webmd h3 {letter-spacing: 1px;margin: 0;text-decoration: none !important;font-size: 26px;padding-bottom: 10px;border-bottom: 1px solid #000;}.from_webmd .logoTitle {height: 18px;margin-top: -5px}.from_webmd .content {display: flex}.from_webmd .wrapper {padding-right: 24px;flex-grow: 1;}.from_webmd h5 {font-size: 18px;color: #000;line-height: 16px;margin: 10px 0;}.from_webmd .content ul {padding: 0;margin: 0;list-style: none}.from_webmd ul li {padding: 10px 0;line-height: 15px}.from_webmd ul li a {font-size: 15px}.webmdrx a {background: #1D72A8;border-radius: 3px;padding: 5px 15px;text-align: center;display:inline-block;transition: background 250ms}.webmdrx p {font-size: 14px;color: #fff;margin: 0}.webmdrx_img {background: url(https://images.rxlist.com/images/rxlist/webmdrx-btn.png) 0 0 no-repeat;width: 91px;height: 15px;float: right;margin: 5px 0 0 6px}.webmdrx a:hover {background: #000;text-decoration: none}/*** Header ***/body.freeze {position: fixed;overflow-y: scroll;width: 100%}body>header:after {content: '';background: rgba(0, 0, 0, 0);width: 100%;height: 100vh;position: fixed;top: 50px;z-index: -1;transition: all 400ms}body.freeze>header:after,body>header.miniMenu:after {background: rgba(0, 0, 0, .7);z-index: 9999}.masterhead {height: 65px;background: #fff;border-bottom: 1px solid #ddd;z-index: 999999;position: relative;margin: 0}.masterhead .wrapper {position: relative}.masterhead .menu>span {padding: 18px;font-size: 29px;display: inline-block;cursor: pointer;transition: color 250ms}.masterhead .menu>span:hover,.masterhead .search button:hover {color: #2196f3}.masterhead .logo {top: 18px;left: 55px;position: absolute}.masterhead .search {top: 0;right: 90px;position: absolute}.masterhead .search button {border: none;background: transparent;outline: none;font-size: 19px;color: #232323;padding: 24px 8px 18px;transition: color 250ms;cursor: pointer}.masterhead .search button .icon-close {font-size: 26px;margin: -4px;display: block}.masterSub,.searchBar {background: #fff;width: 100%;top: -100vh;z-index: 99999;position: fixed;transition: .4s top ease}.masterSub {overflow-x: hidden}.masterSub.on,.searchBar.on {top: 175px}.masterSub nav {max-width: 1645px;min-width: 843px;height: 45vh;padding: 18px 0 55px;}.masterSub nav .wrapper {width: 35%;margin: 0 20px;float: left}.masterSub nav .wrapper h3 {border-bottom: 1px solid #ddd;padding: 5px 8px}.masterSub nav a {color: #232323;font-size: 16px;text-decoration: none;padding: 10px;display: block;transition: all 250ms}.masterSub nav .trustBadge {position: static;border: none}.masterSub nav .trustBadge .icon-shield {display: none}.masterSub nav a:hover {background: #000;color: #fff}.masterSub .stack .icon-arrow-right2 {vertical-align: middle}.masterSub .stack .sideBar {background: #6896DA;width: calc(100vw - 350px);height: 45vh;top: 0;left: 100vw;padding: 30px;z-index: 99999;position: absolute;transition: .3s left ease}.masterSub .stack.on {background: #6896DA;transition: all 250ms}.masterSub .stack.on a {color: #fff}.masterSub .stack.on a:hover {background: none}.masterSub .stack.on .sideBar {left: calc(100vw - 40%)}.masterSub .stack .sideBar a {color: #fff;width: 300px}.masterSub .stack .sideBar a:hover {background: #fff;color: #000}.socialWrapper {top: 22px;right: 20px;position: absolute}.socialWrapper li {list-style: none;float: left}.socialWrapper li a {color: #232323;font-size: 20px;padding: 20px 8px 19px;transition: all 250ms;cursor: pointer}.socialWrapper li a:hover {color: #2196f3;text-decoration: none}.socialWrapper a[data-title]:hover:before {right: -15px}.sc-searchbox {position: relative}.sc-searchbox .sc-searchbox-input-wrapper {display: flex}.sc-searchbox .sc-searchbox-input {flex-grow: 1}.sc-searchbox .sc-searchbox-list {position: absolute;width: 100%;z-index: 50;background: #fff;box-sizing: border-box}.sc-searchbox .sc-searchbox-list .sc-searchbox-list-item.sc-searchbox-item-active {background: #f5f5f5}.nav-search.sc-searchbox .sc-searchbox-form {padding: 125px 20%}.nav-search.sc-searchbox .sc-searchbox-input {font-size: 18px;padding: 12px 20px;border: none;outline: none;background: #f5f5f5}.nav-search.sc-searchbox .sc-searchbox-input:focus {background: #000;color: #fff}.nav-search.sc-searchbox .icon-search:before {display: none}.nav-search.sc-searchbox .sc-searchbox-button {padding: 7px 25px;font-weight: 600;background: #6896DA;color: #fff;outline: none;border: none;transition: all 250ms}.nav-search.sc-searchbox .sc-searchbox-button:hover {background: #000 !important}.nav-search.sc-searchbox .sc-searchbox-list {background: #fff;padding: 6px;border: 1px solid #ddd;border-top: none;color: #232323;width: 60%;z-index: 1000}.nav-search.sc-searchbox .sc-searchbox-list .sc-searchbox-list-item.sc-searchbox-item-active {background: #000;color: #fff;cursor: pointer}.nav-search.sc-searchbox .sc-searchbox-list-item {padding: 5px 8px;border-radius: 3px}/*** Footer ***/#sponsors {margin: 40px auto;padding: 20px;clear: both;max-width: 1250px;width: calc(100vw - 80px);}.hstitle {font-size: 26px;font-weight: 600;margin: 0 0 15px 0}.hstitle span {font-size: 14px;font-weight: 400}#sponsors .wrapper ul {list-style: none;padding: 0;margin: 0;column-count: 3;column-gap: 50px}#sponsors .wrapper li {font-size: 13px;line-height: 15px;padding: 5px 0;break-inside: avoid}#sponsors .wrapper li a {color: #2196f3;text-decoration: none;cursor: pointer;word-break: break-word}#sponsors .wrapper li a:hover {text-decoration: underline}footer {max-width: 1250px;margin: 130px auto 50px;padding: 0 20px;position: relative;width: calc(100vw - 80px);}footer .social-section {list-style: none;margin: 0;padding: 0;top: -40px;right: 30px;position: absolute}footer .social-section li {float: left}footer .social-section li a {color: #232323;font-size: 20px;padding: 8px;cursor: pointer;transition: all 250ms}footer .social-section li a:hover {color: #2196f3;text-decoration: none}footer .social-section a[data-title]:hover:before {right: 0}footer nav {padding: 20px 0 40px;border-top: 2px solid #ddd;border-bottom: 2px solid #ddd;display: flex;justify-content: space-between}footer .col {width: 26%}footer .col ul {list-style: none;margin: 0;padding: 0}footer .col li a {color: #666;font-size: 13px;line-height: 14px;text-decoration: none;padding: 6px 0;display: block}footer .col li a:hover {text-decoration: underline}footer .footerCopy {display: flex;justify-content: space-between}footer .badge {padding: 10px 0}footer .copyright {text-align: right;margin: 10px 0}footer .ccpaFtrLnk {font-size: 12px;color: #2196f3}footer .copyright p {font-size: 12px;line-height: 15px;width: 430px;margin: 5px 0}footer .copyright p a {color: #232323;text-decoration: underline}/*** HP ***/.promoSearch:after,.news_hp:after,.topRx:after {content: "";position: absolute;width: 20px;height: 40px;left: 0;bottom: -40px;border-radius: 10px 0 0 0;box-shadow: 0 -20px 0 0 #d5edfc;background: transparent}.promoSearch:after {box-shadow: 0 -20px 0 0 #0171bb}.news_hp:before,.topRx:before {content: "";position: absolute;width: 20px;height: 40px;left: 0;top: -40px;border-radius: 0 0 0 10px;box-shadow: 0 20px 0 0 #d5edfc;background: transparent}.promoSearch,.shortcut,.news_hp,.AdWrapper,.topRx,.media {padding: 40px 5vw;text-align: center;position: relative}.news_hp h2,.topDrug h2,.topRx h2,.media h2 {font-size: 30px;padding-bottom: 15px;text-transform: uppercase}.shortcut a,.news_hp a,.topDrug a,.topRx a,.media a {color: #232323;transition: 250ms all}.promoSearch {background: #0171bb;border-radius: 0 0 10px 0}.promoSearch img {width: 300px;height: 200px;margin-bottom: 20px}.promoSearch .sc-searchbox .sc-searchbox-input-wrapper {position: relative;z-index: 51}.promoSearch .sc-searchbox input {font-size: 15px;padding: 0 45px 0 20px;border-radius: 10px;border: 0;outline: 0;height: 50px}.promoSearch .sc-searchbox button {font-size: 18px;color: #0171bb;background: transparent;border: 0;outline: 0;position: absolute;right: 15px;top: 16px}.promoSearch .sc-searchbox .sc-searchbox-list {position: absolute;top:45px;padding: 70px 10px 15px 10px;z-index: 50;background: #000;text-align: left;border-radius: 10px;border-top-left-radius: 0px;border-top-right-radius: 0px;}.promoSearch .sc-searchbox .sc-searchbox-list-item {color: #fff;padding: 10px}.promoSearch .sc-searchbox .sc-searchbox-list .sc-searchbox-list-item.sc-searchbox-item-active {background: #fff;color: #232323;cursor: pointer}.promoSearch p {color: #fff;font-size: 14px}.promoSearch p a {color: #adf;font-size: 14px;text-decoration: underline;transition: 250ms all}.promoSearch p a:after {content: ',';display: inline-block}.promoSearch p a:last-child:after {display: none}.promoSearch p a:hover {color: #fff}.shortcut {display: flex;flex-wrap: wrap;justify-content: center}.shortcut a {font-size: 16px;font-weight: 600;background: #d5edfc;border-radius: 10px;padding: 20px 15px 20px 50px;margin: 5px;width: 100px;height: 40px;text-align: left;position: relative;display: flex;align-items: center}.shortcut span {color: #2196f3;font-size: 25px;top: 28px;left: 14px;position: absolute;transition: 250ms all}.shortcut a:hover,.news_hp .wrapper a:hover,.topDrug .az li a:hover,.media .wrapper a:hover,#A_Z li a:hover {background: #000;color: #fff;text-decoration: none}.shortcut a:hover *,.news_hp .wrapper a:hover *,.media .wrapper a:hover * {color: #fff}.news_hp,.topRx {background: #d5edfc;border-radius: 0 10px 10px 0}.news_hp .wrapper a {text-align: left;border-radius: 10px;height: 85px;padding: 20px;margin-bottom: 14px;background: #fff;display: block}.news_hp .wrapper span {color: #2196f3;font-size: 12px;font-weight: bold;line-height: 12px;text-transform: uppercase;display: block;transition: 250ms all}.news_hp .wrapper h3 {font-size: 16px;line-height: 20px;margin: 10px 0}.news_hp .wrapper .timestamp {color: #999;font-size: 12px;transition: 250ms all}main#HP .AdWrapper #rightAd_rdr {position: absolute;right: 5vw;top: auto;bottom: 90px}.topDrug .az ul,#A_Z ul {list-style: none;padding: 0;display: flex;flex-wrap: wrap;justify-content: center}.topDrug .az li,#A_Z li {margin: 6px;padding: 0 !important}.topDrug .az li a,#A_Z li a {color: #fff;font-size: 24px;font-weight: 600;line-height: 40px;border-radius: 100%;padding: 5px;width: 40px;height: 40px;background: #e5e5e5;display: inline-block;transition: all 250ms}.topDrug .az li a.active,#A_Z li a.active {background: #2196f3}.topDrug .azList {height: 300px;width: calc(100% - 340px);margin: 40px 0;overflow-y: auto;position: relative}.topDrug .azList ul {display: none;list-style: none;margin: 20px;padding: 0;column-count: 2;column-gap: 30px;text-align: left;width: calc(100% - 40px);position: absolute}.topDrug .azList #list-azA {display: block}.topDrug .azList li {border-bottom: 1px dotted #ddd;padding: 0 !important;width: 100%;display: inline-block}.topDrug .azList li a {color: #2196f3;font-size: 16px;padding: 8px 0;display: block}.topRx ul {list-style: none;margin: 0;padding: 0;text-align: left;column-count: 2;column-gap: 50px}.topRx li {padding: 0 !important;border-bottom: 1px solid #f1f6f9;display: flex;align-items: center}.topRx li:before {content: "\e605";font-family: 'icomoon';color: #fff;font-size: 14px;line-height: 16px;width: 15px;height: 15px;background: #2196f3;border-radius: 100%}.topRx li a {font-size: 16px;padding: 8px;width: 100%;min-height: 38px;display: flex;align-items: center}.media #leftAd_rdr {position: absolute}.media .container {margin-left: 200px}.media .wrapper a {text-align: left;background: #d5edfc;border-radius: 10px;margin-bottom: 14px;display: block;height: 70px;padding: 10px}.media .wrapper img {border-radius: 10px;width: 70px;height: 70px;position: absolute}.media .wrapper h3 {font-size: 16px;line-height: 18px;margin: 10px 0 10px 80px}/*** Article ***/.rxArt main {display: flex;}.rxArt main#HP,.rxArt.imgcol main {display: table;width: 100%}.story {margin: 0;max-width: 950px;}.story .share {float: right;margin-top: -32px}.story article {font-size: 16px;padding: 5px 0}.story article a:hover {text-decoration: underline}.story article .alert {background: #ed1c24;font-size: 12px;color: #fff;padding: 5px 10px;border-radius: 30px;font-weight: 600;text-transform: uppercase;display: inline-block}.story article h3 {text-decoration: underline;text-transform: uppercase}.monograph_sum{width:auto;border: 2px solid #59A3DD;    border-radius: 6px;margin-bottom: 25px;}.monograph_header{background: #F1F8FC;    border-radius: 3px 3px 0px 0px;padding:1px 10px;font-size:17px;line-height:26px;}.monograph_header h2.monograph_source{line-height: 20px;}.monograph_date{float:right;}.monograph_cont{padding:15px;}.drug_fda{  padding-top: 15px;  padding-bottom:10px;  background-image: linear-gradient(to right, #232323 40%, rgba(255, 255, 255, 0) 20%);  background-position:bottom;  background-size: 17px 1px;  background-repeat: repeat-x;}.drug_review_btn{background: #0171BB;border-radius: 3px;}.story article ul {margin: 30px 0}.story article ul li,.story article ol li, .monograph_cont ul li {padding: 8px 0;line-height: 22px;break-inside: avoid}.story .pageSection {margin: 60px 0}.story .pageSection:first-child {margin-top: 20px}.story .pageSection .clear {clear: none}#apPage h5 {font-size: 15px}.bookmark {display: block;position: relative;top: -230px}#apPgNum {font-size: 18px;font-weight: 600;text-align: left;color: #333333;padding: 5px 10px;margin-bottom: 25px;border-left:5px solid #2196f3;}#apPgNum span{font-size:26px;line-height:30px;}.rxArt.pgcon #apPgNum {background: #92A74E}.rxArt.pgsideeffect #apPgNum {background: #F3614D}.slide-viewpoert {margin-bottom: 25px}.monomodmsg {font-size: 14px;text-align: right;margin: 10px 0}/**.rxArt .stickyColLeft,.rxArt .stickyColRight{padding:0px 20px}**/.rxArt #rxlistAD160,.rxArt #rightAd_rdr {position: sticky;position: -webkit-sticky;top: 182px}.story .driver {display: inline-block;font-size: 18px;font-weight: 600}.story .btn_driver a {display: inline-block;color: #fff;padding: 6px 40px;border-radius: 3px;background: #2196f3;transition: background 250ms}.story .btn_driver a:hover {text-decoration: none;background: #000}.story .Red,.story .final {color: #f00;text-transform: uppercase;font-size: 16px;font-weight: 600}#Disc_Warning {border-radius: 12px;padding: 15px 20px;margin: 20px 0 -40px 0;line-height: 17px;font-size: 16px;font-weight: 600;text-transform: uppercase;color: #fff;background: #da1b23}.pgContent .blackBorderBox_fmt {    border-radius: 6px;    padding: 25px;    background: #F9F4F4;margin:20px 0;}.blackBorderBox_fmt b{font-weight:400;line-height:26px;}.blackBorderBox_fmt p:nth-child(2)>b{color: #DB5757;    font-size: 20px;    font-weight: 600;    line-height: 30px;    text-align: center;}.mnvit_copy {margin: 20px 0;width: 100%;max-width: 470px}.pgContent center {overflow-x: auto}.pgContent .artTable,.pgContent .blacktbl,.pgContent .blackpic {width: 100%;margin-bottom: 10px;border-spacing: 0;text-align: center;table-layout: fixed}.pgContent .artTable tr td:nth-child(odd),.pgContent .blacktbl tr td:nth-child(odd) {background: #eee}.pgContent .artTable tr td:first-child,.pgContent .blacktbl tr td.EmphTd {border-left: 1px solid #989898;text-align: center;background: #555;color: #fff;font-weight: 600}.pgContent .artTable tr td,.pgContent .blacktbl tr td {font-size: 12px;padding: 5px;border-bottom: 1px solid #e0e0e0;border-top: none}.pgContent .blackpic img {width: auto;height: auto;max-width: 100%}#forPatients {margin: 20px 0}#forPatients .forPatientsHdr {margin: 0;padding: 5px;text-align: center;border-radius: 3px 3px 0 0;background: #92A74E;color: #fff;font-size: 18px}#forPatients .forPatientContent {padding: 0 25px 25px 25px;border: 1px solid #92a74e}#fdaWrapper {background: #003152;color: #fff;margin: 30px auto;max-width: 715px}#fdaWrapper img {padding: 25px;position: absolute}#fdaWrapper h3 {padding: 15px;margin: 0 0 0 190px;font-size: 19px;line-height: 24px;border-left: 1px solid #4d6f86;text-decoration: none}#fdaWrapper p {padding: 11px 15px;font-size: 12px;margin: 0 0 0 190px;border-left: 1px solid #4d6f86}#fdaWrapper p a {color: #fff;text-decoration: underline}.medianet {margin: 50px auto}.story .fdbTerms {border-radius: 5px;padding: 15px 20px;margin: 20px 0;background: #000}.story .fdbTerms a {font-size: 14px;display: inline-block;color: #fff}.consumerHeading {font-weight: 600;display: block;margin: 30px 0 5px}.continue_reading {font-weight: 600;color: #6cc2ff;margin: 50px auto;text-align: center;display: table}.continue_reading:before,.continue_reading:after {content: '.............';font-size: 15px;color: #ccc;top: -5px;letter-spacing: 2px;position: relative;display: table-cell}.story #sponsors .wrapper ul {column-count: 2}.apPageBottom {border-top: 1px solid #ccc;margin: 40px 0}.apPageBottom #refs {font-size: 14px;font-style: italic;margin: 10px 0;color: #2196f3}.apPageBottom #refs .icon-search {font-size: 12px;color: #F26522;padding: 0 4px;vertical-align: middle;display: inline-block}.apPageBottom #refs:hover {cursor: pointer;text-decoration: underline}.apPageBottom #refStash {display: none;background: #eee;padding: 20px;margin-bottom: 20px;font-size: 12px}.lastreviewed {margin: 10px 0;font-size: 14px;color: #777}.story .source,.story .credit,.story .disclaimer,.story .Sizeminus {font-size: 12px}.otherNames p {font-size: 14px}/*** Article (hero) ***/.wrapper-hero {padding: 30px 2% 10px;position: relative;margin: 0;}.wrapper-hero .hero h1,.pageWrapper h1 {text-transform: uppercase;margin: 45px 0 15px}.story .slideshow h1 {font-size: 42px}.wrapper-hero .hero ul {margin: 0;padding: 0}.wrapper-hero .hero ul li {list-style: none;line-height: 26px;padding: 2px 0;}.wrapper-hero .hero ul li[itemprop="name"] span {font-weight: 400}.wrapper-hero .hero ul li[itemprop="name"] a {color: #2196f3}.wrapper-hero .hero .drug_name {margin: 5px 0 10px -22px}.wrapper-hero .hero .drug_name [class^="drug"] {padding: 8px 12px;margin: 0 10px;display: inline-block;position: relative}.wrapper-hero .hero .drug_name [class^="drug"]:after {content: " | ";color: #aaa;position: absolute;right: -13px}.wrapper-hero .hero .drug_name span:last-of-type:after {display: none}.wrapper-hero .hero .drug_name [class^="drug"] a {color: #2196f3;font-size: 18px;line-height: 22px;text-decoration: none;display: inline-block}.wrapper-hero .hero .drug_name [class^="drug"] a:hover {text-decoration: underline}.wrapper-hero .monolastreviewed,.wrapper-hero .reviewer,.wrapper-hero .reviewdate {    line-height: 26px;padding: 5px 0 10px;}.wrapper-hero .monolastreviewed a {color: #232323;margin-right: 10px}.wrapper-hero .monolastreviewed i {font-style: normal}.wrapper-hero .hero ul+p {color: #fff;font-size: 14px;background: #333;text-align: center;padding: 5px 0;width: 150px}.author a {color: #2196f3;text-decoration: none}.author a:hover {text-decoration: underline}.breadcrumbs {color: #777777;font-size: 14px;line-height: 16px;width: 95%;top: 20px;position: absolute;text-transform: uppercase}.breadcrumbs a {color: #2196f3;font-size:14px;line-height:16px;}.breadcrumbs a:after {font-family: 'icomoon';content: "\e605";padding-left: 4px;display: inline-block;vertical-align: middle;color: #232323;}.trustBadge {color: #4CAF50;font-size: 14px;padding: 6px 10px 5px 35px;margin: 10px 0;border: 1px solid #4CAF50;position: relative;display: inline-block;transition: all 250ms;display:none;}.trustBadge .icon-shield {font-size: 19px;color: #4CAF50;position: absolute;left: 8px;top: 5px;transition: all 700ms}.trustBadge:hover {text-decoration: none;background: #000;color: #fff;border-color: #fff;cursor: pointer}.trustBadge:hover .icon-shield {color: #fff}.trustBadgeContent {text-align: center;padding: 30px}.trustBadgeContent ul {padding: 0;margin: 0;display: inline-block}.trustBadgeContent li {float: left;list-style: none}.trustBadgeContent .trustLink {margin: 20px 0}.trustBadgeContent .trustLink li:before {content: "|";padding: 0 10px}.trustBadgeContent .trustLink li:first-child:before {display: none}.trustBadgeContent .trustLink a {color: #2196f3;font-size: 16px;text-decoration: none}.trustBadgeContent .trustLink a:hover {text-decoration: underline}.trustBadgeContent .badge {display: block;margin: 15px auto;width: 340px;height: 60px}.trustBadgeContent p {font-size: 12px;margin: 5px 0}.trustBadgeContent p a {color: #2196f3}.drugDropdown {height: 30px;list-style: none;margin: 10px 0 16px;padding: 0}.drugDropdown li {float: left;}.drugDropdown li>a {text-decoration: none;background: #F1F5F7;margin-right: 15px;padding: 7px 10px;display: inline-block;position: relative;border-radius: 3px;    width: 160px;    color: #2196F3;white-space: nowrap;font-size: 15px;}.drug_review_btn a{background: none !important;color:#ffffff !important;}.drugDropdown .drugSelect {padding: 6px 25px 6px 10px;}.drugDropdown .drugSelect:after {font-family: 'icomoon';    content: "\e605";    font-size: 27px;    position: absolute;    top: -1px;    right: 1px;    transform: rotate(90deg);    background: #DBEBF8;    color: #2196F3;    width: 29px;    height: 31px;    text-align: center;}.drugDropdown a.prof:hover,.drugDropdown a.sideEffect:hover{background: #555;color: #fff}.drugDropdown .drugOption {display: none;position: absolute;border-radius: 0px 3px 3px 3px;    margin:0;background: #EAF4FC;z-index: 9;max-height: 40vh;width: 194px;overflow-y: auto;box-shadow: 0 6px 4px -4px #ccc;font-size: 15px;}.drugDropdown li:hover .drugSelect {background: #EAF4FC;border-radius: 3px 3px 0px 0px;}.drugDropdown li:hover .drugSelect:after{background: #2196F3;transform: rotate(270deg);color:#ffffff;line-height:35px;border-radius: 0px 0px 3px 3px;}.drugDropdown li:hover .drugOption {display: block;}.drugDropdown .drugOption a {display: block;line-height: 30px;text-decoration: none;padding: 8px 10px}.drugDropdown a.sideEffect {background: #F3614D;color: #fff;display:none;}.drugDropdown a.prof {background: #47638D;color: #fff;}.drugOption::-webkit-scrollbar-track {box-shadow: inset 0 0 6px rgba(0, 0, 0, 0.3);background: #fafafa}.drugOption::-webkit-scrollbar {width: 3px;background: #fafafa}.drugOption::-webkit-scrollbar-thumb {background: #000}.drugOption::-webkit-scrollbar-thumb:hover {background: #2196f3}/*** Article (submenu) ***/.submenu .icon-menu {display: none}.submenu .tab {border-bottom: 5px solid #eee}.submenu .tab a {color: #47638D;font-size: 18px;font-weight: 600;padding: 10px 12px;margin-bottom: -7px;text-decoration: none;height: 32px;border-bottom: 5px solid #eee;display: inline-block;opacity: .3;transition: all 250ms}.submenu .tab a.con {color: #92A74E}.submenu .tab a.sideEffect {color: #F3614D}.submenu .tab a.active {cursor: default}.submenu .tab a.prof.active,.submenu .tab a.prof:hover {border-bottom: 5px solid #47638D;opacity: 1}.submenu .tab a.con.active,.submenu .tab a.con:hover {border-bottom: 5px solid #92A74E;opacity: 1}.submenu .tab a.sideEffect.active,.submenu .tab a.sideEffect:hover {border-bottom: 5px solid #F3614D;opacity: 1}.submenu .tab a span {font-size: 32px;margin-right: 8px;vertical-align: -32%}.submenu .tab a .icon-pro {font-size: 26px}.submenu .toc.link {    background: #F1F8FC;    border-radius: 6px 6px 0px 0px;    padding: 0px 16px 0px 16px;}.submenu .icon-menu:before {margin-right:20px;}.submenu .icon-menu:after{content: url("https://images.rxlist.com/images/mobile/rxlist/logo-rxl.png");background-repeat: no-repeat;margin-left:20px;}.submenu .toc.link ul {padding: 0;margin: 5px 0 0px -6px;list-style: none;display: inline-block}.submenu .toc.link ul li {padding: 0;float: left;}/* .submenu .toc.link li.active a {    background: #2196F3;    color: #ffffff;    border-radius: 3px;} */.submenu .toc.link a {color: black;line-height: 25.5px;text-decoration: none;padding: 6px 6px;margin: 0 6px;display: inline-block;position: relative;}.submenu .toc.link a:hover {color: #2196f3;}.submenu .toc.link a:after {content: " | ";color: #aaa;position: absolute;right: -13px}.submenu .toc.link li:last-child a:after {display: none}.submenu .toc.link a:hover {text-decoration: underline}.miniMenu .masterSub {top: 50px}/*.miniTitle .hero h1 {position: fixed;top: -33px;left: 70px;font-size: 24px !important;line-height: 26px;width: calc(100% - 650px);white-space: nowrap;overflow: hidden;text-overflow: ellipsis;z-index: 9999999;transition: all 250ms}*/.submenu.stuck h2.drug_fda {    display: none;}/* .submenu.stuck {position: fixed;top: -150px;left: 0;right: 0;background: #fff;box-shadow: 0 1px 5px 0 #ccc;height: 50px;z-index: 999999}.submenu.stuck>span[class*="icon-"] {color: #2196f3;display: block;padding: 0 20px;font-size: 30px;cursor: pointer;line-height: 50px;position: absolute} */.submenu.stuck>span[class*="icon-"]:hover {color: #232323;}.submenu.stuck .tab {border: none;right: 10px;position: absolute}.submenu.stuck .tab a {display: none;font-size: 16px;line-height: 18px;height: auto;margin: 0;padding: 15px 35px 15px 20px;border-bottom: none !important;white-space: nowrap}.submenu.stuck .tab a span {font-size: 20px;vertical-align: text-bottom}.submenu.stuck .tab a.active {display: block;cursor: pointer;top: 0;right: 0;position: absolute}.submenu.stuck .tab a.active:after {font-family: 'icomoon';content: "\e605";color: #232323;font-size: 22px;position: absolute;right: 8px;z-index: -1;transform: rotate(90deg)}/* .submenu.stuck .tab.select:before {content: '';width: 100%;height: 50px;display: block;border-bottom: 2px solid #eee} */.submenu.stuck .tab a.option {display: block;background: #fff;box-shadow: inset 0px -1px 3px -1px #ccc;opacity: 1}.submenu.stuck .tab a.option:hover {color: #232323}.submenu.stuck .toc.link ul {bottom: 18px;  right: 100px;margin: 0;position: fixed;}.submenu.stuck .toc.link li {float: none;/* background:white; */}.submenu.stuck .toc.link a {font-size: 17px !important;line-height: 19px !important;margin: 0;padding: 10px 30px;white-space: nowrap}.submenu.stuck .toc.link a:after {display: none}.submenu.stuck .toc.link a:hover {text-decoration: none}/* .submenu.stuck .toc.link li.active a {display: block;color: #232323;top: 0;right: 0;position: absolute;background: none;} *//* .submenu.stuck .toc.link li.active:after {font-family: 'icomoon';content: "\e605";font-size: 22px;position: absolute;right: 0;top: 14px;z-index: -1;transform: rotate(90deg)} */.submenu.stuck li.active {display: block;background: #2196f3;border-radius: 10px;}.submenu.stuck li.active a {color: white;}.submenu.stuck li {display: none;}.submenu.stuck ul:hover li {display: block;}/* .submenu.stuck .toc.link .select:before {content: '';width: 100%;height: 50px;display: block;border-bottom: 2px solid #eee} *//* .submenu.stuck .toc.link a.option {display: block;padding: 15px 20px;background: #fff;box-shadow: inset 0px -1px 3px -1px #ccc;transition: all 250ms}.submenu.stuck .toc.link a.option:hover {color: #232323;} *//*** Article (right column) ***/aside {width: 310px}aside .sideBox {padding: 20px 0;z-index: 0;position: relative}aside .sideBox.promo {padding-top: 0}aside .dialog-activator:after{content:'Tools';font-weight: 700;    font-size:24px;line-height: 140%;color: #333333;text-align: center;display: flex;justify-content: center;}aside .sideBox.promo a {text-decoration: none;}aside .sideBox.promo .rrpromo:hover{background:#000;border-radius:3px;}aside .sideBox.promo .rrpromo {border-bottom: 1px solid #E3E6E8;}aside .sideBox.promo .rrpromo .icon-arrow-right2{   display: none;}aside .sideBox.promo .rrpromo p {font-size: 14px;line-height: 21px;font-weight: 700;margin: 16px 0 14px 5px;color: #2196F3;}aside .sideBox.promo .rrpromo span[class^="icon-"] {font-size: 25px;color: #2196F3;padding: 8px;margin: 1px 5px 1px 0;float: right;transition: all 250ms}aside .sideBox.promo .rrpromo span[class^="icon-arrow"] {background: none !important;color: #232323;font-size: 35px;float: right;margin: 0;padding: 0}aside .sideBox.promo .rrpromo span {font-size: 12px;color: #777777;display: inline-block;font-weight:400;line-height:18px;}aside .sideBox.slide h2,aside .featured_slideshow h3 {background: #777777;color: #fff;font-size: 16px;padding: 6px;margin: 0;text-align: center;text-decoration: none !important}aside .sideBox.slide .owl-carousel {width: 310px;min-height: 250px;display: inline-block;margin: 0 auto}aside .sideBox.slide .wrapper {text-align: center;background: #000;background: rgba(0, 0, 0, .3);position: absolute;top: 166px;height: 40px;display: table;width: 100%;transition: all 250ms;z-index: 1}aside .sideBox.slide .wrapper span {vertical-align: middle;padding: 11px 45px;color: #fff;width: 190px;white-space: nowrap;overflow: hidden;text-overflow: ellipsis;display: inline-block;font-size: 14px}aside .sideBox.slide .item img {height: 210px}aside .sideBox.slide .item p {font-size: 14px;font-style: italic;line-height: 17px;margin: 6px}aside .sideBox.slide .owl-nav [class*='owl-'] {color: #fff;font-size: 45px;opacity: 0.5;position: absolute;top: 158px}aside .sideBox.slide .owl-nav [class*='owl-']:hover {opacity: 1}aside .sideBox.slide .owl-nav .owl-prev {left: 0}aside .sideBox.slide .owl-nav .owl-next {right: 0}aside .sideBox.reviews {border-left: 5px solid #568a10;background: #e8f7b8;margin: 20px 0;padding: 0}aside .sideBox.reviews a {text-decoration: none;color: #568a10;font-weight: 600;font-size: 18px;text-transform: uppercase;padding: 16px 10px;width: calc(100% - 20px);display: inline-block;transition: all 250ms}aside .sideBox.reviews a:hover {color: #e8f7b8;background: #568a10}aside #rightAd_rdr {width: 310px;margin: 20px auto}aside .featured_slideshow {padding: 20px 0}aside .featured_slideshow .content {padding: 0;list-style: none}aside .featured_slideshow .content li {border-top: 1px solid #ccc;padding: 10px 0}aside .featured_slideshow .content li:first-child {border: none;padding-top: 0}aside .featured_slideshow .content img {width: 79px;height: 79px;float: left;transition: opacity 400ms}aside .featured_slideshow .content p {color: #777777;display: inline-block;width: calc(100% - 90px);height: 73px;margin: 6px 0 0 10px;font-size: 16px;line-height: 18px}aside .featured_slideshow .content p span {display: block;font-size: 13px;line-height: 15px;color: #777777;padding-top: 8px}aside .featured_slideshow .content li:hover * {color: #2196f3;cursor: pointer}aside #rightAd_rdr.sidebox:after {display: none}aside .sideBox ul {padding: 0;list-style-type: none;display: inline;}aside .sideBox ul li {display: inline;}aside .sideBox ul li a:after {content: ", ";}aside .sideBox ul li a:last-child:after {content: ""}/*** Article (lite TOC $ vitTOC) ***/.apPage .toc_lite, .vitTOC{background-color: #F1F8FC;padding:10px;}.apPage .toc_lite .owl-carousel,.vitTOC {margin: 0px !important;list-style: none;display: inline-block;column-count: 1 !important;padding:0px;}.apPage .toc_lite .owl-carousel>li,.vitTOC>li {padding: 0 !important;float: left}.apPage .toc_lite .owl-carousel>li>a,.vitTOC>li>a {font-size: 18px;line-height: 22px;padding: 8px 12px;margin: 0 10px;border-radius: 5px;display: inline-block;position: relative}.apPage .toc_lite .owl-carousel>li>a:hover,.apPage .toc_lite .owl-carousel .open,.vitTOC>li>a:hover {background: #2196f3;color: #fff;text-decoration: none}.apPage .toc_lite .owl-carousel>li>a:after,.vitTOC>li>a:after {content: " | ";color: #aaa;position: absolute;right: -13px}.apPage .toc_lite .owl-carousel>li:last-child a:after,.vitTOC>li:last-child a:after {display: none}.apPage .toc_lite .sub {display: none;border: 2px solid #2196f3;border-radius: 0 0 5px 5px;list-style: none;margin: -5px 0 0 10px;padding: 3px;width: auto;max-width: 26vw;background: #fff;position: absolute;z-index: 1}.apPage .toc_lite .sub li {padding: 0 !important;line-height: 22px !important}.apPage .toc_lite .sub li a {color: #232323;font-weight: 400;padding: 4px 0;display: block}.apPage .toc_lite .sub li span[class^="icon-"] {color: #f7941d;background: #fff;position: absolute;left: 10px;margin-top: 12px}/*** Article (interval) ***/.mediaPrmo {border-radius: 10px;height: 300px;max-width: 800px;margin: 50px auto;display: block;position: relative;clear: both;background: #999;transition: all 250ms;}.mediaPrmo {border-radius: 10px;height: 300px;max-width: 800px;margin: 50px auto;display: block;position: relative;clear: both;background: #999;transition: all 250ms}.mediaPrmo img {border-radius: 10px;object-fit: cover;width: 45%;height: 300px;position: absolute;transition: all 250ms}.mediaPrmo .skew {position: absolute;left: 38%;width: 150px;height: 300px;background: #999;transform: skew(-10deg);transition: all 250ms}.mediaPrmo [class^="icon-"] {position: absolute;right: 10px;top: 10px;color: #fff;opacity: .8;transition: all 250ms}.mediaPrmo .label,.mediaPrmo .caption,.mediaPrmo .desc,.mediaPrmo .btn {display: block;color: #fff;margin: 25px 20px 25px 45%;text-align: center;position: relative;transition: all 250ms}.mediaPrmo .label {font-size: 15px;padding-top: 30px}.mediaPrmo .label:before,.mediaPrmo .label:after {content: "";border: .5px solid #fff;width: 20px;margin: 5px 10px;display: inline-block}.mediaPrmo .caption {font-size: 20px;font-weight: 600;line-height: 24px}.mediaPrmo .desc {font-size: 14px}.mediaPrmo .btn {color: #777777;padding: 10px;font-weight: 600;border-radius: 5px;background: #fff;transition: all 250ms}.mediaPrmo:hover {text-decoration: none !important;background: #eee}.mediaPrmo:hover img {width: 33%;filter: grayscale(100%)}.mediaPrmo:hover .skew {background: #eee;left: 25%}.mediaPrmo:hover [class^="icon-"] {color: #232323;}.mediaPrmo:hover .label,.mediaPrmo:hover .caption,.mediaPrmo:hover .desc,.mediaPrmo:hover .btn {margin-left: 30%;color: #232323;}.mediaPrmo:hover .label:before,.mediaPrmo:hover .label:after {border-color: #000}.mediaPrmo:hover .btn {background: #000;color: #fff}.article-promo {margin: 50px 0;padding: 20px 0;border: 0 solid #f2f2f2;border-width: 5px 0;text-align: center}.article-promo .item {padding: 0 15px;width: calc(33% - 30px);max-width: 150px;height: 230px;display: inline-table}.article-promo a img {width: 100%;max-width: 150px;transition: opacity 250ms}.article-promo a span {font-size: 14px;font-weight: 600;color: #232323;margin: 20px 0;text-align: left;width: 100%;display: inline-block}.article-promo .icon-slideshow:before {content: 'SLIDESHOW'}.article-promo .icon-quiz:before {content: 'QUIZ'}.article-promo .icon-image:before {content: 'IMAGE'}.article-promo a p {font-size: 14px;margin-top: -10px;line-height: 16px !important;text-align: left}.article-promo a:hover img {opacity: .6}.pgContent .learn_more_zomig {background: #f7941d;color: #fff;font-size: 16px;padding: 5px 55px 5px 15px;border-radius: 3px;margin-top: 15px;display: inline-block;position: relative;transition: background 250ms}.pgContent .learn_more_zomig span {font-weight: 600;font-size: 18px}.pgContent .learn_more_zomig .icon-arrow-right2 {position: absolute;right: 0;top: 0;border-left: 1px solid rgba(255, 255, 255, 0.30)}.pgContent .learn_more_zomig .icon-arrow-right2:before {border-left: 1px solid rgba(0, 0, 0, 0.15);font-size: 38px}.pgContent .learn_more_zomig:hover {text-decoration: none;background: #000}#crsprm-2081-assmnt {max-width: 748px;border-color: #eee;border-style: solid;border-width: 5px 0;clear: both;margin: 50px auto;overflow: hidden;padding: 18px 0}#crsprm-2081-assmnt .cross-promo__hero {float: left;margin-right: 40px}#crsprm-2081-assmnt .cross-promo__content {padding-top: 10px}#crsprm-2081-assmnt .cross-promo__subheading {color: #3a6d69;font-size: 12px;font-weight: 600;text-transform: uppercase}#crsprm-2081-assmnt .cross-promo__subheading img.logoTitle {margin: 6px 0 10px 5px}#crsprm-2081-assmnt a:hover {text-decoration: none}#crsprm-2081-assmnt .cross-promo__heading {color: #232323;font-size: 30px;font-weight: 600;line-height: 32px;margin-bottom: 20px}#crsprm-2081-assmnt .cross-promo__cta {color:#232323;font-size: 17px}#crsprm-2081-assmnt .cross-promo__cta::after {content: '';display: inline-block;width: 30px;height: 30px;margin: 0 0 -5px 8px;vertical-align: bottom;background-image: url(https://images.medicinenet.com/images/ads/btn-blue-arrow.png)}.webmd_lab_ad {margin: 40px 0}.webmd_lab_testing {border: 1px solid #eee;margin: 0 auto;background: #fafeff;padding: 0 40px;max-width: 550px}.webmd_lab_testing h4 {font-size: 26px;color: #232323;line-height: 28px;margin: 30px 0 -5px 0}.webmd_lab_testing p {color: #777777;line-height: 18px !important}.webmd_lab_testing .webmd_lab_testing_btn {background: #f26522;width: 300px;border-radius: 3px;padding: 6px;color: #fff;text-align: center;font-size: 18px}.webmd_lab_testing a:hover {text-decoration: none !important}.webmd_lab_testing span.icon-arrow-right2:before {position: absolute;font-size: 29px}.webmd_lab_testing .webmd_lab_logo {font-size: 10px;color: #aaa;margin: 25px 0}.webmd_lab_ad:after {content: '';background: url(https://images.medicinenet.com/images/ads/rightad_toptransparent.gif) no-repeat center 0;height: 10px;display: block}.webmdrx_coup .webmdrx p {text-align: left;padding-right: 100px;width: 140px;white-space: nowrap;overflow: hidden;text-overflow: ellipsis;position: relative}.webmdrx_coup .webmdrx .webmdrx_img {position: absolute;right: 0}.webmdrx_coup h3 {margin: 5px 0;font-size: 14px;line-height: 16px;text-decoration: none !important}.webmdrx_coup .wrapper {margin: 10px 0;padding: 10px 10px 20px;box-shadow: 0 0 4px 0 #ddd;max-width: 600px;position: relative}.webmdrx_coup .wrapper img {width: 40px;padding: 0 20px 2px}.webmdrx_coup .wrapper .pharmName {position: absolute;font-size: 10px;text-align: center;width: 80px;white-space: nowrap;overflow: hidden;text-overflow: ellipsis}.webmdrx_coup .wrapper .reg {position: absolute;top: 20px;left: 20%;color: #777777;font-size: 13px}.webmdrx_coup .wrapper .reg span {text-decoration: line-through}.webmdrx_coup .wrapper .reg p {margin: 0}.webmdrx_coup .wrapper .cou {position: absolute;top: 17px;left: 45%}.webmdrx_coup .wrapper .cou span {font-size: 15px;font-weight: 600}.webmdrx_coup .wrapper .cou p {margin: -3px 0;font-size: 13px;color: #777777;}.webmdrx_coup .wrapper a {position: absolute;top: 18px;right: 5%;color: #fff !important;font-size: 14px;font-weight: 600;background: #02c96a;padding: 8px 25px;transition: all 250ms}.webmdrx_coup .wrapper a:hover {text-decoration: none !important;background: #000}/*** Article (landing) ***/#Drugs_AZlist ul,.quizAtoZ,.sc_az ul {padding: 0;display: inline-block}#Drugs_AZlist ul li,.quizAtoZ li,.sc_az li {list-style: none;padding: 0;margin: 6px;float: left}#Drugs_AZlist li a,.quizAtoZ li a,.sc_az li a {text-decoration: none;display: inline-block;padding: 10px;color: #6896da;font-size: 24px;font-weight: 600;line-height: 30px;border-radius: 3px;width: 30px;height: 30px;text-align: center;background: #f5f5f5;transition: all 250ms}#Drugs_AZlist li a:hover,.quizAtoZ li a:hover,.sc_az li a:hover {background: #000;color: #fff;text-decoration: none}.Rxl_landing_DC,.Rxl_landing_feat,.sc_common_ss {margin: 50px 0;clear: both}.Rxl_landing_DC ul,.sc_common_ss ul,.sc_popular_sym ul {margin: 0;font-size: 18px}.Rxl_landing_feat img {margin-right: 20px}.Rxl_landing_feat .feat_quiz {text-decoration: underline}#Drugs_AZlist .roundtop {padding: 20px 0;text-transform: uppercase;font-size: 19px;font-weight: 600;text-decoration: underline}.contentstyle h4,.AZ_results h4 {font-size: 20px;margin: 20px 0}.contentstyle h4 a,.AZ_results h4 a {margin: 4px 2px;padding: 5px 15px;border-radius: 20px;background: #f5f5f5;display: inline-block;transition: all 250ms}.contentstyle h4 a:hover,.AZ_results h4 a:hover {background: #000;color: #fff;text-decoration: none}.contentstyle h5,.AZ_results h5 {background: #6896DA;margin: 30px 0 0 0;padding: 5px 10px;color: #6896DA}.contentstyle h5 a,.AZ_results h5 a {color: #fff;font-size: 24px;cursor: default;pointer-events: none}.contentstyle ul,.AZ_results ul {list-style-type: none;margin: 0;padding: 0;display: block !important}.contentstyle li,.AZ_results li,.drugChecker_Page .drug_A-Z_list li {padding: 0 !important;position: relative}.contentstyle li a,.AZ_results li a,.drugChecker_Page .drug_A-Z_list li a {padding: 10px !important;font-size: 16px;display: block;transition: all 250ms}.contentstyle li:nth-child(even) *,.AZ_results li:nth-child(even) *,.drugChecker_Page .drug_A-Z_list li:nth-child(even) * {background: #f5f5f5}.contentstyle li:hover *,.AZ_results li:hover *,.drugChecker_Page .drug_A-Z_list li:hover * {background: #000 !important;color: #fff;text-decoration: none !important}.contentstyle li span,.AZ_results li span {position: absolute;right: 10px;top: 13px;font-size: 14px;background: #fff;transition: all 250ms}#imageCategories:first-child a {border: none}#imageCategories a {text-decoration: none;padding: 20px 0;min-height: 180px;display: inline-block;border-top: 1px solid #eee}#imageCategories img {width: auto;position: absolute;transition: all 250ms}#imageCategories h4 {color: #232323;margin: 10px 0 10px 200px;font-size: 20px;line-height: 22px;transition: color 250ms}#imageCategories p {font-size: 16px;line-height: 22px;color: #777777;margin: 10px 0 10px 200px;display: inline-block;transition: color 250ms}#imageCategories a:hover * {color: #2196f3}#imageCategories a:hover img {filter: grayscale(100%)}.quizLinks_fmt {margin: 30px 0}.quizLinks_fmt .alpha {color: #fff;font-weight: 600;background: #6896da;font-size: 24px;padding: 8px 20px;margin-top: 30px;position: relative}.quizLinks_fmt .alpha .top {visibility: hidden}.quizLinks_fmt .alpha .top:after {content: "\e605";font-family: 'icomoon' !important;font-size: 40px;color: #fff;padding: 0 10px;position: absolute;right: 0;top: -6px;visibility: visible;transform: rotate(-90deg)}.quizLinks_fmt .alpha .top:hover:after {color: #aac7f3}.quizLinks_fmt .quizLink_fmt {padding: 20px;min-height: 79px;width: calc(100% - 40px);display: inline-block;transition: all 250ms}.quizLinks_fmt .quizLink_fmt:nth-child(odd) {background: #f5f5f5}.quizLinks_fmt .quizLink_fmt img {border-radius: 3px;position: absolute}.quizLinks_fmt .quizLink_fmt h3 {margin: 0 0 0 90px;color: #2196f3;line-height: 20px;text-decoration: none;text-transform: capitalize;transition: all 250ms}.quizLinks_fmt .quizLink_fmt p {color: #232323;margin: 10px 0 0 90px;font-size: 14px;line-height: 18px;transition: all 250ms}.quizLinks_fmt .quizLink_fmt:hover {background: #000;text-decoration: none}.quizLinks_fmt .quizLink_fmt:hover * {color: #fff}#accordion h3 {margin: 5px 0;text-decoration: none}#accordion h3 a {color: #fff;background: #6896da;font-size: 20px;line-height: 26px;padding: 10px 60px 10px 15px;text-transform: capitalize;display: block;text-decoration: none;position: relative;transition: all 250ms}#accordion h3 a:after {content: "\e605";font-family: 'icomoon' !important;font-size: 40px;padding: 0 10px;position: absolute;top: 50%;right: 0;transform: translateY(-50%) rotate(90deg)}#accordion h3 a:hover {background: #000}#accordion .fold {display: none;position: relative}#accordion h3:first-child+.fold {display: block}#accordion .fold ul {list-style: none;padding: 0;display: block;column-count: 2}#accordion .fold ul li {padding: 0}#accordion .fold a {padding: 20px;height: 260px;width: calc(100% - 40px);max-width: 200px;text-align: center;display: inline-block;transition: background 250ms}#accordion .fold a img {border-radius: 3px}#accordion .fold a h4 {color: #232323;font-size: 20px;line-height: 22px;text-align: left;margin: 20px 0 10px;transition: color 250ms}#accordion .fold a p {color: #232323;font-size: 16px;line-height: 20px;text-align: left;margin: 0;transition: color 250ms}#accordion .fold a:hover {text-decoration: none;background: #000 !important}#accordion .fold a:hover * {color: #fff}#centering_area .breadcrumb {margin: 30px auto 0;font-size: 14px;width: 1100px}#centering_area .breadcrumb a:after {font-family: 'icomoon';content: "\e605";padding-left: 4px;display: inline-block;vertical-align: middle;color: #232323;}#symptom_checker {width: 1100px;margin: 0 auto}#symptom_checker .sc_content_well {margin: 50px 0}#symptom_checker .sc_content_well h3 {text-decoration: underline;text-transform: uppercase}#symptom_checker .sc_common_ss ul li,#symptom_checker .sc_popular_sym ul li {padding: 5px 0}#symptom_checker .sc_common_ss ul li a,#symptom_checker .sc_popular_sym ul li a {color: #2196f3;text-decoration: none;cursor: pointer}#symptom_checker .sc_common_ss ul li a:hover,#symptom_checker .sc_popular_sym ul li a:hover {text-decoration: underline}#centering_area .medianet,#centering_area .from_webmd {width: 1100px}#search {max-width: 1265px;margin: 0 auto;padding: 0 20px;grid-template-columns: 0 auto 350px}#search .story {margin: 0;padding: 0 20px 30px 20px;width:100%;max-width: 1400px;}#search .breadcrumbs {display: none}#search .story article {padding: 25px 0}#search .searchresults {width: auto;padding: 0;text-align: left;position: relative;margin: 70px 0}#search .searchresults.main {margin-top: 30px}#search .searchresults h3 {color: #fff;font-size: 20px;background: #6896da;text-decoration: none !important;padding: 5px 10px;margin: 10px 0}#search .searchresults ul {padding: 0;margin: 0;list-style: none;overflow: hidden;display: block !important}#search .searchresults li {padding: 0 !important;border-top: 1px solid #eee}#search .searchresults li:first-child {border: none}#search .searchresults li a {font-weight: 600;font-size: 18px;line-height: 22px;padding: 15px;display: block;transition: all 250ms}#search .searchresults li img {margin-right: 15px;float: left}#search .searchresults li .brand {font-size: 18px;color: #2196f3;font-weight: 600;line-height: 22px}#search .searchresults li .generic {color: #232323;font-size: 15px;font-weight: 400;line-height: 19px}#search .searchresults li span {font-size: 12px;color: #777777;line-height: 14px;display: block;transition: all 250ms}#search .searchresults li p {font-size: 14px;color: #232323;line-height: 18px;font-style: italic;transition: all 250ms}#search .searchresults li a:hover {background: #000;color: #fff;text-decoration: none}#search .searchresults li a:hover * {color: #fff}#search .searchresults .gradient,#ForumCenter_fmt .sideBox[class$=List] .gradient {width: 100%;height: 30px;position: absolute;bottom: 0;background: -moz-linear-gradient(top, rgba(255, 255, 255, 0) 0%, rgba(255, 255, 255, 0) 1%, rgba(255, 255, 255, 1) 100%);background: -webkit-linear-gradient(top, rgba(255, 255, 255, 0) 0%, rgba(255, 255, 255, 0) 1%, rgba(255, 255, 255, 1) 100%);background: linear-gradient(to bottom, rgba(255, 255, 255, 0) 0%, rgba(255, 255, 255, 0) 1%, rgba(255, 255, 255, 1) 100%);filter: progid:DXImageTransform.Microsoft.gradient(startColorstr='#00ffffff', endColorstr='#ffffff', GradientType=0)}#search .searchresults .more,#ForumCenter_fmt .sideBox[class$=List] .more {border-top: 1px solid #DCDCDC;position: relative}#search .searchresults .more span,#ForumCenter_fmt .sideBox[class$=List] .more span {border: 1px solid #dcdcdc;border-radius: 3px;border-top: 1px solid #fff;padding: 3px 20px;margin-top: -1px;position: absolute;top: 50%;left: calc(50% - 42px);cursor: pointer;font-size: 40px;line-height: 20px;color: #2196f3;-webkit-transition: color 200ms;transition: color 200ms}#search .searchresults .more span:before,#ForumCenter_fmt .sideBox[class$=List] .more span:before {transform: rotate(90deg);display: block}#search .searchresults .more span:hover,#ForumCenter_fmt .sideBox[class$=List] .more span:hover {color: #ccc;background: #fff;background: -moz-linear-gradient(top, #fff 0%, #eee 100%);background: -webkit-linear-gradient(top, #fff 0%, #eee 100%);background: linear-gradient(to bottom, #fff 0%, #eee 100%);filter: progid:DXImageTransform.Microsoft.gradient(startColorstr='#fff', endColorstr='#eee', GradientType=0)}#search .searchresults .more span.active:before,#ForumCenter_fmt .sideBox[class$=List] .more span.active:before {transform: rotate(-90deg)}#search #noresult {margin: 50px 0}/*** Article (user reviews) ***/.pgContent .related .relMono {font-size: 22px}#patientComments_fmt {padding: 30px;margin: 30px 0;background: #f5f5f5;border: 1px solid #d9d9d9;border-radius: 5px;position: relative}#patientComments_fmt:before,#patientComments_fmt:after {content: "";position: absolute;width: 0;height: 0;border-style: solid;border-color: transparent;border-top: 0}#patientComments_fmt:before {top: -8px;left: 25px;border-bottom-color: #D9D9D9;border-width: 8px}#patientComments_fmt:after {top: -7px;left: 26px;border-bottom-color: #f5f5f5;border-width: 7px}#patientComments_fmt .commentTop {font-style: italic}#patientComments_fmt .patComment {padding: 40px 20px;position: relative}#patientComments_fmt .patComment:before {content: open-quote;font-size: 100px;position: absolute;color: #e4e4e4;margin: -55px 0 0 -35px}#patientComments_fmt .patComment:after {content: close-quote;font-size: 100px;position: absolute;color: #e4e4e4;margin: -55px -15px 0 0;right: 0}#patientComments_fmt .suggReading a {text-transform: capitalize}/*** Article (FAQ) ***/#faqContent #faq-top,#faqContent h2 {display: none}#faqContent .faq-reviewed p {font-size: 14px;line-height: 16px}#faqContent #faqPromo {margin: 20px 0;padding: 20px;border: 1px solid #dedede;border-radius: 10px}#faqContent #faqPromo .faqContImg img {margin-right: 8px;float: left}#faqContent #faqPromo .faqContTitle {font-size: 16px;font-weight: 600;display: block}#faqContent #faqPromo .faqContTag {font-size: 13px;margin: 10px 0;display: block}#faqContent .faqAnswers img {width: 100%;height: auto;border-radius: 5px;max-width: 800px;margin: 10px auto;display: block}#faqContent .faqAnswers img.spec {max-width: 180px}#faqContent .faqAnswers .q,#faqContent .faqAnswers .a {font-size: 22px;font-weight: 600;color: #6896DA;padding-right: 5px}#faqContent .faqAnswers .ques {font-size: 22px;font-style: italic;line-height: 24px}#faqContent .faqAnswers .faqHead+p {padding: 20px;margin: 15px 0;background: #f5f5f5;border: 1px solid #d9d9d9;border-radius: 3px;position: relative}#faqContent .faqAnswers .faqHead+p:before,#faqContent .faqAnswers .faqHead+p:after {content: "";position: absolute;width: 0;height: 0;border-style: solid;border-color: transparent;border-top: 0}#faqContent .faqAnswers .faqHead+p:before {top: -8px;left: 25px;border-bottom-color: #D9D9D9;border-width: 8px}#faqContent .faqAnswers .faqHead+p:after {top: -7px;left: 26px;border-bottom-color: #f5f5f5;border-width: 7px}#faqContent .faqAnswers .backToTop {font-size: 15px;text-align: right;margin: -10px 0 40px 0;display: block}#faqContent .faq-source {border-top: 1px solid #ccc;font-size: 14px;font-style: italic;line-height: 16px;margin: 40px 0;padding: 10px 0;display: block}#faqContent .starCont .faqHead {font-size: 18px;text-decoration: underline;text-transform: uppercase}/*** Article (secondary) ***/.rxlsecondary .toc,.RXLSyndicated .toc {position: relative;border-bottom: 1px solid #ccc;margin: 20px 0}.rxlsecondary .toc ul li,.RXLSyndicated .toc ul li {list-style: none}.rxlsecondary .toc ul li:before,.RXLSyndicated .toc ul li:before {font-family: 'icomoon';content: "\e909";font-size: 15px;vertical-align: text-bottom;position: absolute;left: 12px;transition: transform 250ms}.rxlsecondary .toc ul li a,.RXLSyndicated .toc ul li a {color: #2196f3;text-decoration: none}.rxlsecondary .toc ul li:hover,.RXLSyndicated .toc ul li:hover {cursor: pointer}.rxlsecondary .toc ul li:hover a,.RXLSyndicated .toc ul li:hover a {text-decoration: underline}.rxlsecondary .toc ul li:hover:before,.RXLSyndicated .toc ul li:hover:before {transform: rotate(90deg)}.authEditorWrap {padding: 10px 15%;max-width: 1100px}.authEditorWrap .authEditorCont {list-style: none;font-size: 16px;color: #e0f0ff;line-height: 18px;text-align: center;padding: 4px 0}.authEditorWrap .authEditorCont * {display: inline}.authEditorWrap .authEditorCont a {color: #fff}.authEditorWrap .authEditorCont .magOnOff,.authEditorWrap .authEditorCont .authEditorPopOut {display: none}/*** Article (syndicated) ***/.RXLSyndicated .wrapper h3 {font-size: 26px;line-height: 30px;text-decoration: none}.RXLSyndicated .apPage {clear: both}.RXLSyndicated .wrapper p {line-height: 32px}.RXLSyndicated .wrapper ul {display: block}.RXLSyndicated .wrapper ul li,.RXLSyndicated .wrapper ol li {padding: 8px 0;line-height: 26px}.RXLSyndicated .AP-wrapper {width: 340px;margin: 0 40px 30px 0;float: left}#lrgArtImg {margin: 20px auto;max-width: 650px}#lrgArtImg img {width: 100% !important}#lrgArtImg .lrgArtImgCap {font-size: 13px;color: #777777;line-height: 15px;display: inline-block;padding: 5px 0}.RXLSyndicated .AP-wrapper .slide span {font-size: 12px}.forum_symptom_checker {margin: 50px auto;max-width: 600px}.forum_symptom_checker a {background: #fafafa;border: 5px solid #eee;border-radius: 10px;height: 223px;display: block;transition: all 250ms}.forum_symptom_checker a:hover {border-color: #ddd;background: #fff;text-decoration: none !important}.forum_symptom_checker .sym_image {float: left}.forum_symptom_checker .sym_text {margin: 0 20px 0 165px}.forum_symptom_checker .sym_h3 {font-size: 30px;font-weight: 600;text-decoration: none}.forum_symptom_checker .sym_h3 .green {color: #588527}.forum_symptom_checker .sym_h3 .blue {color: #2196f3}.RXLSyndicated .aia_rdr {width: 420px;float: right;border: 1px solid #ddd;margin: 0 0 20px 20px;clear: both}.RXLSyndicated .aia_title_bar_fmt {background: #5385b5;padding: 8px;text-align: center;color: #fff}.RXLSyndicated .aia_rdr h4 {margin: 0;font-size: 18px}.RXLSyndicated .aia_content_fmt {font-size: 15px;padding: 0 15px}.RXLSyndicated .aia_rdr li {padding: 10px 0;line-height: 17px}.separator {display: none}.article-extra .thumbnails h3,#ForumCenter_fmt .sideBox h3 {font-size: 24px}.article-extra .thumbnails ul {padding: 0;margin: 0;display: block}.article-extra .thumbnails .relCondImageQuizContent li,.article-extra .thumbnails .mainart li {padding: 0 !important;list-style: none}.article-extra .thumbnails .relCondImageQuizContent li:nth-child(even),.article-extra .thumbnails .mainart li:nth-child(even) {background: #f5f5f5}.article-extra .thumbnails .relCondImageQuizContent li a,.article-extra .thumbnails .mainart li a {padding: 14px;min-height: 79px;width: calc(100% - 28px);transition: all 250ms;display: inline-block;color: #777777;}.article-extra .thumbnails .relCondImageQuizContent li img,.article-extra .thumbnails .mainart li img {border-radius: 3px;float: left;margin-right: 15px}.article-extra .thumbnails .relCondImageQuizContent li h2,.article-extra .thumbnails .mainart li h2 {margin: 0 0 0 90px;font-size: 18px;line-height: 20px;color: #2196f3}.article-extra .thumbnails .relCondImageQuizContent li p,.article-extra .thumbnails .mainart li p {margin: 10px 0 0 90px;font-size: 16px;line-height: 18px !important}.article-extra .thumbnails .relCondImageQuizContent li a:hover,.article-extra .thumbnails .mainart li a:hover {color: #fff;background: #2196f3;text-decoration: none}.article-extra .thumbnails .relCondImageQuizContent li a:hover h2,.article-extra .thumbnails .mainart li a:hover h2 {color: #fff}.article-extra .thumbnails .Tab_Items ul {padding-left: 30px}#A_Z ul {justify-content: left;text-align: center}/*** Article (ForumCenter) ***/#ForumCenter_fmt .sideBox[class$=List] {margin-bottom: 50px}#ForumCenter_fmt .sideBox[class$=List] .wrapper {margin: 0;position: relative;overflow: hidden}#ForumCenter_fmt .sideBox[class$=List] .wrapper ul {margin: 0;padding: 0;list-style: none;display: block}#ForumCenter_fmt .sideBox[class$=List] .wrapper ul li {padding: 0}#ForumCenter_fmt .sideBox[class$=List] .wrapper ul li:nth-child(even) {background: #f5f5f5}#ForumCenter_fmt .sideBox[class$=List] .wrapper ul li:last-child {margin-bottom: 20px}#ForumCenter_fmt .sideBox[class$=List] .wrapper ul li a {padding: 20px;min-height: 79px;width: calc(100% - 40px);display: inline-block;transition: all 250ms}#ForumCenter_fmt .sideBox[class$=List] .wrapper ul li a:hover {color: #fff;background: #2196f3;text-decoration: none}#ForumCenter_fmt .sideBox[class$=List] .wrapper ul li a:hover p {color: #fff}#ForumCenter_fmt .sideBox[class$=List] .wrapper ul li a img {border-radius: 3px;position: absolute}#ForumCenter_fmt .sideBox[class$=List] .wrapper ul li a h2 {margin: 0 0 0 100px;font-size: 18px;line-height: 18px}#ForumCenter_fmt .sideBox[class$=List] .wrapper ul li a p {color: #232323;margin: 10px 0 0 100px;font-size: 15px;line-height: 18px;transition: all 250ms}#ForumCenter_fmt .sideBox[class$=List] .more span:before {content: "\e605"}/*** Slideshows ***/.slideshow #apPage:before {content: "";border-top: 4px dotted #ddd;margin: 10% auto;padding-bottom: 25px;display: block;text-align: center;width: 150px}.slideshow #apPage:first-child:before {display: none}.slideshow .apPage {text-align: center}.slideshow .apPage h3 {font-size: 26px;text-decoration: none}.slideshow .apPage img {width: 100%;max-width: 493px;border-radius: 5px}.slideshow .apPage .content {text-align: justify;margin: 25px auto 80px;max-width: 493px}#slideshow_resources {margin: 60px 5%}#slideshow_resources .resources_left {border-top: 1px solid #ccc;border-bottom: 1px solid #ccc;padding: 10px 0}#slideshow_resources .copyright p {float: right;font-size: 13px;line-height: 16px;text-align: right}#slideshow_resources p {margin: 5px 0}#slideshow_resources p a {font-style: italic}#slideshow_resources p a:hover {text-decoration: underline}#slideshow_resources p a:after {font-family: 'icomoon' !important;content: "\e612";font-size: 12px;color: #F26522;padding: 0 4px;vertical-align: middle;font-style: normal;display: inline-block}#slideshow_resources h4,#slideshow_resources p a img {display: none}#slideshow_resources #sources_fmt,#slideshow_resources #disclaimer_fmt {background: #eee;padding: 10px 20px 20px 20px;margin-bottom: 20px;font-size: 13px}#slideshow_resources #sources_fmt .heading {font-weight: 600;margin: 15px 0}#slideshow_resources #sources_fmt p,#slideshow_resources #disclaimer_fmt p {margin: 10px 0}.pageWrapper #headline .author {list-style: none;padding: 0;margin: -10px 0 0 0;font-size: 14px}.pageWrapper #headline .author a {color: #000}.pageWrapper #headline .reviewdate {font-size: 14px}/*** Images ***/.imgcath{    font-size: 50px;    line-height: 54px;    margin:32px 0 0 0;    font-weight: 600;    font-style: normal;    display: inline-block;    font-family: 'Raleway', sans-serif;}.imagecol.content {display: flex;justify-content: space-between}.imagecol .pageWrapper {padding: 40px 0}.imagecol .apPage {text-align: center}.imagecol .apPage h1 {line-height: 28px;margin: 40px auto;font-size: 18px;color: #fff;padding: 5px 10px;background: #000;text-decoration: none;text-transform: none}.imagecol .apPage img {max-width: 493px;width: 100%;margin-bottom: 20px}.imagecol .apPage .content {text-align: justify}.imagecol .apPage .source {text-align: left;font-style: italic}body.imgcol footer,body.imgcol #sponsors {display: none}/*** Quizzes ***/.wrapper-hero.quiz .reviewer {margin: 10px 0}.wrapper-hero.quiz .reviewer a {text-decoration: none;color: #2196f3}.wrapper-hero.quiz .reviewer a:hover {text-decoration: underline}article#quizWrapper {max-width: 800px !important;margin: 0 auto;padding: 0}#quiz-wrapper .instream-ad {text-align: center}#quizWrapper .question {background: #6896DA;margin: 30px 0;width: 100%;border-radius: 5px;display: table}#quizWrapper .question-header {position: absolute}#quizWrapper .question-number {color: #fff;font-size: 16px;font-weight: 600;position: absolute;z-index: 0;padding: 10px}#quizWrapper .question-number i {width: 0;height: 0;border-style: solid;border-width: 70px 70px 0 0;border-color: #000 transparent transparent transparent;position: absolute;left: 0;top: 0;z-index: -1}#quizWrapper .question-message.show {color: #fff;font-size: 20px;font-weight: 600;text-transform: uppercase;background: #ed1c24;width: calc(100vw - 431px);max-width: 736px;padding: 19px 0;border-radius: 0 5px 0 0;text-align: center}#quizWrapper .question img {width: 100%;border-radius: 5px 5px 0 0}#quizWrapper .question-content {padding: 50px 30px 30px 30px;min-height: 380px}#quizWrapper .question-content h2 {font-size: 26px;line-height: 34px;color: #fff;margin: 20px 0 30px 0}#quizWrapper .question-content .answer {margin: 6px 0;background: #fff;cursor: pointer;width: 100%;min-height: 55px;display: table;transition: all 250ms}#quizWrapper .question-content .answer:hover {background: #f26522;color: #fff}#quizWrapper .question-content .answer-letter {background: #000;color: #fff;font-size: 20px;font-weight: 600;padding: 0 20px;vertical-align: middle;width: 15px;display: table-cell}#quizWrapper .question-content .answer-text {font-size: 17px;padding: 10px 15px;vertical-align: middle;display: table-cell}#quizWrapper .question-content .image-type {border: 5px solid #000;background: #000;color: #fff;width: calc(100% - 10px)}#quizWrapper .question-content .image-type img {border-radius: 0}#quizWrapper .question-content .image-type .answer-text {text-align: center;padding: 10px 15px;display: block}#quizWrapper .question-content .image-type:hover {border: 5px solid #f26522}#quizWrapper .question-content .correct,#quizWrapper .question-content .correct:hover {background: #dff0d8;color: #598527;cursor: auto}#quizWrapper .question-content .correct .answer-letter {background: #598527}#quizWrapper .question-content .correct:after {font-family: 'icomoon' !important;content: "\e628";font-size: 20px;color: #63bf71;vertical-align: middle;text-align: center;width: 55px;display: table-cell}#quizWrapper .question-content .incorrect,#quizWrapper .question-content .incorrect:hover {background: #f2dede;color: #a94442;cursor: auto}#quizWrapper .question-content .incorrect .answer-letter {background: #9e0b0f}#quizWrapper .question-content .incorrect:after {font-family: 'icomoon' !important;content: "\e629";font-size: 20px;color: #ff6363;vertical-align: middle;text-align: center;width: 55px;display: table-cell}#quizWrapper .question-content .image-type.correct {border-color: #598527;background: #598527;color: #fff}#quizWrapper .question-content .image-type.incorrect {border-color: #9e0b0f;background: #9e0b0f;color: #fff}#quizWrapper .question-content .explanation.hide {visibility: hidden;display: block}#quizWrapper .question-content .explanation.show {visibility: visible;background: #fff;margin-top: -6px}#quizWrapper .question-content .explanation-heading {font-weight: 600;padding: 20px}#quizWrapper .question-content .explanation-correct-answer {display: block;color: #598527;font-size: 150%}#quizWrapper .question-content .explanation-content {padding: 20px;border-top: 1px solid #ddd}#quizWrapper .question-content .explanation-content>span {font-weight: 600}#quizWrapper .question-content .notselected,#quizWrapper .question-content .image-type.correct:after,#quizWrapper .question-content .image-type.incorrect:after {display: none}#quizWrapper .question .question-next-button {visibility: hidden;color: #fff;border: 1px solid rgba(255, 255, 255, 0.5);padding: 10px 0;margin: 0 40% 30px 40%;font-size: 16px;text-transform: capitalize;text-align: center;display: block;border-radius: 5px;cursor: pointer;transition: background 250ms}#quizWrapper .question.answered .question-next-button.show {visibility: visible}#quizWrapper .question.answered .question-next-button:hover {background: rgba(255, 255, 255, 0.2)}#quizWrapper .quiz-check-button {background: #f26522;color: #fff;font-size: 24px;text-transform: uppercase;text-align: right;border-radius: 5px;padding: 20px 60px;position: relative;cursor: pointer;transition: background 250ms}#quizWrapper .quiz-check-button:after {font-family: 'icomoon' !important;content: "\e605";font-size: 50px;position: absolute;top: 0}#quizWrapper .quiz-check-button:hover {background: #000}#quizWrapper #quizResources {border-top: 1px solid #ccc;margin: 40px 0;padding: 10px 0;font-size: 14px}#quizWrapper #quizResources p {margin: 5px 0}#quizWrapper #quizResources p a {font-style: italic}#quizWrapper #quizResources p a:hover {text-decoration: underline}#quizWrapper #quizResources p a:after {font-family: 'icomoon' !important;content: "\e612";font-size: 12px;color: #F26522;padding: 0 4px;vertical-align: middle;font-style: normal;display: inline-block}#quizWrapper #quizResources p a img {display: none}#quizWrapper #sources_fmt,#quizWrapper #disclaimer_fmt {background: #eee;padding: 10px 20px 20px 20px;margin-bottom: 20px;font-size: 13px}#quizWrapper #sources_fmt .heading {font-weight: 600;margin: 15px 0}#quizWrapper #sources_fmt p,#quizWrapper #disclaimer_fmt p {margin: 10px 0}#quizWrapper .quiz-status {position: fixed;top: 0;right: 0;left: 0;z-index: 999999;background: rgba(80, 114, 165, 0.95);padding: 12px 20px;height: 26px;display: none}#quizWrapper .quiz-status h1 {color: #fff;font-size: 20px !important;line-height: 24px;margin: 0;max-width: calc(100% - 125px);white-space: nowrap;overflow: hidden;text-overflow: ellipsis}#quizWrapper .quiz-status .quiz-progressbar {background: #fbc98e;margin: 14px -20px 0 -20px}#quizWrapper .quiz-status .quiz-progress-indicator {background: #f26522;height: 6px;transition: width 1s}#quizWrapper .quiz-status .quiz-status-right {position: absolute;right: 20px;top: 11px;font-size: 20px;color: #fff;line-height: 25px}#quizWrapper .quiz-status .quiz-correct-num {float: left;margin-right: 10px}#quizWrapper .quiz-status .quiz-incorrect-num {float: right}#quizWrapper .quiz-status .quiz-correct-num:before {font-family: 'icomoon' !important;content: "\e628";font-size: 20px;color: #63bf71;margin: 0 5px;vertical-align: text-bottom}#quizWrapper .quiz-status .quiz-incorrect-num:before {font-family: 'icomoon' !important;content: "\e629";font-size: 20px;color: #ff6363;margin: 0 5px;vertical-align: text-bottom}#quizWrapper .quiz-modal-overlay {background: rgba(0, 0, 0, 0.8);position: fixed;top: 0;left: 0;right: 0;height: 100%;z-index: 999999}#quizWrapper .quiz-modal {background: #fff;width: 60%;border-radius: 3px 3px 0 0;position: absolute;top: 50%;left: 50%;transform: translate(-50%, -50%)}#quizWrapper .quiz-modal-header {background: #f26522;color: #fff;font-size: 20px;font-weight: 600;padding: 13px 20px;border-radius: 3px 3px 0 0;text-align: center;position: relative}#quizWrapper .quiz-modal-header .facebook-like {background: #4267b2;border: 1px solid #4267b2;color: #fff;font-size: 14px;text-decoration: none;border-radius: 5px;padding: 4px 7px 3px 1px;position: absolute;right: 12px;top: 12px}#quizWrapper .quiz-modal-header .facebook-like:before {font-family: 'icomoon' !important;content: "\e608";font-size: 14px;color: #fff;margin: 0 6px;vertical-align: text-bottom}#quizWrapper .quiz-modal-header .facebook-like:hover {background: #000;border: 1px solid #000}#quizWrapper .quiz-modal-content {padding: 40px}#quizWrapper .quiz-modal-content .quiz-modal-message {font-size: 18px}#quizWrapper .quiz-modal-content .quiz-result {border-top: 1px solid #ddd;border-bottom: 1px solid #ddd;margin: 50px 0;padding: 15px 0}#quizWrapper .quiz-modal-content .quiz-result-text {font-size: 18px;font-weight: 600;line-height: 26px}#quizWrapper .quiz-modal-content .quiz-result-text:before {font-family: 'icomoon' !important;content: "\e605";font-size: 20px;font-weight: bold;margin-right: 4px;vertical-align: text-bottom}#quizWrapper .quiz-modal-content .quiz-result-text-bold {color: #f26522}#quizWrapper .quiz-modal-content .quiz-related-text {font-size: 18px;font-weight: 600;padding-bottom: 8px}#quizWrapper .quiz-modal-content .quiz-related a {display: block;line-height: 26px;font-size: 18px}#quizWrapper .quiz-modal-content .quiz-button {background: #4e6d9f;color: #fff;font-size: 18px;font-weight: 600;line-height: 21px;padding: 15px 50px;border-radius: 3px;width: 140px;text-align: center;margin: 50px auto 0 auto;transition: background 250ms}#quizWrapper .quiz-modal-content .quiz-button.startover:before {font-family: 'icomoon' !important;content: "\e630";font-size: 20px;color: #fff;margin-right: 10px;vertical-align: text-bottom}#quizWrapper .quiz-modal-bottom:after {font-family: 'icomoon' !important;content: "\e605";font-size: 40px;color: #fff;position: absolute;right: 10px;bottom: -55px}#quizWrapper .quiz-modal-bottom a {color: #fff;font-size: 18px;background: #6896da;padding: 15px 70px 15px 15px;position: absolute;bottom: -51px;right: 0;left: 0;border-radius: 0 0 3px 3px;text-align: right;white-space: nowrap;overflow: hidden;text-overflow: ellipsis;transition: background 250ms}#quizWrapper .quiz-modal-bottom .next-quiz-bold {font-weight: 600;padding: 0 10px}#quizWrapper .quiz-modal-content .quiz-button:hover,#quizWrapper .quiz-modal-bottom a:hover {text-decoration: none;background: #000;cursor: pointer}@media screen and (-ms-high-contrast: active),screen and (-ms-high-contrast: none) {article#quizWrapper {width: 100%;padding: 0 10%}}/*** Pill Identifier ***/#srch-drug-pillid,.PillId_fmt,#imageSlider,#PillID_fmt .sc-searchbox,.nav-search.sc-searchbox.drug-search {width: calc(100% - 52px);max-width: 600px;margin: 50px auto;border: 1px solid #ccc;padding: 25px;background: #fafafa}#pill_identifier_fmt .frmPillIdentifier-field-fmt {padding: 10px;position: relative}#srch-drug-pillid label,.PillId_fmt .HighlightedMsg {float: left;color: #888;font-size: 16px;font-weight: 600;line-height: 30px}#pill_identifier_fmt .frmPillIdentifier-field-fmt img {float: left;margin: 9px 10px 0 7px}#simprint,#scolor,#sshape {border: 1px solid #ccc;padding: 5px 10px;outline: none;border-radius: 3px}form#frmPillIdentifier #drug-pill-imprints-wrap {position: absolute;left: 177px;top: 39px;z-index: 1}#drug-pill-imprints-suggest {border: 1px solid #ccc;background: #fff;padding: 5px;border-radius: 3px;margin-top: -1px}#drug-pill-imprints-suggest p {margin: 0;padding: 5px 10px}#drug-pill-imprints-suggest .selected p {background: #000;color: #fff;cursor: pointer;border-radius: 3px}#pill_identifier_fmt .overlay,#pill_identifier_fmt .radio-color,#pill_identifier_fmt .jawsonly,#pill_identifier_fmt .shim {display: none}#pill_identifier_fmt #colorSwatch,#pill_identifier_fmt #shapeSwatch {border: 1px solid #ccc;background: #fff;width: 460px;padding: 15px;border-radius: 5px;margin-top: -1px;position: absolute;z-index: 10000}#pill_identifier_fmt .colorContent ul,#pill_identifier_fmt .shapeContent ul {display: block;margin: 0;padding: 0}#pill_identifier_fmt .colorContent li {float: left;background: url(https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/miscellaneous/pill_identifier/pill_id_color_solid_sprite.gif) no-repeat top left;height: 78px;width: 92px;padding: 0;list-style: none}#pill_identifier_fmt li.pc-solid-white {background-position: -1px -2px}#pill_identifier_fmt li.pc-solid-offwhite {background-position: -87px -2px}#pill_identifier_fmt li.pc-solid-clear {background-position: -174px -2px}#pill_identifier_fmt li.pc-solid-black {background-position: -1px -76px}#pill_identifier_fmt li.pc-solid-gray {background-position: -87px -76px}#pill_identifier_fmt li.pc-solid-brown {background-position: -174px -76px}#pill_identifier_fmt li.pc-solid-tan {background-position: -1px -149px}#pill_identifier_fmt li.pc-solid-red {background-position: -87px -149px}#pill_identifier_fmt li.pc-solid-pink {background-position: -174px -149px}#pill_identifier_fmt li.pc-solid-orange {background-position: -1px -220px}#pill_identifier_fmt li.pc-solid-peach {background-position: -87px -220px}#pill_identifier_fmt li.pc-solid-yellow {background-position: -173px -220px}#pill_identifier_fmt li.pc-solid-green {background-position: 0px -293px}#pill_identifier_fmt li.pc-solid-blue {background-position: -87px -293px}#pill_identifier_fmt li.pc-solid-purple {background-position: -173px -293px}#pill_identifier_fmt .pillcolor-solid a {display: block;height: 76px}#pill_identifier_fmt .pillcolor-solid a:hover,#pill_identifier_fmt .pillshape a:hover {background: rgba(0, 114, 188, 0.2);border-radius: 5px}#pill_identifier_fmt .shapeContent li {float: left;background: url(https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/miscellaneous/pill_identifier/pill_id_shape_sprite.gif) no-repeat top left;height: 70px;width: 75px;padding: 0;list-style: none}#pill_identifier_fmt li.ps-circle {background-position: 0px 0px}#pill_identifier_fmt li.ps-oblong {background-position: -78px 0px}#pill_identifier_fmt li.ps-oval {background-position: -155px 0px}#pill_identifier_fmt li.ps-square {background-position: -227px 0px}#pill_identifier_fmt li.ps-rectangle {background-position: -1px -63px}#pill_identifier_fmt li.ps-diamond {background-position: -78px -63px}#pill_identifier_fmt li.ps-triangle {background-position: -153px -63px}#pill_identifier_fmt li.ps-pentagon {background-position: -226px -63px}#pill_identifier_fmt li.ps-hexagon {background-position: -1px -130px}#pill_identifier_fmt li.ps-heptagon {background-position: -80px -130px}#pill_identifier_fmt li.ps-octagon {background-position: -152px -130px}#pill_identifier_fmt li.ps-other {background-position: -226px -130px}#pill_identifier_fmt .pillshape a {display: block;height: 68px}#PillID_fmt .submit_button {background: #6896da;border: 0;outline: 0;color: #fff;text-transform: uppercase;border-radius: 3px;padding: 10px;margin: 30px;width: calc(100% - 60px);transition: all 250ms}#PillID_fmt .submit_button:hover {background: #000}#PillID_fmt .sc-searchbox-input,.nav-search.sc-searchbox.drug-search .sc-searchbox-input {border: 1px solid #ccc;border-right: none;outline: none;border-radius: 3px 0 0 3px}#PillID_fmt .sc-searchbox-input:focus,.nav-search.sc-searchbox.drug-search .sc-searchbox-input:focus {border-color: #000}#PillID_fmt .sc-searchbox-button,.nav-search.sc-searchbox.drug-search .sc-searchbox-button {background: #6896da}#PillID_fmt .sc-searchbox-list {max-width: calc(100% - 50px)}.PillId_fmt .search {border: 1px solid #ccc;padding: 5px 10px;margin-left: 10px;outline: none}#PillID_fmt .PillId_fmt .submit_button {margin-bottom: 10px}#imageSlider {text-align: center;z-index: 0;position: relative}#imageSlider .sliderwrapper {min-height: 355px;position: relative}#imageSlider .contentdiv {position: absolute;top: 50%;left: 50%;transform: translate(-50%, -50%)}#imageSlider .contentdiv h1 {font-size: 20px;line-height: 22px}#imageSlider .contentdiv img {border-radius: 5px}#imageSlider .contentdiv p {font-size: 16px;line-height: 20px}.pagination2 a {background: #ccc;font-size: 18px;color: #fff !important;border-radius: 5px;border: none !important;padding: 5px 14px;margin: 4px 2px !important;display: inline-block;transition: all 250ms}.pagination2 a.selected {background: #6896da}.pagination2 a:hover {text-decoration: none !important;background: #000}.drugSearchResult {padding: 0;margin: 0;list-style: none;width: calc(100vw - 407px)}.drugSearchResult li {padding: 25px !important;margin: 10px 0;background: #fafafa;border: 1px solid #ccc;display: inline-block;width: calc(100% - 50px)}.drugSearchResult .drug_img img {width: auto;height: 125px;border-radius: 5px;transition: 250ms all}.drugSearchResult .drug_img a:hover img {opacity: .8}.drugSearchResult .drug_info .drug_name {margin: 15px 0}.drugSearchResult .drug_info .drug a:hover {text-decoration: underline}.drugSearchResult.fdbdrug {overflow-x: auto;display: inline-flex;min-height: 300px}.drugSearchResult.fdbdrug::-webkit-scrollbar-track {box-shadow: inset 0 0 3px rgba(0, 0, 0, 0.2);background-color: #F5F5F5}.drugSearchResult.fdbdrug::-webkit-scrollbar {height: 15px;background-color: #F5F5F5}.drugSearchResult.fdbdrug::-webkit-scrollbar-thumb {background-color: #000}.drugSearchResult.fdbdrug::-webkit-scrollbar-thumb:hover {background: #2196f3}.drugSearchResult.fdbdrug li {width: 167px;margin: 10px 5px;padding: 15px !important}.drugSearchResult.fdbdrug .drug_info .drug_name {font-size: 12px}h3.drugheader {font-size: 18px;text-align: center;color: #333;text-decoration: none !important;text-transform: capitalize;padding: 5px 10px;margin: 60px 0 25px 0;background: #ddd}/*** Drug Checker ***/.drugChecker_Page ul {margin: 0 0 -3px !important;padding: 0;list-style-type: none}.drugChecker_Page .drug_header img.pillimage {float: right;width: 276px;height: 228px}.drugChecker_Page .drug_header .drugresults.p2 li {position: relative;list-style: none;padding: 10px 0}.drugChecker_Page .drug_header .drugresults.p2 li:before {top: 2px !important}.drugChecker_Page .drug_header .drugresults.p2 li a {margin-left: 40px}.drugChecker_Page .drug_A-Z_list {border-bottom: 1px solid #ccc;padding-bottom: 20px}.drugChecker_Page .drug_A-Z_list h4 {color: #fff;border-bottom: 1px solid #ccc;padding: 40px 0;margin: 0 0 20px}.drugChecker_Page .drug_A-Z_list h4 a {display: inline-block;padding: 10px;margin: 5px 0;color: #6896DA;font-size: 24px;font-weight: 600;line-height: 30px;border-radius: 3px;width: 30px;height: 30px;text-align: center;background: #f5f5f5;transition: all 250ms}.drugChecker_Page .drug_A-Z_list h4 a:hover {background: #000;color: #fff;text-decoration: none}.drugChecker_Page .drug_A-Z_list h4 a.disabled {color: #ddd;pointer-events: none}.drugChecker_Page .drug_A-Z_list h4 a:last-child {font-size: 17px;vertical-align: bottom}.drugChecker_Page #drugNameInput {padding: 30px 0}.drugChecker_Page #drugNameInput h3 {float: left;color: #888;font-size: 16px;margin: 5px 10px 5px 0;text-decoration: none;text-transform: capitalize}.drugChecker_Page #txtAutoComplete {width: 395px;height: 30px}.drugChecker_Page #drugNameOutput {margin: 20px 0;display: none}.drugChecker_Page #drugNameOutput .listresult {border: 1px solid #ccc;border-radius: 10px;padding: 20px}.drugChecker_Page #drugNameOutput .listresult li {font-size: 14px;background: #000;color: #fff;margin: 5px 0;padding: 5px 35px 5px 10px;position: relative}.drugChecker_Page #drugNameOutput .listresult li .remove:before {font-family: 'icomoon';content: "\e624";font-size: 15px;color: #fff;position: absolute;right: 6px;top: 5px}.drugChecker_Page #drugNameOutput .listresult .buttons input {background: #6896da;border: 0;outline: 0;color: #fff;text-transform: uppercase;border-radius: 3px;padding: 10px;margin-right: 5px;transition: all 250ms}.drugChecker_Page #drugNameOutput .listresult .buttons input:hover {background: #000}.drugChecker_Page #foundCount {font-weight: 600;color: #f00;margin: 20px 0;display: block}.drugChecker_Page #resultSevUrl li {margin: 10px 0;line-height: 16px;font-size: 13px}.drugChecker_Page .tabWrap {margin: 20px 0}.drugChecker_Page .tabList li {display: inline-block;margin-right: 3px;padding: 9px 0;z-index: 1;position: relative}.drugChecker_Page .tabList li a {color: #fff;padding: 10px 25px;background: #6896DA;border: 1px solid #6896DA;border-radius: 3px 3px 0 0;transition: all 250ms}.drugChecker_Page .tabList li a:hover {text-decoration: none;background: #000;border-color: #000}.drugChecker_Page .tabList li.active a {color: #232323;background: #fff;border-color: #ccc;border-bottom-color: #fff}.drugChecker_Page .tabContent {border: 1px solid #ccc;margin: -2px 0 40px;padding: 20px;position: relative}.drugChecker_Page .tabContent .sevdesctitle {font-size: 19px;font-weight: 600;margin-left: 40px}.drugChecker_Page .tabContent .sevdesc {display: inline-block;font-size: 15px;line-height: 17px;margin-left: 40px}.drugChecker_Page .tabContent .intsource,.drugChecker_Page .tabContent .intcopyright,.drugChecker_Page .drug_disclaimer {font-size: 13px}.drugChecker_Page .divider {border-top: 1px dotted #ddd;margin: 30px 0}.drugChecker_Page .pillIcon:before,.drugChecker_Page .drug_header .drugresults.p2 ul li:before {font-family: 'icomoon';content: "\e905";font-size: 26px;position: absolute;top: 15px}.drugChecker_Page .serious.pillIcon:before,.drugChecker_Page .drug_header .drugresults.p2 ul li.serious:before {color: #cc0000}.drugChecker_Page .significant.pillIcon:before,.drugChecker_Page .drug_header .drugresults.p2 ul li.significant:before {color: #ff6600}.drugChecker_Page .minor.pillIcon:before,.drugChecker_Page .drug_header .drugresults.p2 ul li.minor:before {color: #ffaf00}.drugChecker_Page .drugexplained {border: 1px solid #ccc;padding: 20px}.drugChecker_Page .drugexplained h3 {margin: 0}.drugChecker_Page .drugexplaindetail {padding: 5px 0;position: relative}.drugChecker_Page .drugexplaindetail h3 {font-size: 16px;margin: 16px 0 2px 40px;text-decoration: none}.drugChecker_Page .drugexplaindetail p {line-height: 20px;margin: 0 0 0 40px}.drugChecker_Page .drug_content {margin: 30px 0}.drugChecker_Page .intChkDriverText {text-align: center;margin: 40px 0 0 0}.drugChecker_Page .intChkDriverBtn {text-align: center;margin: 20px 0 40px}.drugChecker_Page .intChkDriverBtn a {background: #6896da;color: #fff;text-transform: uppercase;border-radius: 3px;padding: 10px 30px;transition: all 250ms}.drugChecker_Page .intChkDriverBtn a:hover {background: #000;color: #fff;text-decoration: none}/*** Pharmacy Locater ***/.cityAlphaDiv h3 {color: #6896da;font-size: 24px;background: #6896DA;margin: 0;padding: 5px 10px;text-decoration: none !important;position: relative}.cityAlphaDiv h3 span {position: absolute;left: 16px;color: #fff}.cityAlphaDiv ul {list-style-type: none;margin: 0;padding: 0;display: block !important}.cityAlphaDiv li {padding: 0 !important}.cityAlphaDiv li a {padding: 10px !important;font-size: 16px;display: block;transition: all 250ms}.cityAlphaDiv li:nth-child(even) a {background: #f5f5f5}.cityAlphaDiv li a:hover {background: #000;color: #fff;text-decoration: none}.cityAlphaDiv .noCityLetter {color: #ec4747;font-size: 18px}#divCityAZ table {width: 100% !important;table-layout: fixed}#divCityAZ table ul {list-style-type: none;margin: 0 5px;padding: 0;display: block}#divCityAZ table li {padding: 0;border-bottom: 1px solid #ddd}#divCityAZ table li a {padding: 10px 15px;font-size: 16px;display: block;white-space: nowrap;overflow: hidden;text-overflow: ellipsis;transition: all 250ms}#divCityAZ table li a:hover {background: #000;color: #fff;text-decoration: none}#divCityAZ table img {margin-right: 10px}#localTopicsPharm .legend,#tabcontentcontainer .tabcontent {display: none}#map_canvas_pharmacy,#map_canvas_hospital {width: 100% !important;margin: 15px 0}#localTopicsPharmTabs {margin: 20px 0;position: relative}#localTopicsPharmTabs #tablist {margin: 0;padding: 0;width: 100%}#localTopicsPharmTabs #tablist li {float: left;list-style: none;padding: 0;margin-right: 10px}#localTopicsPharmTabs #tablist li a {color: #fff;font-weight: 600;text-transform: uppercase;text-decoration: none;padding: 10px 20px;background: #ec4747 !important;display: inline-block;border-radius: 3px 3px 0 0;transition: all 250ms}#localTopicsPharmTabs #tablist li a.current {background: #2196f3 !important}#localTopicsPharmTabs #tablist li a:hover {background: #000 !important}#localTopicsPharmTabs #tabcontentcontainer,#localTopicsHospitalsContent {background: #fff !important;height: 400px;overflow-y: auto;clear: both}#tabcontentcontainer .tabcontent:before {content: "";width: 100%;position: absolute;border-top: 3px solid #2196f3;margin-top: -3px}#tabcontentcontainer .tabcontent:last-child:before {border-color: #ec4747}#localTopicsPharmDiv,#localTopicsHospitalsDiv {padding: 15px;margin-right: 15px;position: relative}#localTopicsPharmDiv:nth-child(even),#localTopicsHospitalsDiv:nth-child(even) {background: #f2f2f2}#localTopicsPharmDiv img,#localTopicsHospitalsDiv img {position: absolute}#localTopicsPharmDiv p,#localTopicsHospitalsDiv p {margin: -3px 90px 0 26px}#localTopicsPharmDiv .pharmacy a,#localTopicsHospitalsDiv .hospital a {font-weight: 600;text-decoration: underline}#localTopicsPharmDiv h2 {position: absolute;font-size: 12px;color: #ec4747;right: 10px;top: 3px}#hospitalTerms {font-size: 11px;padding: 30px 0}#hospitalTerms span {font-weight: 600}#pharm,#emerg,#hospitals {margin-top: 70px}/*** Responsive ***/@media (min-width:768px) {.story {width: calc(100% - 352px);padding: 0 50px 0 0;}.masterhead,.rxArt .adTopWrapper.hide,.wrapper-hero,.submenu.stuck {max-width: calc(100vw - 80px);margin: 0 auto;}.masterSub.on,.masterSub {max-width: calc(100vw - 80px);margin: 0 auto;left: 0;right: 0;}.miniTitle .hero h1 {left: 150px;}}@media (max-width:1023px) {.topDrug .azList ul {column-count: 1}}@media (min-width:1024px) and (max-width:1199px) {.submenu .tab a {font-size: 13px;padding: 10px;height: 22px}.submenu .tab a span,.submenu .tab a .icon-pro {font-size: 20px}.submenu .toc.link a {font-size: 16px;line-height: 18px;padding: 6px 10px}.webmdrx_coup .wrapper .reg {display: none}.webmdrx_coup .wrapper .cou {left: 26%}}@media (min-width:1024px) {.stickyColLeft {display: block}#quiz-wrapper .story {width: 100%;padding: 0 20px 30px 20px}.article-promo .item {padding: 0 2px;width: calc(33% - 6px)}.drugChecker_Page .drug_A-Z_list li a {width: calc(100vw - 645px)}.drugSearchResult {width: calc(100vw - 597px)}}@media (min-width:1200px) {.wrapper-sponsors {padding: 40px 5%}.wrapper-sponsors h2 {font-size: 30px}.wrapper-sponsors .sponsors ul li a {font-size: 18px}.wrapper-sponsors .sponsors ul {margin: 16px 0}footer nav a {padding: 0 15px}footer nav .network a:after {padding: 0 20px}footer nav .network a {font-size: 16px}main section>.wrapper {max-width: 1100px}.story header h2 {font-size: 30px;margin: 20px 190px 10px 0;line-height: 30px}.story article .alert {font-size: 16px;padding: 8px 16px}.share a {font-size: 22px;width: 40px;height: 40px;margin: 0 2px}.share span {padding: 9px;line-height: 39px}#accordion .fold ul {column-count: 3}.article-promo .item {padding: 0 20px}#quizWrapper .question-message.show {min-width: 758px}}@media (min-width:1300px) {main#HP .container {column-count: 2;column-gap: 14px}.masterhead .wrapper {}.breadcrumbs {width: calc(95% - 375px)}#quiz-wrapper .story {padding: 0 20px 30px 0}#quizWrapper .question-message.show {width: calc(100vw - 557px)}.Rxl_landing_DC ul,.sc_common_ss ul,.sc_popular_sym ul,.drugCentRelatedDrugs ul {column-count: 2;column-gap: 50px;list-style-position: inside;display: block !important}.Rxl_landing_DC ul li,.sc_common_ss ul li,.sc_popular_sym ul li,.drugCentRelatedDrugs ul li {break-inside: avoid}.drugSearchResult {width: 100%}.drugSearchResult .drug_img {float: left;margin: 0 30px 5px 0}.drugSearchResult .drug_info .drug_name {margin: 0 0 15px 0}}@media (min-width:1350px) {.masterhead,.rxArt .adTopWrapper.hide,.wrapper-hero,.submenu.stuck {max-width: 1250px;}.masterSub.on,.masterSub {width: 1250px;left: 0;right: 0;}}@media (min-width:1400px) {main section>.wrapper {max-width: 1200px}.submenu.stuck .tab {width: 190px}.submenu.stuck .tab a {font-size: 16px}.submenu.stuck .toc.link a {font-size: 15px}.story header h2 {font-size: 42px;line-height: 42px}.story article {font-size: 17px}.pgContent #artPromoCunk .artPCLinks {width: 72%}#accordion .fold ul {column-count: 4}.slideshow .apPage h3 {font-size: 30px}.slideshow .apPage .content {font-size: 18px;max-width: 800px}/**.mediaPrmo img{width:60%}**/.mediaPrmo .skew {left: 55%}.mediaPrmo .label,.mediaPrmo .caption,.mediaPrmo .desc,.mediaPrmo .btn {margin-left: 60%}.miniTitle .hero h1 {left: 200px;}}@media (min-width:1500px) {main#HP .promoSearch {display: flex;align-items: center}.promoSearch{padding:40px 12vw;}main#HP .promoSearch img {margin: 0 80px 0;}main#HP .sc-searchbox {width: 100%}main#HP .promoSearch .sc-searchbox .sc-searchbox-list {width: calc(60vw - 350px)}.article-promo .item {padding: 0 10px;height: 125px;width: calc(33% - 20px);max-width: 350px}.article-promo a img {position: absolute}.article-promo a span,.article-promo a p {margin-left: 160px;font-size: 15px}.story #sponsors .wrapper ul {column-count: 3}#lrgArtImg {float: right;clear: both;margin: 20px 0 20px 20px !important;width: 500px !important}.miniTitle .hero h1 {left: 250px;}/**.story{margin:0 6%;width: calc(76% - 240px)}**//**.masterhead .wrapper{margin:0 4%}**//**.wrapper-hero{margin:0 4%}**//**.masterSub nav{margin:0 3%}**/}@media (min-width:1600px) {.miniTitle .hero h1 {left: 300px;}/**.wrapper-hero{margin:0 4%}.story{margin:0 6%;width: calc(86% - 400px)}**//**.masterhead .wrapper{margin:0 5%}**//**.masterSub nav{margin:0 5%}**/}@media (min-width:1800px) {.miniTitle .hero h1 {left: 400px;}}/*** Print ***/@media print {*,*:before,*:after {background: transparent !important;color: #000 !important;box-shadow: none !important;text-shadow: none !important}a,a:visited {text-decoration: underline}abbr[title]:after {content: " (" attr(title) ")"}a[href^="#"]:after,a[href^="javascript:"]:after {content: ""}pre,blockquote {border: 1px solid #999;page-break-inside: avoid;padding: 20px}thead {display: table-header-group}tr,img {page-break-inside: avoid}img {max-width: 100% !important}p,h2,h3 {orphans: 3;widows: 3}h2,h3 {page-break-after: avoid}#backTop,.adTopWrapper,header,.sticky-wrapper,.stickyColLeft,.stickyColRight,.toc,.webmdrx,.driver,.btn_driver,.medianet,.article-promo,#crsprm-2081-assmnt,#fdaWrapper,.from_webmd,.aia_rdr,.forum_symptom_checker,.article-extra,#footerAd_rdr,#sponsors,footer {display: none !important}.wrapper-hero {padding: 0 !important}}</style>
<style>.moduleSpacer_rdr{background:url(https://images.medicinenet.com/images/sponsorbox/spacer.gif) 0 0;clear:both;font-size:1%;height:4px}.sponsorBox_right_rdr{width:470px;background-color:#fff;padding-right:4px;clear:both}.sponsorBox_right_rdr a:link,.sponsorBox_right_rdr a:visited{color:#069!important;text-decoration:none}.sponsorBox_right_rdr a:hover,.sponsorBox_right_rdr a:active{color:#24a2dd!important;text-decoration:underline}.sponsorBox_right_rdr.sponsorBoxCenterArea{padding-right:0}.sponsorBox_header_fmt{background:url(https://images.medicinenet.com/images/sponsorbox/sponsorBoxBorderTop.gif) repeat-x;height:33px;padding:1px 0 0}.sponsorBox_topLeft_fmt{float:left;margin:-1px 0 0 0;padding:0}.sponsorBox_topRight_fmt{float:right;margin:-1px 0 0 0}.sponsorBox_mainLinks_fmt{background:url(https://images.medicinenet.com/images/sponsorbox/sponsorBoxBorderRight.gif) repeat-y 100% 0;clear:both}.sponsorBox_mainLinksContent_fmt{padding:0;background:url(https://images.medicinenet.com/images/sponsorbox/sponsorBoxBorderLeft.gif) repeat-y}* html .sponsorBox_mainLinksContent_fmt{height:0}.sponsorBox_sponsorText_fmt{background:url(https://images.medicinenet.com/images/sponsorbox/SponsorBoxText.gif) no-repeat;float:left;width:13px;margin:0}.sponsorBox_links_fmt{float:left;width:350px}.sponsorBox_links_wide_fmt{float:left;width:350px}.sponsorBox_links_fmt ul,.sponsorBox_links_wide_fmt ul,.sponsorBox_linksRightAligned_fmt ul,.sponsorBox_center_links_fmt ul,.sponsorBox_center_linksRightAligned_fmt ul{clear:left;list-style:none;margin:0;padding:0 0 0 9px}.sponsorBox_links_fmt li,.sponsorBox_links_wide_fmt li,.sponsorBox_linksRightAligned_fmt li,.sponsorBox_center_links_fmt li,.sponsorBox_center_linksRightAligned_fmt li{background:url(https://images.medicinenet.com/images/sponsorbox/sponsorBoxListBullet.gif) no-repeat 0 3px;font-size:90%;list-style-image:none!important;margin:4px 0 0;padding:0 0 0 15px}* html .sponsorBox_links_fmt li,* html .sponsorBox_links_wide_fmt li,* html .sponsorBox_linksRightAligned_fmt li,* html .sponsorBox_center_links_fmt li,* html .sponsorBox_center_linksRightAligned_fmt li{background-position:0 5px;margin:2px 0 0}#middleContent_fmt .sponsorBox_links_fmt li,#middleContent_fmt .sponsorBox_links_wide_fmt li,#middleContent_fmt .sponsorBox_linksRightAligned_fmt li,#middleContent_fmt .sponsorBox_center_links_fmt li,#middleContent_fmt .sponsorBox_center_linksRightAligned_fmt li{font-size:90%}*+html .sponsorBox_mainLinksContent_fmt{min-height:0}*+html .sponsorBox_links_fmt li,*+html .sponsorBox_links_wide_fmt li,*+html .sponsorBox_linksRightAligned_fmt li,*+html .sponsorBox_center_links_fmt li,*+html .sponsorBox_center_linksRightAligned_fmt li{background-position:0 5px;margin:2px 0 0}*+html .sponsorBox_links_fmt{font-size:100%}.sponsorBox_photo_fmt{float:right;padding:7px 8px 6px 0}.sponsorBox_linksRightAligned_fmt{float:right;width:210px}.sponsorBox_photoLeftAligned_fmt{float:left;padding:7px 0 0 8px}.sponsorBox_bottom_fmt{background:url(https://images.medicinenet.com/images/sponsorbox/sponsorBoxBkg.gif) no-repeat 100% 100%}.sponsorBox_bottomBorder_fmt{background:#fff url(https://images.medicinenet.com/images/sponsorbox/sponsorBoxBkg.gif) no-repeat 0 100%;font-size:1%;height:10px;width:20px}* html .sponsorBox_bottomBorder_fmt{height:7px}.sponsorBox_clear_fmt{clear:both}.sponsorBox_header_fmt .sponsorBox_headerTbl_fmt{float:left;width:93%}.sponsorBoxCenterArea .sponsorBox_headerTbl_fmt{float:left;width:95%}.sponsorBox_header_fmt .dottedLineSP{background:url(https://images.medicinenet.com/images/sponsorbox/sponsorBoxDottedLine.gif) no-repeat right top;padding-left:5px;padding-right:8px}.sponsorBox_header_fmt .topLogoSP{padding-left:8px;padding-top:1px}.sponsorBox_bottomLinks_fmt{clear:both;font-size:80%;padding:3px 0 0 20px}.sponsorBox_bottomLinks_fmt a{padding-right:8px}.sponsorBox_right_rdr.sponsorBoxCenterArea .sponsorBox_bottomLinks_fmt a{padding-right:15px}.sponsorBox_header_fmt h1{color:#6C340A!important;font-size:90%;line-height:1em;margin:0;padding:0}.sponsorBox_header_fmt h1 a:link,.sponsorBox_header_fmt h1 a:visited{color:#6C340A!important}.sponsorBox_clearingDiv_fmt{clear:both;font-size:0;height:0}#mainContent_ctr .sponsorBox_right_rdr{padding-right:0}#mainContent_ctr .sponsorBox_headerTbl_fmt{width:93%}#mainContent_ctr .sponsorBox_links_fmt{float:left;width:350px}#mainContent_ctr .sponsorBox_bottomLinks_fmt a{padding-right:15px}#mainContent_ctr .sponsorBox_header_fmt h1{font-size:90%}#mainContent_ctr .sponsorBox_links_fmt li,#mainContent_ctr .sponsorBox_links_wide_fmt li,#mainContent_ctr .sponsorBox_linksRightAligned_fmt li,#mainContent_ctr .sponsorBox_center_links_fmt li,#mainContent_ctr .sponsorBox_center_linksRightAligned_fmt li{background:url(https://images.medicinenet.com/images/sponsorbox/sponsorBoxListBullet.gif) no-repeat 0 5px}#thirdCol_area .sponsorBox_header_fmt h1{font-size:80%}#thirdCol_area .sponsorBox_links_fmt li,#thirdCol_area .sponsorBox_links_wide_fmt li,#thirdCol_area .sponsorBox_linksRightAligned_fmt li,#thirdCol_area .sponsorBox_center_links_fmt li,#thirdCol_area .sponsorBox_center_linksRightAligned_fmt li{font-size:85%}#MiddleCol .sponsorBox_links_fmt{float:left;font-size:90%;width:350px}#MiddleCol .sponsorBox_links_fmt li,#MiddleCol .sponsorBox_links_wide_fmt li,#MiddleCol .sponsorBox_linksRightAligned_fmt li,#MiddleCol .sponsorBox_center_links_fmt li,#MiddleCol .sponsorBox_center_linksRightAligned_fmt li{font-size:110%}#MiddleCol .sponsorBox_header_fmt h1{font-size:100%}td.topPad .sponsorBox_links_fmt{float:left;font-size:90%;width:350px}td.topPad .sponsorBox_links_fmt li,td.topPad.sponsorBox_links_wide_fmt li,td.topPad .sponsorBox_linksRightAligned_fmt li,td.topPad .sponsorBox_center_links_fmt li,td.topPad .sponsorBox_center_linksRightAligned_fmt li{font-size:12px}#sponsorBox_frame_fmt{border:1px solid #000;clear:both;margin:0 0 0 25px;overflow:auto;padding:3px}#sponsorBox_frame_fmt a{color:#069}#sponsorBox_frame_fmt a:hover{text-decoration:underline}#sponsorBox_frame_fmt h1{font-size:11px;margin:1px 0 2px;padding:0}#sponsorBox_frame_fmt h2{color:#00539F;font-size:130%;line-height:1.1em;margin:1px 0 2px}#sponsorBox_frame_fmt h3{color:#00539F;font-size:90%;line-height:1.1em;margin:1px 0 2px}#sponsorBox_frame_fmt p{color:#000;font-size:11px;margin:0 0 5px;padding:0}#sponsorBox_frame_fmt ul{color:#000;margin:10px 0 0 20px;padding:0}#sponsorBox_frame_fmt li{background:#fff;color:#000;font-size:11px;list-style-type:dot;margin:0 0 5px;padding:0}#sponsorBox_frame_fmt{background-color:#fff;border:1px solid #999;height:85px;margin:0 5px 0 17px;overflow:auto;position:relative}#sponsorBox_frame_fmt sup{font-size:90%;vertical-align:text-top}#sponsorBox_bottomLinks_fmt{clear:left;font-size:11px;padding:3px 0 0 20px}.sponsorBox494_rdr{background:#fff;font-family:Arial,Verdana,Helvetica,sans-serif;font-size:10pt;padding-right:4px;position:relative;width:100%}.sponsorBox_bottomLinks_fmt{clear:both;font-size:80%;padding:0 0 0 1px}.sponsorBox_bottomLinks_fmt a.infolnk{padding:0 0 0 15px}.sponsorBox_popupHidden{display:none!important}.sponsorBox494_rdr .sponsorBox_popupVisible{background:#fff;border:2px solid #000;left:16px;display:block!important;position:absolute;top:37px;width:454px}.sponsorBox494_rdr .sponsorBox_PopupContent{background:#fff;height:67px;overflow:auto;padding:2px 5px 0 2px;width:447px}.sponsorBox494_rdr .sponsorBox_PopupClose{font-size:80%;text-align:right;width:454px}.sponsorBox_PopupContent h1,.sponsorBox_PopupContent h2,.sponsorBox_PopupContent h3,.sponsorBox_PopupContent h4,.sponsorBox_PopupContent h5{font-size:90%;line-height:12px;margin:0;padding:0 0 2px}.sponsorBox_PopupContent p{font-size:90%;line-height:12px;margin:0;padding:0 0 2px}.sponsorBox_PopupContent strong{font-size:110%;font-weight:700}.sponsorBox_PopupContent ol,.sponsorBox_PopupContent ul{font-size:90%;line-height:12px;margin:0;padding:0 0 2px}.sponsorBox_PopupContent li{margin:0;padding:0}.sponsorBox494_rdr .sponsorBox_PopupClose a,.sponsorBox494_rdr .sponsorBox_PopupClose a:link,.sponsorBox494_rdr .sponsorBox_PopupClose a:hover,.sponsorBox494_rdr .sponsorBox_PopupClose a:visited{color:#069}.sponsorBox494_rdr .sponsorBox_PopupClose a,.sponsorBox494_rdr .sponsorBox_PopupClose a:link{text-decoration:none}.sponsorBox494_rdr .sponsorBox_PopupClose a:hover,.sponsorBox494_rdr .sponsorBox_PopupClose a:visited{text-decoration:underline}.sponsorBox_bottomLinks_fmt{clear:both;font-size:80%;padding:3px 0 0;margin-left:20px}.sponsorBox_title_fmt{padding:0 0 0 5px;float:left}* html .sponsorBox_title_fmt{float:left;margin-left:8px;padding-left:0}.sponsorBox_attribution_fmt{background:url(https://images.medicinenet.com/images/sponsorbox/SponsorBoxDottedLine.gif) no-repeat;float:right;height:32px;margin:0 0 0 4px;padding:0 3px 0 27px}.sponsorBox_title_fmt a:link,.sponsorBox_title_fmt a:visited{color:#6C340A!important;text-decoration:none}.sponsorBox_title_fmt a:hover,.sponsorBox_title_fmt a:active{text-decoration:underline}.sponsorBox_links_fmt a:link,.sponsorBox_links_fmt a:visited{color:#069!important;text-decoration:none}.sponsorBox_links_fmt a:hover,.sponsorBox_links_fmt a:active{color:#24a2dd!important;text-decoration:underline}.video_container{width:300px;border:1px #ddd solid;background-color:#fff;border-radius:5px;-webkit-border-radius:5px;-moz-border-radius:5px}.video_container .video_header{background-color:#f0f0ee;padding:5px 0 5px 6px}.video_container .video_container_links{border-top:1px #ddd solid}.video_container .video_container_links h3{margin:7px 0 0 6px;padding:0;font-size:100%;font-weight:700}.video_container .video_container_links ul{list-style:none;margin:3px 0 17px 12px;padding:0}.video_container .video_container_links ul li{background:url(https://images.medicinenet.com/images/webmd/li_purple.gif) no-repeat 0 9px;line-height:18px;padding-left:8px;font-size:13px!important}</style>
<style>.cookie-consent-ctr .close,.cookie-consent-ctr .legal{box-sizing:border-box;position:relative;vertical-align:middle}.cookie-consent-ctr{background-color:#EDEFEF;box-sizing:border-box;color:#666;font:14px/1.4 Lato,Arial,sans-serif;min-width:1052px;overflow:hidden;padding:1em;position:relative;text-align:center;z-index:1000}.cookie-consent-ctr .close{background:url(data:image/png;base64,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) no-repeat #EDEFEF;cursor:pointer;display:block;float:right;height:28px;width:28px}.cookie-consent-ctr .legal{display:inline-block;max-width:90%}#colorbox,#webmdHoverClose{position:absolute;z-index:999}.thin .cookie-consent-ctr{min-width:790px}.thin.harmony .cookie-consent-ctr{min-width:768px}.ua_type_mobile .cookie-consent-ctr{min-width:100%}.ua_type_mobile .cookie-consent-ctr .legal{float:left;max-width:80%;text-align:left}#webmdHoverOverlay{background:#fefefe;height:100%;position:fixed;width:100%;z-index:999}#colorbox{background:#fff;-moz-box-shadow:0 0 15px 2px #7f7f7f;-webkit-box-shadow:0 0 15px 2px #7f7f7f;box-shadow:0 0 15px 2px #7f7f7f;-moz-border-radius:10px;border-radius:10px;width:550px;overflow:visible!important;padding:0!important}.browserIE #colorbox{border:1px solid #7f7f7f}#webmdHoverContent{background:#fff;-moz-border-radius:12px;border-radius:12px}.browserIE #webmdHoverContent{border:1px solid #999}.browserIE_7 #colorbox,.browserIE_8 #colorbox{border-color:#DADADA;padding-bottom:2px!important;padding-right:2px!important}.browserIE_7 #webmdHoverContent,.browserIE_8 #webmdHoverContent{border-color:#B9B9B9}#webmdHoverClose{background:url(https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/modules/webmd_overlay_close_x.png) no-repeat;cursor:pointer;display:block;height:34px;text-indent:-5000px;width:34px;top:-15px;right:-15px}#webmdHoverTitle,.app_view #adLabel,.app_view .logo_AdChoices{display:none}#webmd_confirm{text-align:center;padding:28px}#webmd_confirm .webmd_confirm_content{text-align:left}#webmd_confirm .webmd_confirm_buttons{margin-top:10px}#webmd_confirm_false_button{margin-left:12px}</style>

<link href="https://images.rxlist.com/oocommon/css/oo-ui.css" rel="stylesheet">

<script type="text/javascript">
var s_account="webmdcom";
var s_pagename="rxlist.com/omnicef-drug.htm";
var s_bu="cns";
var s_siteclass="od";
var s_site="rxlist";
var s_server_type="MN";
var s_channel_health="rxlist";
var s_refpath="rxlist";
var s_server_number="MA4-NET";
var s_asset="66509rdesc";
var s_template_name="RXL_Drug";
var s_channel="4286";
var s_asset_class="rx-mono";
var s_asset_type="content";
var s_articletype="rx-mono";
var s_pagenum="1";
var s_pub="rxlist";
var s_user_group="unregistered";
</script>
<script type="text/javascript" src="https://img.wbmdstatic.com/webmd_static_vue/webmd-share-static-files/webmd/PageBuilder_Assets/JS/api/oo_shim_head.min.js"></script>
<script async src="https://preferences.trustarc.com/webservices/js?domain=webmd&amp;type=webmd_popnew&amp;js=responsive"></script>
<script src="//assets.adobedtm.com/2c8c1e17b98c/bd8b7ed95b8d/launch-a2e2197ecad5.min.js"></script>

<title>Omnicef (Cefdinir): Side Effects, Uses, Dosage, Interactions, Warnings</title>
<meta NAME="Description" CONTENT="Omnicef (Cefdinir) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources." />
<meta NAME="KeyWords" CONTENT="Omnicef Cefdinir drug description chemical structure black box warning medications drugs generic fda approved patient labeling reviews professionals clinicians clinical" />



        
<script async src="https://images.rxlist.com/rxlist/js/all.min.js"></script>
<meta name="y_key" content="11fe84c14ab87627" /> 

<meta http-equiv="X-UA-Compatible" content="IE=Edge">
<meta http-equiv="content-type" content="text/html; charset=iso-8859-1" />
<link rel="alternate" type="application/rss+xml" title="RxList - Updated and New Drug Monographs" href="https://www.rxlist.com/rss/rxlist_drugs.xml"/>
<link rel="alternate" type="application/rss+xml" title="RxList - News and Features" href="https://www.rxlist.com/rss/rxlist_news.xml"/>
<link rel="alternate" type="application/rss+xml" title="RxList - Health and Medical Slideshows" href="https://www.rxlist.com/rss/rxlist_slideshows.xml" />

<link rel="canonical" href="https://www.rxlist.com/omnicef-drug.htm" />
<meta property="og:title" content="Omnicef (Cefdinir): Side Effects, Uses, Dosage, Interactions, Warnings" />
<meta property="og:description" content="Omnicef (Cefdinir) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources." />
<meta property="og:site_name" content="RxList" />
<meta property="og:image" content="https://images.rxlist.com/images/facebook/rxlist/fb-rxlist-default-2.jpg" /><meta property="fb:page_id" content="131322716913673" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://www.rxlist.com/omnicef-drug.htm" />
<meta property="topicid" content="4286" />
<script type="application/ld+json">
[
{
"@context":"https://schema.org",
"@type":"Drug",
"mainEntityOfPage":"https://www.rxlist.com/omnicef-drug.htm",
"lastReviewed":"6/6/2023",

"warning":"https://www.rxlist.com/omnicef-drug.htm#warnings",
"name":"cefdin",
"drugClass":"Cephalosporins, 3rd Generation",
"isAvailableGenerically":"true",
"relatedDrug":"Cefdinir",
"reviewedBy":{"@type":"Person","name":"John P. Cunha, DO, FACOEP"},
"about":"Omnicef (Cefdinir) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources.",
"datePublished":"6/6/2023",
"headline":"Omnicef (Cefdinir): Side Effects, Uses, Dosage, Interactions, Warnings",
"publisher":{
    "@type":"Organization",
    "name":"RxList",
    "logo": {
        "@type":"ImageObject",
        "url":"https://images.rxlist.com/images/oologos/rxlist-logo.jpg"
        }
    }
}
]
</script></head>
<body class="rxArt pgprof">
<div id="backTop">
    <span class="icon-arrow-right2"></span>
</div>    <script type="module" async src="https://images.rxlist.com/oocommon/js/oo-ui.js"></script>
<svg hidden width="240.12" height="37.437" viewBox="0 0 63.533 9.9052"
  xmlns="https://www.w3.org/2000/svg">
  <symbol id="mni-logo-svg">
  <g transform="translate(-32.677 -80.098)">
    <path d="m34.663 81.236 2.6238 6.5484 2.6238-6.5484h1.3725v8.0257h-1.0583v-3.1254l0.09922-3.3734-2.6348 6.4988h-0.81029l-2.6293-6.4823 0.10473 3.3569v3.1254h-1.0583v-8.0257zm10.804 8.1359q-1.2127 0-1.9734-0.79375-0.76068-0.79926-0.76068-2.1332v-0.18741q0-0.88746 0.33624-1.582 0.34175-0.70004 0.94809-1.0914 0.61185-0.39688 1.3229-0.39688 1.1631 0 1.808 0.76619 0.64492 0.76619 0.64492 2.1938v0.42444h-4.0404q0.02205 0.88194 0.51263 1.4276 0.49609 0.54019 1.2568 0.54019 0.54019 0 0.91502-0.22049 0.37483-0.22049 0.65595-0.58429l0.62287 0.48507q-0.74965 1.152-2.249 1.152zm-0.12678-5.3468q-0.61736 0-1.0363 0.452-0.41892 0.44648-0.51814 1.2568h2.9876v-0.07717q-0.0441-0.77721-0.41892-1.2016-0.37483-0.42995-1.0142-0.42995zm3.3845 2.2049q0-1.3725 0.65044-2.2049 0.65043-0.83785 1.7033-0.83785 1.0473 0 1.6592 0.71658v-3.1089h1.0198v8.4667h-0.93707l-0.04961-0.63941q-0.61185 0.74965-1.7033 0.74965-1.0363 0-1.6922-0.84887-0.65044-0.84887-0.65044-2.2159zm1.0197 0.11576q0 1.0142 0.41892 1.5875 0.41892 0.57326 1.1576 0.57326 0.97014 0 1.4166-0.87092v-2.7395q-0.45751-0.84336-1.4056-0.84336-0.74965 0-1.1686 0.57878-0.41892 0.57878-0.41892 1.7143zm6.7028 2.9159h-1.0198v-5.9642h1.0198zm-1.1024-7.5461q0-0.24805 0.14883-0.41892 0.15434-0.17088 0.452-0.17088 0.29766 0 0.452 0.17088 0.15434 0.17088 0.15434 0.41892t-0.15434 0.41341q-0.15434 0.16536-0.452 0.16536-0.29766 0-0.452-0.16536-0.14883-0.16536-0.14883-0.41341zm5.1263 6.8241q0.5457 0 0.9536-0.33073 0.4079-0.33073 0.452-0.82682h0.96463q-0.02756 0.51263-0.35278 0.97565t-0.87092 0.73863q-0.54019 0.27561-1.1465 0.27561-1.2182 0-1.9403-0.81029-0.71658-0.8158-0.71658-2.2269v-0.17088q0-0.87092 0.31971-1.5489 0.3197-0.678 0.91502-1.0528 0.60082-0.37483 1.4166-0.37483 1.0032 0 1.6647 0.60083 0.66697 0.60082 0.71107 1.5599h-0.96463q-0.0441-0.57878-0.44097-0.94809-0.39136-0.37483-0.97014-0.37483-0.77722 0-1.2072 0.56224-0.42444 0.55673-0.42444 1.6151v0.19292q0 1.0308 0.42444 1.5875t1.2127 0.55673zm4.6247 0.72209h-1.0197v-5.9642h1.0197zm-1.1024-7.5461q0-0.24805 0.14883-0.41892 0.15434-0.17088 0.452-0.17088 0.29766 0 0.452 0.17088t0.15434 0.41892-0.15434 0.41341-0.452 0.16536q-0.29766 0-0.452-0.16536-0.14883-0.16536-0.14883-0.41341zm3.6987 1.582 0.03307 0.74965q0.68351-0.8599 1.7859-0.8599 1.8907 0 1.9072 2.1332v3.9412h-1.0197v-3.9467q-0.0055-0.64492-0.29766-0.9536-0.28663-0.30868-0.89848-0.30868-0.4961 0-0.87092 0.26458-0.37483 0.26458-0.58429 0.69453v4.2499h-1.0197v-5.9642zm7.7391 6.0744q-1.2127 0-1.9734-0.79375-0.76068-0.79926-0.76068-2.1332v-0.18741q0-0.88746 0.33624-1.582 0.34175-0.70004 0.94809-1.0914 0.61185-0.39688 1.3229-0.39688 1.1631 0 1.808 0.76619 0.64492 0.76619 0.64492 2.1938v0.42444h-4.0404q0.02205 0.88194 0.51263 1.4276 0.49609 0.54019 1.2568 0.54019 0.54019 0 0.91502-0.22049 0.37483-0.22049 0.65595-0.58429l0.62287 0.48507q-0.74965 1.152-2.249 1.152zm-0.12678-5.3468q-0.61736 0-1.0363 0.452-0.41892 0.44648-0.51814 1.2568h2.9876v-0.07717q-0.0441-0.77721-0.41892-1.2016-0.37483-0.42995-1.0142-0.42995zm9.9605 5.2366h-1.0638l-4.0404-6.1846v6.1846h-1.0638v-8.0257h1.0638l4.0514 6.2122v-6.2122h1.0528zm4.1948 0.11024q-1.2127 0-1.9734-0.79375-0.76068-0.79926-0.76068-2.1332v-0.18741q0-0.88746 0.33624-1.582 0.34175-0.70004 0.94809-1.0914 0.61185-0.39688 1.3229-0.39688 1.1631 0 1.808 0.76619 0.64492 0.76619 0.64492 2.1938v0.42444h-4.0404q0.02205 0.88194 0.51263 1.4276 0.4961 0.54019 1.2568 0.54019 0.54019 0 0.91502-0.22049 0.37483-0.22049 0.65595-0.58429l0.62287 0.48507q-0.74965 1.152-2.249 1.152zm-0.12678-5.3468q-0.61736 0-1.0363 0.452-0.41892 0.44648-0.51814 1.2568h2.9876v-0.07717q-0.0441-0.77721-0.41892-1.2016-0.37483-0.42995-1.0142-0.42995zm5.0161-2.1718v1.4442h1.1135v0.78824h-1.1135v3.6987q0 0.35829 0.14883 0.54019 0.14883 0.17639 0.50712 0.17639 0.17639 0 0.48507-0.06615v0.82682q-0.40239 0.11024-0.78273 0.11024-0.68351 0-1.0308-0.41341t-0.34727-1.1741v-3.6987h-1.0859v-0.78824h1.0859v-1.4442z" stroke-width=".26458" aria-label="RxList"/>
  </g>
</symbol>
</svg><svg hidden><symbol id="magnifying-glass-icon" width="30px" height="30px" viewBox="0 0 24 24" fill="none"><g stroke="currentColor" stroke-linecap="round" stroke-linejoin="round"/><g><path d="M15 15L21 21" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"/><path d="M17 10C17 13.866 13.866 17 10 17C6.13401 17 3 13.866 3 10C3 6.13401 6.13401 3 10 3C13.866 3 17 6.13401 17 10Z" stroke="currentColor" stroke-width="2"/></g></symbol></svg>
<svg hidden><symbol id="arrow-down-icon" viewBox="0 0 512 512" width="512px" height="512px"><polygon points="396.6,160 416,180.7 256,352 96,180.7 115.3,160 256,310.5 "/></symbol></svg>
<svg hidden><symbol id="arrow-up-icon" viewBox="0 0 512 512" width="512px" height="512px"><polygon points="396.6,352 416,331.3 256,160 96,331.3 115.3,352 256,201.5 "/></symbol></svg>
<svg hidden><symbol id="open-icon" viewBox="0 0 100 100" width="100" height="100"><rect width="100" height="10" y="20"></rect><rect width="100" height="10" y="50"></rect><rect width="100" height="10" y="80"></rect></symbol></svg>
<svg hidden><symbol id="close-icon" viewBox="0 0 100 100" width="100" height="100"><line style="stroke:currentColor;stroke-width:10;" x1="5" y1="5" x2="95" y2="95"></line><line style="stroke:currentColor;stroke-width:10;" x1="95" y1="5" x2="5" y2="95"></line></symbol></svg>
<div tw class="max-w-screen-xl mx-auto sticky w-full bg-white z-[10000] top-0 transition-[top] duration-500">
	<nav id="menu" class="w-full flex justify-between items-center box-border px-4 h-12 lg:h-16 border-b border-slate-400 group">
		<div class="hamburger-icon lg:hidden px-2.5 hover:text-sky-400 cursor-pointer">
			<svg class="open-icon fill-current self-center group-[.open-hamburger]:hidden" viewBox="0 0 100 100" width="20" height="20"><use xlink:href="#open-icon"/></svg>
			<svg class="close-icon fill-current self-center hidden group-[.open-hamburger]:inline-block" viewBox="0 0 100 100" width="20" height="20"><use xlink:href="#close-icon"/></svg>
		</div>
		<div class="bg-white z-10 h-full flex justify-between items-center lg:min-w-[200px] lg:max-w-[200px]">
			<a onclick="wmdTrack('tn-home');" itemprop="url" href="https://www.rxlist.com/">
        <img src="https://images.rxlist.com/images/mobile/rxlist/logo-rxl.png" alt="RxList Logo" title="RxList Logo">
    </a>
		</div>
		<div class="grow"></div>
		<div class="menu-center absolute flex flex-col-reverse justify-end lg:flex-row top-12 lg:top-auto lg:relative w-full h-[calc(100vh-128px)] lg:h-full overflow-y-scroll lg:overflow-initial -left-full lg:left-auto transition-all group-[.open-hamburger]:left-0 bg-black lg:bg-white bg-opacity-80 lg:bg-opacity-100">
		<ul class="menu-items flex lg:flex-col-auto flex-col lg:flex-row flex-nowrap w-full max-h-full h-auto lg:h-full overflow-y-scroll lg:overflow-initial p-0 list-none lg:group-[.open-search]:hidden bg-white">
      <li class="relative justify-around flex flex-col px-2 lg:px-0 whitespace-nowrap group/item border-b border-white lg:hover:border-sky-400 cursor-pointer">
        <div class="menu-item flex bg-white z-10 h-full peer group lg:px-3.5 lg:hover:text-sky-400">
					<div class="pointer-events-none lg:pointer-events-auto flex-grow lg:flex-grow-auto whitespace-nowrap self-center pl-3.5 py-2 group-[.show]:text-sky-400 lg:group-[.show]:text-black group-hover/item:text-sky-400 text-lg lg:text-base text-left hover:no-underline">
						<span>Drugs & Vitamins</span>
					</div>
					<div class="icon-button flex self-center">
						<svg class="icon-down self-center lg:group-hover/item:hidden group-[.show]:hidden" viewBox="0 0 512 512" width="30" height="20"><use xlink:href="#arrow-down-icon"/></svg>
						<svg class="icon-up self-center hidden lg:group-hover/item:inline-block lg:group-hover/item:fill-sky-400 group-[.show]:inline-block" viewBox="0 0 512 512" width="30" height="20"><use xlink:href="#arrow-up-icon"/></svg>
					</div>
				</div>
        <ul class="overflow-visible lg:absolute min-w-full hidden lg:flex lg:opacity-0 peer-[.show]:flex flex-col px-3.5 py-1 gap-y-1 top-16 lg:shadow-md lg:bg-neutral-100 group-focus:flex lg:-z-10 lg:transition lg:ease-in-out lg:-translate-y-[120%] lg:group-hover/item:opacity-100 lg:group-hover/item:-translate-y-0 lg:duration-300 border-t lg:border-t-0 border-sky-400">
          <li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" onclick="wmdTrack('tn-drug');" href="https://www.rxlist.com/drugs/alpha_a.htm">Drugs A-Z</a></li>
          <li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" onclick="wmdTrack('tn-drug');" href="https://www.rxlist.com/script/main/alphaidx.asp?p=a_rx-mcon">Generic Drugs A-Z</a></li>
          <li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" href="https://www.rxlist.com/drug_classification/article.htm">Drugs by Classification</a></li>
          <li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" href="https://www.rxlist.com/drugs_comparison/article.htm">Drugs Comparison (Drug Vs. Drug)</a></li>
          <li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" onclick="wmdTrack('tn-vit');" href="https://www.rxlist.com/supplements/article.htm">Vitamins & Supplements</a></li>
          <li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" onclick="wmdTrack('tn-drugint');" href="https://www.rxlist.com/drug-interaction-checker.htm">Drug Interaction Checker</a></li>
	        <li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" onclick="wmdTrack('tn-pillid');" href="https://www.rxlist.com/pill-identification-tool/article.htm">Pill Identifier</a></li>
        </ul>
      </li>
      <li  class="relative justify-around flex flex-col px-2 lg:px-0 whitespace-nowrap group/item border-b border-white lg:hover:border-sky-400 cursor-pointer">
        <div class="menu-item flex bg-white z-10 h-full peer group lg:px-3.5 lg:hover:text-sky-400">
					<div class="pointer-events-none lg:pointer-events-auto flex-grow lg:flex-grow-auto whitespace-nowrap self-center pl-3.5 py-2 group-[.show]:text-sky-400 lg:group-[.show]:text-black group-hover/item:text-sky-400 text-lg lg:text-base text-left hover:no-underline">
						<span>Tools & Resources</span>
					</div>
					<div class="icon-button flex self-center">
					<svg class="icon-down self-center lg:group-hover/item:hidden group-[.show]:hidden" viewBox="0 0 512 512" width="30" height="20"><use xlink:href="#arrow-down-icon"/></svg>
					<svg class="icon-up self-center hidden lg:group-hover/item:inline-block lg:group-hover/item:fill-sky-400 group-[.show]:inline-block" viewBox="0 0 512 512" width="30" height="20"><use xlink:href="#arrow-up-icon"/></svg>
					</div>
				</div>
        <ul class="overflow-visible lg:absolute min-w-full hidden lg:flex lg:opacity-0 peer-[.show]:flex flex-col px-3.5 py-1 gap-y-1 top-16 lg:shadow-md lg:bg-neutral-100 group-focus:flex lg:-z-10 lg:transition lg:ease-in-out lg:-translate-y-[120%] lg:group-hover/item:opacity-100 lg:group-hover/item:-translate-y-0 lg:duration-300 border-t lg:border-t-0 border-sky-400">
          <li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" onclick="wmdTrack('tn-dict');" href="https://www.rxlist.com/drug-medical-dictionary/article.htm">Medical Dictionary</a></li>
					<li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" onclick="wmdTrack('tn-ss');" href="https://www.rxlist.com/drug-slideshows-all/article.htm">Slideshows</a></li>
					<li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" onclick="wmdTrack('tn-ic');" href="https://www.rxlist.com/image_gallery_collection/article.htm">Images</a></li>
					<li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" onclick="wmdTrack('tn-qz');" href="https://www.rxlist.com/quizzes_a-z_listing/article.htm">Quizzes</a></li>
					<!-- <li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><privacy-button text="Privacy &amp; Other Trust Info"></privacy-button></li> -->
        </ul>
      </li>
			<li class="relative justify-around flex flex-col px-2 lg:px-0 whitespace-nowrap group/item border-b border-white lg:hover:border-sky-400 cursor-pointer">
					<div class="menu-item flex bg-white z-10 h-full peer group">
						<div class="pointer-events-none lg:pointer-events-auto flex-grow lg:flex-grow-auto whitespace-nowrap self-center pl-3.5 py-2 group-[.show]:text-sky-400 lg:group-[.show]:text-black group-hover/item:text-sky-400 text-lg lg:text-base text-left hover:no-underline">
							<span>Privacy & Other Trust Info</span>
						</div>	
						<div class="icon-button flex self-center">
							<svg class="icon-down self-center lg:group-hover/item:hidden group-[.show]:hidden" viewBox="0 0 512 512" width="30" height="20"><use xlink:href="#arrow-down-icon"/></svg>
							<svg class="icon-up self-center hidden lg:group-hover/item:inline-block lg:group-hover/item:fill-sky-400 group-[.show]:inline-block" viewBox="0 0 512 512" width="30" height="20"><use xlink:href="#arrow-up-icon"/></svg>
							</div>
					</div>
					<ul class="overflow-visible lg:absolute min-w-full hidden lg:flex lg:opacity-0 peer-[.show]:flex flex-col px-3.5 py-1 gap-y-1 top-16 lg:shadow-md lg:bg-neutral-100 group-focus:flex lg:-z-10 lg:transition lg:ease-in-out lg:-translate-y-[120%] lg:group-hover/item:opacity-100 lg:group-hover/item:-translate-y-0 lg:duration-300 border-t lg:border-t-0 border-sky-400">
					<li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" href="https://www.rxlist.com/script/main/art.asp?articlekey=64474" target="_blank">Privacy Policy</a></li>
					<li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" href="https://www.rxlist.com/script/main/art.asp?articlekey=64467" target="_blank">About Us</a></li>
					<li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" href="https://www.rxlist.com/contact_us/article.htm" target="_blank">Contact Us</a></li>
					<li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" href="https://www.rxlist.com/script/main/art.asp?articlekey=64473" target="_blank">Terms of Use</a></li>
					<li class="pl-2 lg:pl-0 lg:py-2 hover:text-sky-400 text-lg lg:text-base"><a class="hover:no-underline" href="https://www.rxlist.com/script/main/art.asp?articlekey=77768" target="_blank">Advertising Policy</a></li>
					</ul>
			</li>
    </ul>
		<ce-search-box class="nav-search self-center block w-full h-auto lg:h-11 p-2 lg:p-0 lg:w-1/2 lg:absolute lg:right-0 lg:hidden lg:group-[.open-search]:block bg-white" 
			search-api="/rxl/api/search" 
			submit-api="/search/rxl" 
			show-search-button="True" 
			search-button-text="Search" 
			placeholder="Search RxList..." 
			wrapper-class="nav-search"></ce-search-box>
	</div>
		<div class="search-icon flex px-2 lg:p-2 relative box-content border-l lg:border-l-0 border-black hover:text-sky-400 cursor-pointer">
			<svg class="icon fill-current" viewBox="0 0 30 30" width="30" height="30"><use xlink:href="#magnifying-glass-icon"/></svg>
		</div>
	</div>
</nav>
</div>
    <div class="adTopWrapper">
        <!-- Start 728x90 Ad Tag -->
        <!-- Start 728x90 Ad Tag -->     
<div id="bannerAdContainer">
    <div id="bannerAd_ctr">
        <div id="bannerAd_rdr">
            <div id="bannerAd_fmt"> 
                <script>
var ooAdTarget={targets:{'pvid': window.s_pageview_id || '','tug': window.s_tug || '','pug': window.s_pug || '','art': '66509','pt': '4286','uri': '%2Fomnicef-drug.htm','app': '8','cc': '9993','oohc': '61'},'blockCodes': '_vac_t886_sex3_sex2_sex1_r529_r05_o92_o8_m32_m05_k7_k591_k590_k51_j45_j44_j30_j10_i10_h54_h53_h52_h16_h10_gen2_gen1_g473_g470_g258_g00_food_fit_f65_f50_f43_f1_e1_diet_cust9_cust4_c56_bty21_age234_age133_age132_age123_age122_age121_age11_a6_a5_a49_a403_n952_k21_cust022_supplements_cust031_nn1_cust051_cust056_cust076_cust063_cust091_n898_cust115_a15_'}
</script>
<div id="ads2-pos-101" class="ad_placeholder ad"
    data-is-mobile="false" 
    data-block-codes="_vac_t886_sex3_sex2_sex1_r529_r05_o92_o8_m32_m05_k7_k591_k590_k51_j45_j44_j30_j10_i10_h54_h53_h52_h16_h10_gen2_gen1_g473_g470_g258_g00_food_fit_f65_f50_f43_f1_e1_diet_cust9_cust4_c56_bty21_age234_age133_age132_age123_age122_age121_age11_a6_a5_a49_a403_n952_k21_cust022_supplements_cust031_nn1_cust051_cust056_cust076_cust063_cust091_n898_cust115_a15_" 
    data-pos="101" 
    data-sizes="[[728,90],[970, 90]]">
</div>

            </div>
            <div style="clear:both"></div>
        </div>
    </div>
</div>			
<!-- End 728x90 Ad Tag -->

        <!-- End 728x90 Ad Tag -->
    </div>
    <section class="wrapper-hero">
        <div class="hero" itemscope itemtype="https://schema.org/CreativeWork">
            <h1>
                Omnicef 
            </h1>
            <ul>
   <li itemprop="name">Generic Name: <span><a href="https://www.rxlist.com/cefdinir/generic-drug.htm">cefdinir</a></span></li>                   <li itemprop="name">Brand Name: <span>Omnicef</span></li>
                    <li itemprop="name">Drug Class: <span><a href="https://www.rxlist.com/how_do_third-generation_cephalosporins_work/drug-class.htm">Cephalosporins, 3rd Generation</a></span></li>
            </ul>
        </div>
        <div class="monolastreviewed">
Medical Editor: 
    <!--START HREFPOPOUT-->
    <a onclick="wmdTrack('art-auth');" href="/script/main/art.asp?articlekey=81326" target="_blank">John P. Cunha, DO, FACOEP</a>
    <!--END HREFPOPOUT-->
    
            <i>Last updated on RxList: <span>6/6/2023</span></i>
        </div>
            <div id="breadcrumbs" itemscope itemtype="https://schema.org/WebPage">
                <p class="breadcrumbs" itemprop="breadcrumb">
                    <a href="https://www.rxlist.com">home</a>
                    <a href="https://www.rxlist.com/drugs/alpha_a.htm">drugs a-z list</a>
                    omnicef (cefdinir) drug
                </p>
            </div>
            <!--social icons inserted here from the JS after id=breadcrumb div via append-->
        <ul class="drugDropdown">
            <!-- RELATED CENTER -->
    <!-- RELATED DRUGS -->
    <li>
        <a class="drugSelect">Related Drugs</a>
        <div class="drugOption">
            <a onclick="wmdTrack('lr-reldrug_0');" href="https://www.rxlist.com/acetylcysteine-solution-drug.htm" title="Acetylcysteine Solution">Acetylcysteine Solution</a>
<a onclick="wmdTrack('lr-reldrug_1');" href="https://www.rxlist.com/bactrim-pediatric-drug.htm" title="Bactrim Pediatric">Bactrim Pediatric</a>
<a onclick="wmdTrack('lr-reldrug_2');" href="https://www.rxlist.com/cefaclor-drug.htm" title="Cefaclor">Cefaclor</a>
<a onclick="wmdTrack('lr-reldrug_3');" href="https://www.rxlist.com/ceftin-drug.htm" title="Ceftin">Ceftin</a>
<a onclick="wmdTrack('lr-reldrug_4');" href="https://www.rxlist.com/cefuroxime-drug.htm" title="Cefuroxime">Cefuroxime</a>
<a onclick="wmdTrack('lr-reldrug_5');" href="https://www.rxlist.com/cefzil-drug.htm" title="Cefzil">Cefzil</a>
<a onclick="wmdTrack('lr-reldrug_6');" href="https://www.rxlist.com/cipro-drug.htm" title="Cipro">Cipro</a>
<a onclick="wmdTrack('lr-reldrug_7');" href="https://www.rxlist.com/cipro-iv-drug.htm" title="Cipro IV">Cipro IV</a>
<a onclick="wmdTrack('lr-reldrug_8');" href="https://www.rxlist.com/cipro-xr-drug.htm" title="Cipro XR">Cipro XR</a>
<a onclick="wmdTrack('lr-reldrug_9');" href="https://www.rxlist.com/coly-mycin-drug.htm" title="Coly-Mycin">Coly-Mycin</a>
<a onclick="wmdTrack('lr-reldrug_10');" href="https://www.rxlist.com/duricef-drug.htm" title="Duricef">Duricef</a>
<a onclick="wmdTrack('lr-reldrug_11');" href="https://www.rxlist.com/factive-drug.htm" title="Factive">Factive</a>
<a onclick="wmdTrack('lr-reldrug_12');" href="https://www.rxlist.com/invanz-drug.htm" title="Invanz">Invanz</a>
<a onclick="wmdTrack('lr-reldrug_13');" href="https://www.rxlist.com/levaquin-drug.htm" title="Levaquin">Levaquin</a>
<a onclick="wmdTrack('lr-reldrug_14');" href="https://www.rxlist.com/minocin-drug.htm" title="Minocin">Minocin</a>
<a onclick="wmdTrack('lr-reldrug_15');" href="https://www.rxlist.com/minocin-injection-drug.htm" title="Minocin Injection">Minocin Injection</a>
<a onclick="wmdTrack('lr-reldrug_16');" href="https://www.rxlist.com/noroxin-drug.htm" title="Noroxin">Noroxin</a>
<a onclick="wmdTrack('lr-reldrug_17');" href="https://www.rxlist.com/penicillin-vk-drug.htm" title="Penicillin VK">Penicillin VK</a>
<a onclick="wmdTrack('lr-reldrug_18');" href="https://www.rxlist.com/rocephin-drug.htm" title="Rocephin">Rocephin</a>
<a onclick="wmdTrack('lr-reldrug_19');" href="https://www.rxlist.com/suprax-drug.htm" title="Suprax">Suprax</a>
<a onclick="wmdTrack('lr-reldrug_20');" href="https://www.rxlist.com/synercid-drug.htm" title="Synercid">Synercid</a>
<a onclick="wmdTrack('lr-reldrug_21');" href="https://www.rxlist.com/teflaro-drug.htm" title="Teflaro">Teflaro</a>
<a onclick="wmdTrack('lr-reldrug_22');" href="https://www.rxlist.com/tygacil-drug.htm" title="Tygacil">Tygacil</a>
<a onclick="wmdTrack('lr-reldrug_23');" href="https://www.rxlist.com/xenleta-drug.htm" title="Xenleta">Xenleta</a>

        </div>
    </li>
    <!-- END RELATED DRUGS -->
    
    
<!-- END RELATED CENTER -->
        </ul>
    </section>
    <main class="content">
        <section class="story">
	    <div id="apPage" class="apPage">
		 <div class="monograph_sum">
		 <div class="monograph_header">
                      <h2 class="monograph_source">Drug Summary</h2>
                 </div>
		 <div class="monograph_cont"><h4>What Is Omnicef?</h4>
<p>Omnicef (cefdinir) is a cephalosporin <a href="https://www.rxlist.com/antibiotic/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">antibiotic</a> used to treat many different types of infections caused by bacteria. The brand name Omnicef is discontinued in the U.S. Omnicef is available in <a href="https://www.rxlist.com/generic/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">generic</a> form.</p> 

<h4>What Are Side Effects of Omnicef?</h4>
<p>Common side effects of Omnicef include: 
<ul>
<li>diarrhea, </li>
<li>nausea, </li>
<li>vomiting,</li> 
<li>stomach pain,</li> 
<li>indigestion, </li>
<li>headache,</li> 
<li>dizziness, </li>
<li>diaper rash in an infant taking liquid cefdinir, </li>
<li>itching, </li>
<li>skin rash, or </li>
<li>vaginal itching or</li> 
<li><a href="https://www.rxlist.com/discharge/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">discharge</a>. </li>
</ul>
<p>Tell your doctor if you experience serious side effects of Omnicef including watery or bloody diarrhea, chest pain, fever, chills, body aches, flu symptoms, unusual bleeding, seizures (convulsions), pale or yellowed skin, dark colored urine, fever, confusion or weakness, <a href="https://www.rxlist.com/jaundice/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">jaundice</a> (yellowing of the skin or eyes); fever, <a href="https://www.rxlist.com/sore_throat/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">sore throat</a>, and headache with a severe blistering, peeling, and red skin rash; increased thirst, loss of appetite, swelling, weight gain, feeling short of breath, or urinating less than usual or not at all.</p>

<p>Seek medical care or call 911 at once if you have the following serious side effects:</p>
<ul>
<li>Serious eye symptoms such as sudden vision loss, blurred vision, <a href="https://www.rxlist.com/tunnel_vision/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">tunnel vision</a>, eye pain or swelling, or seeing halos around lights;</li>
<li>Serious heart symptoms such as fast, irregular, or pounding heartbeats; fluttering in your chest; shortness of breath; and sudden dizziness, <a href="https://www.rxlist.com/lightheadedness/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">lightheadedness</a>, or passing out;</li>
<li>Severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff muscles, high fever, profuse sweating, or tremors.</li>
</ul>

<p>This document does not contain all possible side effects and others may occur. Check with your physician for additional information about side effects.</p>

<h4>Dosage for Omnicef</h4>
<p>The recommended dosage of cefdinir for infections in adults and adolescents ranges from 300 mg to 600 mg, taken either once or twice daily. Duration of treatment ranges from 5 to 10 days.</p>

<h4>What Drugs, Substances, or Supplements Interact with Omnicef?</h4>
<p>Cefdinir may interact with probenecid, or vitamin or mineral supplements that contain iron. Other drugs may interact with cefdinir. Tell your doctor all prescription and over-the-counter medications and supplements you use.</p> 

<h4>Omnicef During Pregnancy and Breastfeeding</h4>
<p>Cefdinir should be used only when prescribed during pregnancy. This drug does not pass into breast milk. Consult your doctor before breast-feeding. </p>

<h4>Additional Information</h4>
<p>Our Omnicef (cefdinir) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
</div>
            </div>
	    </div>	
            <nav class="submenu" visibility="hide">
            <span class="icon-menu"></span>
 
            <!--START PROFESSIONAL MENU-->
            <div class="toc link">
		<h2 class="drug_fda">FDA Drug Information</h2>
                <ul class="fda_toc">
                <li><a href="/omnicef-drug.htm#description" id="mnuDESC">Drug Description</a></li>
                    <li><a href="/omnicef-drug.htm#indications" id="mnuIDS1">Indications</a></li>
                    <li><a href="/omnicef-drug.htm#dosage" id="mnuIDS2">Dosage</a></li>
                
                    <li><a href="/omnicef-drug.htm#side_effects" id="mnuAD1">Side Effects</a></li>
                    <li><a href="/omnicef-drug.htm#interactions" id="mnuAD2">Drug Interactions</a></li>

                    <li><a href="/omnicef-drug.htm#warnings" id="mnuWCP1">Warnings</a></li>                        
                    <li><a href="/omnicef-drug.htm#precautions" id="mnuWCP2">Precautions</a></li>         

                        <li><a href="/omnicef-drug.htm#overdosage" id="mnuOD1">Overdose & Contraindications</a></li>
                    
                <li><a href="/omnicef-drug.htm#clinpharm" id="mnuCP">Clinical Pharmacology</a></li>
                <li><a href="/omnicef-drug.htm#medguide" id="mnuPI">Medication Guide</a></li>
                </ul>
            </div>
            <!--END PROFESSIONAL MENU-->
            </nav>

                <article class="pageContainer">	
                    <div>
                    	
<section class="pageSection">
    <div id="apPage" class="apPage">
        <div class="wrapper">
            <a class="bookmark" name="description"></a>
            <div class="pgContent">
                

                
<h2>Description for Omnicef</h2>

<p>OMNICEF (cefdinir) capsules and OMNICEF (cefdinir) for oral suspension contain the active ingredient cefdinir, an extended-spectrum, semisynthetic cephalosporin, for oral administration. Chemically, cefdinir is [6R-[6&alpha;, 7&beta; (Z)]]-7-[[(2-amino-4-thiazolyl)(hydroxyimino)acetyl]amino]3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. Cefdinir is a white to slightly brownish-yellow solid. It is slightly soluble in dilute hydrochloric acid and sparingly soluble in 0.1 M pH 7.0 phosphate buffer. The empirical formula is C<sub>14</sub>H<sub>13</sub>N<sub>5</sub>O<sub>5</sub>S<sub>2</sub> and the molecular weight is 395.42. Cefdinir has the structural formula shown below:</p>

<p></p>

<center>
<table cellspacing="0" class="blackpic" width="543">
	<tbody>
		<tr>
			<td><img alt="OMNICEF&reg;
 (cefdinir) - Structural Formula Illustration" height="202" src="https://images.rxlist.com/images/rxlist/cefdin1.gif" width="543" /></td>
		</tr>
	</tbody>
</table>
</center>

<p></p>

<p>OMNICEF Capsules contain 300 mg cefdinir and the following inactive ingredients: carboxymethylcellulose calcium, NF; polyoxyl 40 stearate, NF; and magnesium stearate, NF. The capsule shells contain FD&amp;C Blue #1; FD&amp;C Red #40; D&amp;C Red #28; titanium dioxide, NF; gelatin, NF; silicon dioxide, NF; and sodium lauryl sulfate, NF.</p>

<p>OMNICEF for Oral Suspension, after reconstitution, contains 125 mg cefdinir per 5 mL or 250 mg cefdinir per 5 mL and the following inactive ingredients: sucrose, NF; citric acid, USP; sodium citrate, USP; sodium benzoate, NF; xanthan gum, NF; guar gum, NF; artificial strawberry and cream flavors; silicon dioxide, NF; and magnesium stearate, NF.</p>

            </div>
            
<div id="667441035-1" class="medianet"><script type="text/javascript">try { window._mNHandle.queue.push(function () { window._mNDetails.loadTag("667441035-1", "510x175", "667441035"); }); } catch (error) { }</script></div>

        </div>
    </div>
</section>
<section class="pageSection">
    <div id="apPage" class="apPage">
        <div class="wrapper">
            <a class="bookmark" name="indications"></a>
            <div class="pgContent">
                

                
<a name="I"></a><h2>Uses for Omnicef</h2>
<p>To reduce the development of
drug-resistant bacteria and maintain the effectiveness of OMNICEF and other
 antibacterial drugs, OMNICEF should be used only to treat or prevent infections
that are proven or strongly suspected to be caused by susceptible bacteria.
When culture and susceptibility information are available, they should be
considered in selecting or modifying antibacterial therapy. In the absence of
such data, local epidemiology and susceptibility patterns may contribute to the
empiric selection of therapy.</p>
<p>OMNICEF (cefdinir) capsules and
OMNICEF (cefdinir) for oral suspension are indicated for the treatment of
patients with mild to moderate infections caused by susceptible strains of the
designated microorganisms in the conditions listed below.</p>
<h4>Adults and Adolescents</h4>
<h5>Community-Acquired Pneumonia</h5>
<p>caused by <i>Haemophilus
influenzae</i> (including &beta;-lactamase producing strains), <i>Haemophilus
parainfluenzae</i> (including &beta;-lactamase producing strains), <i>Streptococcus
pneumoniae</i> (penicillin-susceptible strains only), and <i>Moraxella
catarrhalis</i> (including &beta;-lactamase producing strains) (see<b> <a href="/omnicef-drug.htm#CS">Clinical
Studies</a></b>).</p>
<h5>Acute Exacerbations of Chronic Bronchitis</h5>
<p>caused by <i>Haemophilus influenzae</i> (including
&beta;-lactamase producing strains), <i>Haemophilus parainfluenzae</i> (including
&beta;-lactamase producing strains), <i>Streptococcus pneumoniae</i> (penicillin-susceptible
strains only), and <i>Moraxella catarrhalis</i> (including &beta;-lactamase
producing strains).</p>
<h5>Acute Maxillary Sinusitis</h5>
<p>caused by <i>Haemophilus influenzae</i> (including
&beta;-lactamase producing strains), <i>Streptococcus pneumoniae</i> (penicillin-susceptible
strains only), and <i>Moraxella catarrhalis</i> (including &beta;lactamase
producing strains).</p>
<p><b>NOTE:</b> For information on use in pediatric
patients, see <b><a href="/omnicef-drug.htm#P">Pediatric Use</a></b> and <b>DOSAGE AND ADMINISTRATION</b>.</p>
<h5>Pharyngitis/Tonsillitis</h5>
<p>caused by <i>Streptococcus pyogenes</i> (see <b><a href="/omnicef-drug.htm#CS">Clinical
Studies</a></b>).</p>
<p><b>NOTE:</b> Cefdinir is effective in the eradication of <i>S.
pyogenes </i> from the oropharynx. Cefdinir has not, however, been studied for
the prevention of rheumatic fever following <i>S. pyogenes </i> pharyngitis/tonsillitis.
Only intramuscular penicillin has been demonstrated to be effective for the
prevention of rheumatic fever.</p>
<h5>Uncomplicated Skin and Skin Structure Infections</h5>
<p>caused by <i>Staphylococcus aureus</i> (including
&beta;-lactamase producing strains) and <i>Streptococcus pyogenes</i>.</p>
<h4>Pediatric Patients</h4>
<p><b>Acute Bacterial Otitis Media</b> caused by <i>Haemophilus
influenzae</i> (including &beta;-lactamase producing strains), <i>Streptococcus
pneumoniae</i> (penicillin-susceptible strains only), and <i>Moraxella
catarrhalis</i> (including &beta;-lactamase producing strains).</p>
<h5>Pharyngitis/Tonsillitis</h5>
<p>caused by <i>Streptococcus pyogenes</i> (see <b><a href="/omnicef-drug.htm#CS">Clinical
Studies</a></b>).</p>
<p><b>NOTE:</b> Cefdinir is effective in the
eradication of <i>S. pyogenes </i> from the oropharynx. Cefdinir has not,
however, been studied for the prevention of rheumatic fever following <i>S.
pyogenes </i> pharyngitis/tonsillitis. Only intramuscular penicillin has been
demonstrated to be effective for the prevention of rheumatic fever.</p>
<h5>Uncomplicated Skin and Skin Structure Infections</h5>
<p>caused by <i>Staphylococcus aureus</i> (including
&beta;-lactamase producing strains) and <i>Streptococcus pyogenes</i>.</p>

            </div>
            
        </div>
    </div>
</section>
<section class="pageSection">
    <div id="apPage" class="apPage">
        <div class="wrapper">
            <a class="bookmark" name="dosage"></a>
            <div class="pgContent">
                

                <a name="DAA"></a><h2>Dosage for Omnicef</h2>
<p>(see<b> INDICATIONS AND USAGE</b> for <b>Indicated
Pathogens</b>)</p>
<h4>Capsules</h4>
<p>The recommended dosage and duration of treatment for
infections in adults and adolescents are described in the following chart; the
total daily dose for all infections is 600 mg. Once-daily dosing for 10 days is
as effective as BID dosing. Once-daily dosing has not been studied in pneumonia 
or skin infections; therefore, OMNICEF Capsules should be administered twice
daily in these infections. OMNICEF Capsules may be taken without regard to
meals.</p>
<p align="center"><b>Adults and Adolescents (Age 13 Years and Older)</b><br />
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td class="EmphTd" width="40%">Type of Infection</td>
    <td class="EmphTd" width="30%">Dosage</td>
    <td class="EmphTd" width="30%">Duration</td>
    </tr>
    <tr>
    <td>Community-Acquired Pneumonia</td>
    <td align="center">300 mg q12h</td>
    <td align="center">10 days</td>
    </tr>
    <tr>
    <td>Acute Exacerbations of Chronic Bronchitis</td>
    <td align="center">300 mg q12h or&nbsp; 600 mg q24h</td>
    <td align="center">5 to 10 days 10 days</td>
    </tr>
    <tr>
    <td>Acute Maxillary Sinusitis</td>
    <td align="center">300 mg q12h or&nbsp; 600 mg q24h</td>
    <td align="center">10 days 10 days</td>
    </tr>
    <tr>
    <td>Pharyngitis/Tonsillitis</td>
    <td align="center">300 mg q12h or&nbsp; 600 mg q24h</td>
    <td align="center">5 to 10 days 10 days</td>
    </tr>
    <tr>
    <td>Uncomplicated Skin and Skin Structure    Infections</td>
    <td align="center">300 mg q12h</td>
    <td align="center">10 days</td>
    </tr>
</table>
</center></p>
<h4>PowderFor Oral Suspension</h4>
<p>The recommended dosage and
duration of treatment for infections in pediatric patients are described in the
following chart; the total daily dose for all infections is 14 mg/kg, up to a
maximum dose of 600 mg per day. Once-daily dosing for 10 days is as effective
as BID dosing. Once-daily dosing has not been studied in skin infections;
therefore, OMNICEF for Oral Suspension should be administered twice daily in
this infection. OMNICEF for Oral Suspension may be administered without regard
to meals.</p>
<p align="center"><b>Pediatric Patients (Age 6
Months Through 12 Years)</b><br />
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td class="EmphTd" width="40%">Type of Infection</td>
    <td class="EmphTd" width="30%">Dosage</td>
    <td class="EmphTd" width="30%">Duration</td>
    </tr>
    <tr>
    <td>Acute Bacterial Otitis Media</td>
    <td align="center">7 mg/kg q12h or&nbsp; 14 mg/kg q24h</td>
    <td align="center">5 to 10 days 10 days</td>
    </tr>
    <tr>
    <td>Acute Maxillary Sinusitis</td>
    <td align="center">7 mg/kg q12h or&nbsp; 14 mg/kg q24h</td>
    <td align="center">10 days 10 days</td>
    </tr>
    <tr>
    <td>Pharyngitis/Tonsillitis</td>
    <td align="center">7 mg/kg q12h or&nbsp; 14 mg/kg q24h</td>
    <td align="center">5 to 10 days 10 days</td>
    </tr>
    <tr>
    <td>Uncomplicated Skin and Skin Structure    Infections</td>
    <td align="center">7 mg/kg q12h</td>
    <td align="center">10 days</td>
    </tr>
</table>
</center></p>
<p align="center"><b>OMNICEF FOR ORAL SUSPENSION
PEDIATRIC DOSAGE CHART</b><br />
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td class="EmphTd" width="30%">Weight</td>
    <td class="EmphTd" width="35%">125 mg/5 mL</td>
    <td class="EmphTd" width="35%"colspan="2">250 mg/5 mL</td>
    </tr>
    <tr>
    <td>9 kg/20 lbs</td>
    <td align="center">2.5 mL q12h or 5 mL q24h</td>
    <td  align="center" colspan="2">Use 125 mg/5 mL product</td>
    </tr>
    <tr>
    <td>18 kg/40 lbs</td>
    <td align="center">5 mL q12h or 10 mL q24h</td>
    <td  align="center" colspan="2">2.5 mL q12h or 5 mL q24h</td>
    </tr>
    <tr>
    <td>27 kg/60 lbs</td>
    <td align="center">7.5 mL q12h or 15 mL q24h</td>
    <td  align="center" colspan="2">3.75 mL q12h or 7.5 mL q24h</td>
    </tr>
    <tr>
    <td>36 kg/80 lbs</td>
    <td align="center">10 mL q12h or 20 mL q24h</td>
    <td  align="center" colspan="2">5 mL q12h or 10 mL q24h</td>
    </tr>
    <tr>
    <td> &ge; 43 kg<sup>a</sup>/95 lbs</td>
    <td align="center">12 mL q12h or 24 mL q24h</td>
    <td  align="center" colspan="2">6 mL q12h or 12 mL q24h</td>
    </tr>
    <tr>
    <td class="credit"colspan="4"><sup>a</sup> Pediatric    patients who weigh  &gt;  43 kg should receive the maximum daily dose of 600    mg.</td>
    </tr>
</table>
</center></p>
<h4>Patients With Renal
  Insufficiency</h4>
<p>For adult patients with
creatinine clearance  &lt;  30 mL/min, the dose of cefdinir should be 300 mg
given once daily.</p>
<p>Creatinine clearance is
difficult to measure in outpatients. However, the following formula may be used
to estimate creatinine clearance (CLcr) in adult patients. For estimates to be
valid, serum creatinine levels should reflect steady-state levels of renal
function.</p>
<p><table width="450" cellspacing="0">
  <tr> 
	<td rowspan="2"><b>Males:</b></td>
	<td align="center"><u> (weight in kg) x (140 &ndash; age)</u></td>
  </tr>
  <tr> 
	<td align="center">(72) x serum creatinine</td>
  </tr>
  <tr> 
	<td><b>Females</b></td>
	<td>CLcr =0.85 &times; above value</td>
  </tr>
</table></p>
<p>where creatinine clearance is
in mL/min, age is in years, weight is in kilograms, and serum creatinine is in
mg/dL.<sup>4</sup></p>
<p>The following formula may be
used to estimate creatinine clearance in pediatric patients:</p>
<p><b>CLcr =</b> K × body length or height/ serum
creatinine</p>
<p>where K = 0.55 for pediatric
patients older than 1 year<sup>5</sup> and 0.45 for infants (up to 1 year)<sup>6</sup>.</p>
<p>In the above equation,
creatinine clearance is in mL/min/1.73 m&sup2;, body length or height is in centimeters, and serum
creatinine is in mg/dL.</p>
<p>For pediatric patients with a
creatinine clearance of  &lt;  30 mL/min/1.73 m&sup2;, the dose of cefdinir should be 7 mg/kg (up to 300 mg)
given once daily.</p>
<h4>Patients On Hemodialysis</h4>
<p><a href="https://www.rxlist.com/hemodialysis/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">Hemodialysis</a> removes cefdinir
from the body. In patients maintained on chronic hemodialysis, the recommended
initial dosage regimen is a 300-mg or 7-mg/kg dose every other day.</p>
<p>At the conclusion of each hemodialysis session, 300 mg
(or 7 mg/kg) should be given. Subsequent doses (300 mg or 7 mg/kg) are then
administered every other day.</p>
<p align="center"><b>Directions for Mixing Omnicef for Oral Suspension</b>
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td class="EmphTd" width="20%">Final&nbsp; Concentration</td>
    <td class="EmphTd" width="20%">Final&nbsp;    Volume(mL)</td>
    <td class="EmphTd" width="20%">Amount of Water</td>
    <td class="EmphTd" width="40%">Directions</td>
    </tr>
    <tr>
    <td>125 mg/5 mL</td>
    <td align="center">60&nbsp; 100</td>
    <td align="center">38 mL 63 mL</td>
    <td>Tap bottle to loosen powder, then add water in 2 portions. Shake well    after each aliquot.</td>
    </tr>
    <tr>
    <td>250 mg/5 mL</td>
    <td align="center">60&nbsp; 100</td>
    <td align="center">38 mL 63 mL</td>
    <td>Tap bottle to loosen powder, then add water in 2 portions. Shake well after each aliquot.</td>
    </tr>
</table>
</center></p>
<p>After mixing, the suspension
can be stored at room temperature (25&deg;C/77&deg;F). The container should be kept
tightly closed, and the suspension should be shaken well before each
administration. The suspension may be used for 10 days, after which any unused
portion must be discarded.</p>
<a name="HS"></a><h2>HOW SUPPLIED</h2>
<p><b>OMNICEF Capsules</b>, containing
300 mg cefdinir, as <a href="https://www.rxlist.com/supplements/lavender.htm" rel="vit" onclick="wmdTrack('embd-lnk');">lavender</a> and turquoise capsules imprinted with the product
name, are available as follows:</p>
<p class="EmphText">60 Capsules/Bottle <b>NDC</b> 0074-3769-60<br />
OMNI-PAC&trade; carton of 3 unit-of-use, 5-day, 10-capsule blister cards <b>NDC</b> 0074-3769-30</p>
<p><b>OMNICEF for Oral Suspension</b> is a cream-colored powder
  formulation that, when reconstituted as directed, contains 125 mg cefdinir/5 mL
  or 250 mg cefdinir/5 mL. The reconstituted suspensions have a cream color and
<a href="https://www.rxlist.com/supplements/strawberry.htm" rel="vit" onclick="wmdTrack('embd-lnk');">strawberry</a> flavor. The powder is available as follows:</p>
<h5>125 mg/5 mL</h5>
<p class="EmphText">60-mL bottles <b>NDC</b> 0074-3771-60<br />
100-mL bottles <b>NDC</b> 0074-3771-13<br />
250 mg/5 mL 60-mL bottles <b>NDC</b> 0074-6151-60<br />
100-mL bottles <b>NDC</b> 0074-6151-13</p>
<p><b>Store the capsules and unsuspended powder at 25&deg;C
  (77&deg;F); excursions permitted to 15&deg;-30&deg;C (59&deg;-86&deg;F)
  [see USP Controlled Room Temperature]. Once reconstituted, the oral suspension
can be stored at controlled room temperature for 10 days.</b></p>
<p class="credit">Manufactured by: CEPH International Corporation Carolina,
  Puerto Rico 00986. For: AbbVie Inc., North Chicago, IL 60064, U.S.A., Under
License of: Astellas Pharma Inc. Tokyo, Japan. Revised Nov 2015</p>

            </div>
            <div id="667441035-3" class="medianet"><script type="text/javascript">try { window._mNHandle.queue.push(function () { window._mNDetails.loadTag("667441035-3", "510x175", "667441035"); }); } catch (error) { }</script></div>

        </div>
    </div>
</section>
<section class="pageSection">
    <div id="apPage" class="apPage">
        <div class="wrapper">
            <a class="bookmark" name="side_effects"></a>
            <div class="pgContent">
                

                
<a name="AR"></a><h2>Side Effects for Omnicef</h2>
<h4>Adverse Events</h4>
<h5>Clinical Trials - OMNICEF Capsules (Adult and Adolescent
  Patients)</h5>
<p>In clinical trials, 5093 adult and adolescent patients
(3841 US and 1252 non-US) were treated with the recommended dose of cefdinir
capsules (600 mg/day). Most adverse events were mild and self-limiting. No
deaths or permanent disabilities were attributed to cefdinir. One hundred
forty-seven of 5093 (3%) patients discontinued medication due to adverse events
thought by the investigators to be possibly, probably, or definitely associated
with cefdinir therapy. The discontinuations were primarily for <a href="https://www.rxlist.com/gastrointestinal/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">gastrointestinal</a> 
disturbances, usually diarrhea or nausea. Nineteen of 5093 (0.4%) patients were
discontinued due to rash thought related to cefdinir administration.</p>
<p>In the US, the following adverse events were thought by
investigators to be possibly, probably, or definitely related to cefdinir
capsules in multiple-dose clinical trials (N = 3841 cefdinir-treated patients):</p>
<p align="center"><b>ADVERSE EVENTS ASSOCIATED WITH CEFDINIR CAPSULES US
TRIALS IN ADULT AND ADOLESCENT PATIENTS (N = 3841)<sup>a</sup></b><br />
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td width="40%">Incidence  &ge;  1%</td>
    <td width="35%">Diarrhea</td>
    <td width="25%">15%</td>
    </tr>
    <tr>
    <td></td>
    <td>Vaginal moniliasis</td>
    <td>4% of women</td>
    </tr>
    <tr>
    <td></td>
    <td>Nausea</td>
    <td>3%</td>
    </tr>
    <tr>
    <td></td>
    <td>Headache</td>
    <td>2%</td>
    </tr>
    <tr>
    <td></td>
    <td>Abdominal pain</td>
    <td>1%</td>
    </tr>
    <tr>
    <td></td>
    <td>Vaginitis</td>
    <td>1% of women</td>
    </tr>
    <tr>
    <td>Incidence  &lt;  1% but  &gt;  0.1%</td>
    <td>Rash</td>
    <td>0.90%</td>
    </tr>
    <tr>
    <td></td>
    <td>Dyspepsia</td>
    <td>0.70%</td>
    </tr>
    <tr>
    <td></td>
    <td>Flatulence</td>
    <td>0.70%</td>
    </tr>
    <tr>
    <td></td>
    <td>Vomiting</td>
    <td>0.70%</td>
    </tr>
    <tr>
    <td></td>
    <td>Abnormal stools</td>
    <td>0.30%</td>
    </tr>
    <tr>
    <td></td>
    <td>Anorexia</td>
    <td>0.30%</td>
    </tr>
    <tr>
    <td></td>
    <td>Constipation</td>
    <td>0.30%</td>
    </tr>
    <tr>
    <td></td>
    <td>Dizziness</td>
    <td>0.30%</td>
    </tr>
    <tr>
    <td></td>
    <td>Dry mouth</td>
    <td>0.30%</td>
    </tr>
    <tr>
    <td></td>
    <td>Asthenia</td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td></td>
    <td>Insomnia</td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td></td>
    <td>Leukorrhea</td>
    <td>0.2% of women</td>
    </tr>
    <tr>
    <td></td>
    <td>Moniliasis</td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td></td>
    <td>Pruritus</td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td></td>
    <td>Somnolence</td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td class="credit" colspan="3"><sup>a</sup> 1733    males, 2108 females</td>
    </tr>
</table>
</center></p>
<p>The following laboratory value
changes of possible clinical significance, irrespective of relationship to
therapy with cefdinir, were seen during clinical trials conducted in the US:</p>
<p align="center"><b>LABORATORY VALUE CHANGES OBSERVED WITH CEFDINIR
CAPSULES US TRIALS IN ADULT AND ADOLESCENT PATIENTS (N = 3841)</b><br />
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td width="40%">Incidence &ge;  1%</td>
    <td width="35%">&uarr;Urine leukocytes</td>
    <td width="25%">2%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Urine protein</td>
    <td>2%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr; Gamma-glutamyltransferase<sup>a</sup></td>
    <td>1%</td>
    </tr>
    <tr>
    <td></td>
    <td>&darr;Lymphocytes, &uarr;Lymphocytes</td>
    <td>1%, 0.2%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Microhematuria</td>
    <td>1%</td>
    </tr>
    <tr>
    <td>Incidence  &lt;  1% but  &gt;  0.1%</td>
    <td>&uarr;Glucosea</td>
    <td>0.90%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Urine glucose</td>
    <td>0.90%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr; White blood cells,&darr;White blood cells</td>
    <td>0.9%, 0.7%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr; Alanine aminotransferase (ALT)</td>
    <td>0.70%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Eosinophils</td>
    <td>0.70%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Urine specific gravity,&darr;Urine specific gravity<sup>a</sup></td>
    <td>0.6%, 0.2%</td>
    </tr>
    <tr>
    <td></td>
    <td>&darr;Bicarbonate<sup>a</sup></td>
    <td>0.60%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Phosphorus,&darr;Phosphorusa</td>
    <td>0.6%, 0.3%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr; Aspartate aminotransferase (AST)</td>
    <td>0.40%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr; Alkaline phosphatase</td>
    <td>0.30%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr; Blood urea nitrogen (BUN)</td>
    <td>0.30%</td>
    </tr>
    <tr>
    <td></td>
    <td>&darr;Hemoglobin</td>
    <td>0.30%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr; Polymorphonuclear neutrophils (PMNs), &darr;PMNs</td>
    <td>0.3%, 0.2%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Bilirubin</td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Lactate dehydrogenase<sup>a</sup></td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Platelets</td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Potassium<sup>a</sup></td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Urine pH<sup>a</sup></td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td class="credit" colspan="3"><sup>a</sup> N  &lt;     3841 for these parameters</td>
    </tr>
</table>
</center></p>
<h4>Clinical Trials - OMNICEF For
  Oral Suspension (Pediatric Patients)</h4>
<p>In clinical trials, 2289
pediatric patients (1783 US and 506 non-US) were treated with the recommended
dose of cefdinir suspension (14 mg/kg/day). Most adverse events were mild and
self-limiting. No deaths or permanent disabilities were attributed to cefdinir.
Forty of 2289 (2%) patients discontinued medication due to adverse events
considered by the investigators to be possibly, probably, or definitely
associated with cefdinir therapy. Discontinuations were primarily for
gastrointestinal disturbances, usually diarrhea. Five of 2289 (0.2%) patients
were discontinued due to rash thought related to cefdinir administration.</p>
<p>In the US, the following adverse events were thought by
investigators to be possibly, probably, or definitely related to cefdinir
suspension in multiple-dose clinical trials (N = 1783 cefdinirtreated
patients):</p>
<p align="center"><b>ADVERSE EVENTS ASSOCIATED WITH CEFDINIR SUSPENSION US
TRIALS IN PEDIATRIC PATIENTS (N = 1783)<sup>a</sup></b><br />
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td width="40%">Incidence  &ge; 1%</td>
    <td width="35%">Diarrhea</td>
    <td width="25%">8%</td>
    </tr>
    <tr>
    <td></td>
    <td>Rash</td>
    <td>3%</td>
    </tr>
    <tr>
    <td></td>
    <td>Vomiting</td>
    <td>1%</td>
    </tr>
    <tr>
    <td>Incidence  &lt;  1% but  &gt;  0.1%</td>
    <td>Cutaneous moniliasis</td>
    <td>0.90%</td>
    </tr>
    <tr>
    <td></td>
    <td>Abdominal pain</td>
    <td>0.80%</td>
    </tr>
    <tr>
    <td></td>
    <td>Leukopenia<sup>b</sup></td>
    <td>0.30%</td>
    </tr>
    <tr>
    <td></td>
    <td>Vaginal moniliasis</td>
    <td>0.3% of girls</td>
    </tr>
    <tr>
    <td></td>
    <td>Vaginitis</td>
    <td>0.3% of girls</td>
    </tr>
    <tr>
    <td></td>
    <td>Abnormal stools</td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td></td>
    <td>Dyspepsia</td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td></td>
    <td>Hyperkinesia</td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td></td>
    <td>Increased AST<sup>b</sup></td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td></td>
    <td>Maculopapular rash</td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td></td>
    <td>Nausea</td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td class="credit" colspan="3"><sup>a</sup> 977 males,    806 females&nbsp;<br />
      <sup> b</sup> Laboratory changes were    occasionally reported as adverse events.</td>
    </tr>
</table>
</center></p>
<p>NOTE: In both cefdinir- and
control-treated patients, rates of diarrhea and rash were higher in the
youngest pediatric patients. The incidence of diarrhea in cefdinir-treated
patients  &le;  2 years of age was 17% (95/557) compared with 4% (51/1226) in
those  &gt; 2 years old. The incidence of rash (primarily diaper rash in the
younger patients) was 8% (43/557) in patients  &le;  2 years of age compared
with 1% (8/1226) in those  &gt; 2 years old.</p>
<p>The following laboratory value
changes of possible clinical significance, irrespective of relationship to
therapy with cefdinir, were seen during clinical trials conducted in the US:</p>
<p align="center"><b>LABORATORY VALUE CHANGES OF POSSIBLE CLINICAL
SIGNIFICANCE OBSERVED WITH CEFDINIR SUSPENSION US TRIALS IN PEDIATRIC PATIENTS
(N = 1783)</b><br />
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td width="40%">Incidence  &ge; 1%</td>
    <td width="35%">&uarr;Lymphocytes, <br />
      &darr; Lymphocytes</td>
    <td width="25%">2%, 0.8%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Alkaline phosphatase</td>
    <td>1%</td>
    </tr>
    <tr>
    <td></td>
    <td>&darr;Bicarbonate<sup>a</sup></td>
    <td>1%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Eosinophils</td>
    <td>1%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Lactate dehydrogenase</td>
    <td>1%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Platelets</td>
    <td>1%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;PMNs, <br />
      &darr;PMNs</td>
    <td>1%, 1%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Urine protein</td>
    <td>1%</td>
    </tr>
    <tr>
    <td>Incidence  &lt;  1% but  &gt;  0.1%</td>
    <td>&uarr;Phosphorus, <br />
      &darr;Phosphorus</td>
    <td>0.9%, 0.4%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Urine pH</td>
    <td>0.80%</td>
    </tr>
    <tr>
    <td></td>
    <td>&darr;White blood cells, <br />
      &uarr;White blood cells</td>
    <td>0.7%, 0.3%</td>
    </tr>
    <tr>
    <td></td>
    <td>&darr;Calcium<sup>a</sup></td>
    <td>0.50%</td>
    </tr>
    <tr>
    <td></td>
    <td>&darr;Hemoglobin</td>
    <td>0.50%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Urine leukocytes</td>
    <td>0.50%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Monocytes</td>
    <td>0.40%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;AST</td>
    <td>0.30%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Potassium<sup>a</sup></td>
    <td>0.30%</td>
    </tr>
    <tr>
    <td></td>
    <td>&uarr;Urine specific gravity, <br />
      &darr;Urine specific gravity</td>
    <td>0.3%, 0.1%</td>
    </tr>
    <tr>
    <td></td>
    <td>&darr;Hematocrit<sup>a</sup></td>
    <td>0.20%</td>
    </tr>
    <tr>
    <td class="credit"colspan="3"><sup>a</sup> N=1387 for    these parameters</td>
    </tr>
</table>
</center></p>
<h4>Postmarketing Experience</h4>
<p>The following adverse
experiences and altered laboratory tests, regardless of their relationship to
cefdinir, have been reported during extensive postmarketing experience,
beginning with approval in Japan in 1991: shock, anaphylaxis with rare cases of
fatality, facial and laryngeal edema, feeling of suffocation, serum
sickness-like reactions, conjunctivitis, stomatitis, Stevens-Johnson syndrome,
toxic epidermal necrolysis, exfoliative dermatitis, erythema multiforme,
 erythema nodosum, acute hepatitis, cholestasis, fulminant hepatitis, hepatic
failure, jaundice, increased amylase, acute enterocolitis, bloody diarrhea,
 hemorrhagic colitis, melena, pseudomembranous colitis, pancytopenia,
 granulocytopenia, leukopenia, thrombocytopenia, idiopathic thrombocytopenic
purpura, hemolytic anemia, acute respiratory failure, asthmatic attack,
drug-induced pneumonia, eosinophilic pneumonia, idiopathic interstitial 
pneumonia, fever, acute renal failure, nephropathy, bleeding tendency,
coagulation disorder, disseminated intravascular coagulation, upper GI bleed,
 peptic ulcer, ileus, loss of consciousness, allergic vasculitis, possible
cefdinir-diclofenac interaction, cardiac failure, chest pain, myocardial
infarction, hypertension, involuntary movements, and rhabdomyolysis.</p>
<h4>Cephalosporin Class Adverse
  Events</h4>
<p>The following adverse events
and altered laboratory tests have been reported for cephalosporinclass
antibiotics in general:</p>
<p>Allergic reactions,
anaphylaxis, Stevens-Johnson syndrome, erythema multiforme, toxic epidermal
necrolysis, renal dysfunction, toxic nephropathy, hepatic dysfunction including
cholestasis, aplastic anemia, hemolytic anemia, hemorrhage, false-positive test
for urinary glucose, neutropenia, pancytopenia, and agranulocytosis.
Pseudomembranous colitis symptoms may begin during or after antibiotic 
treatment (see <b><a href="/omnicef-drug.htm#W">WARNINGS</a></b>).</p>
<p>Several cephalosporins have
been implicated in triggering seizures, particularly in patients with renal
impairment when the dosage was not reduced (see<b> <a href="/omnicef-drug.htm#DAA">DOSAGE AND ADMINISTRATION</a></b>
and <b><a href="/omnicef-drug.htm#OD">OVERDOSAGE</a></b>). If seizures associated with drug therapy occur, the
drug should be discontinued. <a href="https://www.rxlist.com/anticonvulsant/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">Anticonvulsant</a> therapy can be given if clinically
indicated.</p>

            </div>
            
        </div>
    </div>
</section>
<section class="pageSection">
    <div id="apPage" class="apPage">
        <div class="wrapper">
            <a class="bookmark" name="interactions"></a>
            <div class="pgContent">
                

                <a name="DI"></a><h2>Drug Interactions for Omnicef</h2>
<h4>Antacids (Aluminum- or Magnesium-containing)</h4>
<p>Concomitant administration of 300-mg cefdinir capsules
with 30 mL Maalox&reg; TC
suspension reduces the rate (Cmax) and extent (AUC) of absorption by
approximately 40%. Time to reach Cmax is also prolonged by 1 hour. There are no
significant effects on cefdinir pharmacokinetics if the antacid is administered
2 hours before or 2 hours after cefdinir. If antacids are required during
OMNICEF therapy, OMNICEF should be taken at least 2 hours before or after the
antacid.</p>
<h4>Probenecid</h4>
<p>As with other &beta;-lactam antibiotics, probenecid
inhibits the renal excretion of cefdinir, resulting in an approximate doubling
in AUC, a 54% increase in peak cefdinir plasma levels, and a 50% prolongation
in the apparent elimination t&frac12;.</p>
<h4>Iron Supplements and Foods Fortified With Iron</h4>
<p>Concomitant administration of cefdinir with a therapeutic
iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented
with 10 mg of elemental iron reduced extent of absorption by 80% and 31%,
respectively. If iron supplements are required during OMNICEF therapy, OMNICEF
should be taken at least 2 hours before or after the supplement.</p>
<p>The effect of foods highly fortified with elemental iron
(primarily iron-fortified breakfast cereals) on cefdinir absorption has not
been studied.</p>
<p>Concomitantly administered iron-fortified infant formula 
(2.2 mg elemental iron/6 oz) has no significant effect on cefdinir
pharmacokinetics. Therefore, OMNICEF for Oral Suspension can be administered
with iron-fortified infant formula.</p>
<p>There have been reports of reddish stools in patients
receiving cefdinir. In many cases, patients were also receiving iron-containing
products. The reddish color is due to the formation of a nonabsorbable complex
between cefdinir or its breakdown products and iron in the gastrointestinal
tract.</p>
<h4>Drug/Laboratory Test Interactions</h4>
<p>A false-positive reaction for ketones in the urine may
occur with tests using nitroprusside, but not with those using
nitroferricyanide. The administration of cefdinir may result in a
false-positive reaction for glucose in urine using Clinitest&reg;, Benedict's solution, or
Fehling's solution. It is recommended that glucose tests based on enzymatic
glucose oxidase reactions (such as Clinistix&reg; or Tes-Tape&reg;)
be used. Cephalosporins are known to occasionally induce a positive direct
Coombs' test.</p>

            </div>
            <div id="667441035-5" class="medianet"><script type="text/javascript">try { window._mNHandle.queue.push(function () { window._mNDetails.loadTag("667441035-5", "510x175", "667441035"); }); } catch (error) { }</script></div>

        </div>
    </div>
</section>
<section class="pageSection">
    <div id="apPage" class="apPage">
        <div class="wrapper">
            <a class="bookmark" name="warnings"></a>
            <div class="pgContent">
                

                
<a name="W"></a><h2>Warnings for Omnicef</h2>
<p><b>BEFORE THERAPY WITH OMNICEF (CEFDINIR) IS INSTITUTED,
CAREFUL INQUIRY SHOULD BE MADE TO DETERMINE WHETHER THE PATIENT HAS HAD
PREVIOUS HYPERSENSITIVITY REACTIONS TO CEFDINIR, OTHER CEPHALOSPORINS,
PENICILLINS, OR OTHER DRUGS. IF CEFDINIR IS TO BE GIVEN TO PENICILLIN-SENSITIVE
PATIENTS, CAUTION SHOULD BE EXERCISED BECAUSE CROSS-HYPERSENSITIVITY AMONG
&beta;-LACTAM ANTIBIOTICS HAS BEEN CLEARLY DOCUMENTED AND MAY OCCUR IN UP TO
10% OF PATIENTS WITH A HISTORY OF PENICILLIN ALLERGY. IF AN ALLERGIC REACTION
TO CEFDINIR OCCURS, THE DRUG SHOULD BE DISCONTINUED. SERIOUS ACUTE
HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER
EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS
ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS
CLINICALLY INDICATED.</b></p>
<p><i>Clostridium difficile</i> associated diarrhea (CDAD)
has been reported with use of nearly all <a href="https://www.rxlist.com/antibacterial/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">antibacterial</a> agents, including
OMNICEF, and may range in severity from mild diarrhea to fatal <a href="https://www.rxlist.com/colitis/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">colitis</a>.
Treatment with antibacterial agents alters the normal <a href="https://www.rxlist.com/flora/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">flora</a> of the <a href="https://www.rxlist.com/colon/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">colon</a> 
leading to overgrowth of <i>C. difficile</i>.</p>
<p><i>C. difficile</i> produces toxins A and B which
contribute to the development of CDAD. Hypertoxin producing strains of <i>C.
difficile</i> cause increased morbidity and mortality, as these infections can
be <a href="https://www.rxlist.com/refractory/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">refractory</a> to <a href="https://www.rxlist.com/antimicrobial/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">antimicrobial</a> therapy and may require <a href="https://www.rxlist.com/colectomy/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">colectomy</a>. CDAD must be
considered in all patients who present with diarrhea following antibacterial
use. Careful <a href="https://www.rxlist.com/medical_history/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">medical history</a> is necessary since CDAD has been reported to occur
over two months after the administration of antibacterial agents.</p>
<p>If CDAD is suspected or confirmed, ongoing antibacterial
use not directed against <i>C. difficile</i> may need to be discontinued.
Appropriate fluid and <a href="https://www.rxlist.com/electrolyte/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">electrolyte</a> management, protein supplementation, antibacterial
treatment of <i>C. difficile</i>, and surgical evaluation should be instituted
as clinically indicated.</p>

            </div>
            
        </div>
    </div>
</section>
<section class="pageSection">
    <div id="apPage" class="apPage">
        <div class="wrapper">
            <a class="bookmark" name="precautions"></a>
            <div class="pgContent">
                

                <a name="P"></a><h2>Precautions for Omnicef</h2>
<h4>General</h4>
<p>Prescribing OMNICEF in the absence of a proven or
strongly suspected bacterial infection or a <a href="https://www.rxlist.com/prophylactic/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">prophylactic</a> indication is unlikely
to provide benefit to the patient and increases the risk of the development of
drug-resistant bacteria.</p>
<p>As with other broad-spectrum antibiotics, prolonged
treatment may result in the possible emergence and overgrowth of resistant
organisms. Careful observation of the patient is <a href="https://www.rxlist.com/essential/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">essential</a>. If superinfection
occurs during therapy, appropriate alternative therapy should be administered.</p>
<p>Cefdinir, as with other broad-spectrum antimicrobials
(antibiotics), should be prescribed with caution in individuals with a history
of colitis.</p>
<p>In patients with transient or persistent renal
insufficiency (creatinine clearance  &lt;  30 mL/min), the total daily dose of
OMNICEF should be reduced because high and prolonged plasma concentrations of
cefdinir can result following recommended doses (see<b> <a href="/omnicef-drug.htm#DAA">DOSAGE AND
ADMINISTRATION</a></b>).</p>
<h4>Carcinogenesis, Mutagenesis, Impairment Of Fertility</h4>
<p>The <a href="https://www.rxlist.com/carcinogenic/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">carcinogenic</a> potential of cefdinir has not been
evaluated. No mutagenic effects were seen in the bacterial reverse mutation
assay (Ames) or point mutation assay at the hypoxanthine-guanine 
phosphoribosyltransferase locus (HGPRT) in V79 Chinese hamster lung cells. No
clastogenic effects were observed <i>in vitro</i> in the structural chromosome
aberration assay in V79 Chinese hamster lung cells or <i>in vivo</i> in the
micronucleus assay in mouse <a href="https://www.rxlist.com/bone_marrow/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">bone marrow</a>. In rats, fertility and reproductive
performance were not affected by cefdinir at oral doses up to 1000 mg/kg/day
(70 times the human dose based on mg/kg/day, 11 times based on mg/m&sup2;/day).</p>
<h4>Pregnancy</h4>
<h5>Teratogenic Effects</h5>
<p><i>Pregnancy Category B</i></p>
<p>Cefdinir was not <a href="https://www.rxlist.com/teratogenic/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">teratogenic</a> in rats at oral doses up to
1000 mg/kg/day (70 times the human dose based on mg/kg/day, 11 times based on
mg/m&sup2;/day) or in rabbits at
oral doses up to 10 mg/kg/day (0.7 times the human dose based on mg/kg/day,
0.23 times based on mg/m&sup2;/day).
Maternal toxicity (decreased body weight gain) was observed in rabbits at the
maximum tolerated dose of 10 mg/kg/day without adverse effects on offspring.
Decreased body weight occurred in rat fetuses at  &ge;  100 mg/kg/day, and in
rat offspring at  &ge;  32 mg/kg/day. No effects were observed on maternal
reproductive parameters or offspring survival, development, behavior, or
reproductive function.</p>
<p>There are, however, no adequate and well-controlled
studies in pregnant women. Because animal reproduction studies are not always
predictive of human response, this drug should be used during pregnancy only if
clearly needed.</p>
<h4>Labor And Delivery</h4>
<p>Cefdinir has not been studied for use during labor and
delivery.</p>
<h4>Nursing Mothers</h4>
<p>Following administration of single 600-mg doses, cefdinir
was not detected in human breast milk.</p>
<h4>Pediatric Use</h4>
<p>Safety and efficacy in neonates and infants less than 6
months of age have not been established. Use of cefdinir for the treatment of
acute maxillary <a href="https://www.rxlist.com/sinusitis/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">sinusitis</a> in pediatric patients (age 6 months through 12 years)
is supported by evidence from adequate and well-controlled studies in adults
and adolescents, the similar <a href="https://www.rxlist.com/pathophysiology/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">pathophysiology</a> of acute sinusitis in adult and
pediatric patients, and comparative pharmacokinetic data in the pediatric
population.</p>
<h4>Geriatric Use</h4>
<p>Efficacy is comparable in geriatric patients and younger
adults. While cefdinir has been well-tolerated in all age groups, in clinical
trials geriatric patients experienced a lower rate of adverse events, including
diarrhea, than younger adults. Dose adjustment in elderly patients is not
necessary unless renal function is markedly compromised (see<b> <a href="/omnicef-drug.htm#DAA">DOSAGE AND
ADMINISTRATION</a></b>).</p>

            </div>
            
        </div>
    </div>
</section>
<section class="pageSection">
    <div id="apPage" class="apPage">
        <div class="wrapper">
            <a class="bookmark" name="overdosage"></a>
            <div class="pgContent">
                

                
<a name="OD"></a><h2>Overdose Information for Omnicef</h2>
<p>Information on cefdinir
overdosage in humans is not available. In acute rodent toxicity studies, a
single oral 5600-mg/kg dose produced no adverse effects. Toxic signs and
symptoms following overdosage with other &beta;-lactam antibiotics have
included nausea, vomiting, epigastric distress, diarrhea, and convulsions.
 Hemodialysis removes cefdinir from the body. This may be useful in the event of
a serious toxic reaction from overdosage, particularly if renal function is
compromised.</p>
<a name="CI"></a><h2>Contraindications for Omnicef</h2>
<p>OMNICEF (cefdinir) is contraindicated in patients with
known <a href="https://www.rxlist.com/allergy/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">allergy</a> to the cephalosporin class of antibiotics.</p>

            </div>
            
        </div>
    </div>
</section>
<section class="pageSection">
    <div id="apPage" class="apPage">
        <div class="wrapper">
            <a class="bookmark" name="clinpharm"></a>
            <div class="pgContent">
                <!--MOD_TOPOFPAGE_10-->
                
<a name="CP"></a><h2>Clinical Pharmacology for Omnicef</h2>
<h4>Pharmacokinetics And Drug Metabolism</h4>
<h5>Absorption</h5>
<p><i>Oral Bioavailability</i></p>
<p>Maximal plasma cefdinir concentrations occur 2 to 4 hours
postdose following capsule or suspension administration. Plasma cefdinir
concentrations increase with dose, but the increases are less than
dose-proportional from 300 mg (7 mg/kg) to 600 mg (14 mg/kg). Following
administration of suspension to healthy adults, cefdinir bioavailability is
120% relative to capsules. Estimated bioavailability of cefdinir capsules is
21% following administration of a 300 mg capsule dose, and 16% following
administration of a 600 mg capsule dose. Estimated absolute bioavailability of
cefdinir suspension is 25%. Cefdinir oral suspension of 250 mg/5 mL strength
was shown to be bioequivalent to the 125 mg/5 mL strength in healthy adults
under fasting conditions.</p>
<p><i>Effect of Food</i></p>
<p>The Cmax and AUC of cefdinir from the capsules are
reduced by 16% and 10%, respectively, when given with a high-fat meal. In
adults given the 250 mg/5 mL oral suspension with a high-fat meal, the Cmax and
AUC of cefdinir are reduced by 44% and 33%, respectively. The magnitude of
these reductions is not likely to be clinically significant because the safety
and efficacy studies of oral suspension in pediatric patients were conducted
without regard to food intake. Therefore, cefdinir may be taken without regard
to food.</p>
<p><i>Cefdinir Capsules</i></p>
<p>Cefdinir plasma concentrations and pharmacokinetic
parameter values following administration of single 300- and 600-mg oral doses
of cefdinir to adult subjects are presented in the following table:</p>
<p align="center"><b>Mean (&plusmn; SD) Plasma Cefdinir Pharmacokinetic Parameter
Values Following Administration of Capsules to Adult Subjects</b><br />
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td class="EmphTd" width="25%">Dose</td>
    <td class="EmphTd" width="25%">Cmax (&mu;g/mL)</td>
    <td class="EmphTd" width="25%">tmax (hr)</td>
    <td class="EmphTd" width="25%">AUC (&mu;g&bull;hr/mL)</td>
    </tr>
    <tr>
    <td align="center">300 mg</td>
    <td align="center">1.6 (0.55)</td>
    <td align="center">2.9 (0.89)</td>
    <td align="center">7.05 (2.17)</td>
    </tr>
    <tr>
    <td align="center">600 mg</td>
    <td align="center">2.87 (1.01)</td>
    <td align="center">3 (0.66)</td>
    <td align="center">11.1 (3.87)</td>
    </tr>
</table>
</center></p>
<p><i>Cefdinir Suspension</i></p>
<p>Cefdinir plasma concentrations
and pharmacokinetic parameter values following administration of single 7- and
14-mg/kg oral doses of cefdinir to pediatric subjects (age 6 months-12 years)
are presented in the following table:</p>
<p align="center"><b>Mean (&plusmn; SD) Plasma Cefdinir Pharmacokinetic Parameter
Values Following Administration of Suspension to Pediatric Subjects</b><br />
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td class="EmphTd" width="25%">Dose</td>
    <td class="EmphTd" width="25%">Cmax(&mu;g/mL)</td>
    <td class="EmphTd" width="25%">tmax(hr)</td>
    <td class="EmphTd" width="25%">AUC(&mu;g&bull;hr/mL)</td>
    </tr>

    <tr>
    <td align="center">7 mg/kg</td>
    <td align="center">2.3 (0.65)</td>
    <td align="center">2.2 (0.6)</td>
    <td align="center">8.31 (2.5)</td>
    </tr>

    <tr>
    <td align="center">14 mg/kg</td>
    <td align="center">3.86 (0.62)</td>
    <td align="center">1.8 (0.4)</td>
    <td align="center">13.4 (2.64)</td>
    </tr>
</table>
</center></p>
<p><i>Multiple Dosing</i></p>
<p>Cefdinir does not accumulate in
plasma following once- or twice-daily administration to subjects with normal
renal function.</p>
<h5>Distribution</h5>
<p>The mean volume of distribution
(Vdarea) of cefdinir in adult subjects is 0.35 L/kg (&plusmn; 0.29); in pediatric subjects
(age 6 months-12 years), cefdinir Vdarea is 0.67 L/kg (&plusmn; 0.38). Cefdinir is 60%
to 70% bound to plasma proteins in both adult and pediatric subjects; binding
is independent of concentration.</p>
<p><i>Skin Blister</i></p>
<p>In adult subjects, median
(range) maximal blister fluid cefdinir concentrations of 0.65 (0.33-1.1) and
1.1 (0.49-1.9) &mu;g/mL were observed 4 to 5 hours following administration
of 300- and 600mg doses, respectively. Mean (&plusmn; SD) blister Cmax and AUC
(0-&infin;) values were 48% (&plusmn; 13) and 91% (&plusmn; 18) of corresponding plasma
values.</p>
<p><i>Tonsil Tissue</i></p>
<p>In adult patients undergoing
elective tonsillectomy, respective median tonsil tissue cefdinir concentrations
4 hours after administration of single 300- and 600-mg doses were 0.25
(0.220.46) and 0.36 (0.22-0.80) &mu;g/g. Mean tonsil tissue concentrations
were 24% (&plusmn; 8) of corresponding plasma concentrations.</p>
<p><i>Sinus Tissue</i></p>
<p>In adult patients undergoing
elective maxillary and ethmoid sinus surgery, respective median sinus tissue
cefdinir concentrations 4 hours after administration of single 300- and 600-mg
doses were  &lt;  0.12 ( &lt;  0.12-0.46) and 0.21 ( &lt;  0.12-2.0) &mu;g/g. Mean
sinus tissue concentrations were 16% (&plusmn; 20) of corresponding plasma
concentrations.</p>
<p><i>Lung Tissue</i></p>
<p>In adult patients undergoing
diagnostic bronchoscopy, respective median bronchial mucosa cefdinir
concentrations 4 hours after administration of single 300- and 600-mg doses
were 0.78 ( &lt;  0.06-1.33) and 1.14 ( &lt;  0.06-1.92) &mu;g/mL, and were 31%
(&plusmn; 18) of corresponding plasma concentrations. Respective median epithelial 
lining fluid concentrations were 0.29 ( &lt;  0.3-4.73) and 0.49 ( &lt;  0.3-0.59)
&mu;g/mL, and were 35% (&plusmn; 83) of corresponding plasma concentrations.</p>
<p><i>Middle Ear Fluid</i></p>
<p>In 14 pediatric patients with acute bacterial otitis 
media, respective median middle ear fluid cefdinir concentrations 3 hours after
administration of single 7- and 14-mg/kg doses were 0.21 ( &lt;  0.09-0.94) and
0.72 (0.14-1.42) &mu;g/mL. Mean middle ear fluid concentrations were 15% (&plusmn;
15) of corresponding plasma concentrations.</p>
<p><i>CSF</i></p>
<p>Data on cefdinir penetration into human cerebrospinal
fluid are not available.</p>
<h5>Metabolism and Excretion</h5>
<p>Cefdinir is not appreciably metabolized. Activity is
primarily due to parent drug. Cefdinir is eliminated principally via renal
excretion with a mean plasma elimination half-life (t&frac12;) of 1.7 (&plusmn; 0.6) hours.
In healthy subjects with normal renal function, renal clearance is 2.0 (&plusmn; 1.0)
mL/min/kg, and apparent oral clearance is 11.6 (&plusmn; 6.0) and 15.5 (&plusmn; 5.4)
mL/min/kg following doses of 300- and 600-mg, respectively. Mean percent of
dose recovered unchanged in the urine following 300- and 600-mg doses is 18.4%
(&plusmn; 6.4) and 11.6% (&plusmn; 4.6), respectively. Cefdinir clearance is reduced in
patients with renal dysfunction (see<b> Special Populations</b> - <b>Patients
with Renal Insufficiency</b>).</p>
<p>Because renal excretion is the predominant pathway of
elimination, dosage should be adjusted in patients with markedly compromised
renal function or who are undergoing hemodialysis (see<b> <a href="/omnicef-drug.htm#DAA">DOSAGE AND
ADMINISTRATION</a></b>).</p>
<h4>Special Populations</h4>
<h5>Patients with Renal Insufficiency</h5>
<p>Cefdinir pharmacokinetics were investigated in 21 adult
subjects with varying degrees of renal function. Decreases in cefdinir
elimination rate, apparent oral clearance (CL/F), and renal clearance were
approximately proportional to the reduction in creatinine clearance (CLcr). As
a result, plasma cefdinir concentrations were higher and persisted longer in
subjects with renal impairment than in those without renal impairment. In
subjects with CLcr between 30 and 60 mL/min, Cmax and t&frac12; increased by
approximately 2-fold and AUC by approximately 3-fold. In subjects with CLcr  &lt;
30 mL/min, Cmax increased by approximately 2-fold, t&frac12; by approximately 5fold,
and AUC by approximately 6-fold. Dosage adjustment is recommended in patients
with markedly compromised renal function (creatinine clearance  &lt;  30 mL/min;
see<b> <a href="/omnicef-drug.htm#DAA">DOSAGE AND ADMINISTRATION</a></b>).</p>
<h5>Hemodialysis</h5>
<p>Cefdinir pharmacokinetics were studied in 8 adult
subjects undergoing hemodialysis. <a href="https://www.rxlist.com/dialysis/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">Dialysis</a> (4 hours duration) removed 63% of
cefdinir from the body and reduced apparent elimination t&frac12; from 16 (&plusmn; 3.5) to
3.2 (&plusmn; 1.2) hours. Dosage adjustment is recommended in this patient population
(see<b> <a href="/omnicef-drug.htm#DAA">DOSAGE AND ADMINISTRATION</a></b>).</p>
<h5>Hepatic Disease</h5>
<p>Because cefdinir is predominantly renally eliminated and
not appreciably metabolized, studies in patients with hepatic impairment were
not conducted. It is not expected that dosage adjustment will be required in
this population.</p>
<h5>Geriatric Patients</h5>
<p>The effect of age on cefdinir pharmacokinetics after a
single 300-mg dose was evaluated in 32 subjects 19 to 91 years of age. Systemic
exposure to cefdinir was substantially increased in older subjects (N = 16), Cmax
by 44% and AUC by 86%. This increase was due to a reduction in cefdinir
clearance. The apparent volume of distribution was also reduced, thus no
appreciable alterations in apparent elimination t&frac12; were observed (elderly: 2.2
&plusmn; 0.6 hours vs young: 1.8 &plusmn; 0.4 hours). Since cefdinir clearance has been shown
to be primarily related to changes in renal function rather than age, elderly
patients do not require dosage adjustment unless they have markedly compromised
renal function (creatinine clearance  &lt;  30 mL/min, see<b> Patients with Renal
Insufficiency, above</b>).</p>
<h5>Gender and Race</h5>
<p>The results of a meta-analysis of clinical
pharmacokinetics (N = 217) indicated no significant impact of either gender or
race on cefdinir pharmacokinetics.</p>
<h4>Microbiology</h4>
<h5>Mechanism of Action</h5>
<p>As with other cephalosporins, bactericidal activity of
cefdinir results from inhibition of cell wall synthesis. Cefdinir is stable in
the presence of some, but not all, &beta;-lactamase enzymes. As a result, many
organisms resistant to penicillins and some cephalosporins are susceptible to
cefdinir.</p>
<h5>Mechanism of Resistance</h5>
<p>Resistance to cefdinir is primarily through hydrolysis by
some &beta;-lactamases, alteration of <a href="https://www.rxlist.com/penicillin/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">penicillin</a>-binding proteins (PBPs) and
decreased permeability. Cefdinir is inactive against most strains of Enterobacter
spp., Pseudomonas spp., Enterococcus spp., penicillin-resistant streptococci,
and <a href="https://www.rxlist.com/methicillin/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">methicillin</a>-resistant staphylococci. &beta;-lactamase negative,
ampicillin-resistant (BLNAR) H. influenzae strains are typically
non-susceptible to cefdinir.</p>
<h5>Antimicrobial Activity</h5>
<p>Cefdinir has been shown to be active against most strains
of the following microorganisms, both <i>in vitro</i> and in clinical infections as
described in <a href="/omnicef-drug.htm#I"><b>INDICATIONS AND USAGE</b></a>.</p>
<h5>Gram-Positive Bacteria</h5>
<p class="EmphText"><i>Staphylococcus aureus</i> (methicillin-susceptible
  strains only)<i><br />
  Streptococcus pneumoniae</i> (penicillin-susceptible
  strains only)<i><br />
  Streptococcus pyogenes</i>
</p>
<h5>Gram-Negative Bacteria</h5>
<p class="EmphText"><i>Haemophilus influenzae</i><i><br />
  Haemophilus parainfluenzae</i><i><br />
  Moraxella catarrhalis</i>
</p>
<p>The following <i>in vitro</i> data are available, but their
clinical significance is unknown.</p>
<p>Cefdinir exhibits <i>in vitro</i> minimum inhibitory
concentrations (MICs) of 1 mcg/mL or less against ( &ge;  90%) strains of the
following microorganisms; however, the safety and effectiveness of cefdinir in
treating clinical infections due to these microorganisms have not been
established in adequate and well-controlled clinical trials.</p>
<h5>Gram-Positive Bacteria</h5>
<p class="EmphText"><i>Staphylococcus epidermidis</i> (methicillin-susceptible
  strains only)<i><br />
  Streptococcus agalactiae</i><br />
  Viridans group streptococci
</p>
<h5>Gram-Negative Bacteria</h5>
<p class="EmphText"><i>Citrobacter koseri</i><i><br />
  Escherichia coli</i><i><br />
  Klebsiella pneumoniae</i><i><br />
  Proteus mirabilis</i>
</p>
<h4>Susceptibility Test Methods</h4>
<p>When available, the clinical microbiology laboratory
should provide periodic reports that describe the regional/local susceptibility
profile of potential nosocomial and community-acquired pathogens. These reports
should aid the physician in selecting an antibacterial drug for treatment.</p>
<h5>Dilution Techniques</h5>
<p>Quantitative methods are used to determine antimicrobial 
minimum inhibitory concentrations (MICs). These MICs provide estimates of the
susceptibility of bacteria to antimicrobial compounds. The MICs should be
determined using a standardized test method<sup>1</sup> (broth and/or agar). The
MIC values should be interpreted according to criteria provided in Table 1.</p>
<h5>Diffusion Techniques</h5>
<p>Quantitative methods that require measurement of zone
diameters also provide reproducible estimates of the susceptibility of bacteria
to antimicrobial compounds. The zone size should be determined using a
standardized method.<sup>2</sup> The procedure uses paper disks impregnated
with 5 mcg cefdinir to test the susceptibility of bacteria. The disk diffusion
interpretive criteria are provided in Table 1.</p>
<p align="center"><b>Table 1: Susceptibility Test Interpretive Criteria for
Cefdinir</b><br />
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td class="EmphTd" width="34%" rowspan="2">Microorganisms<sup>a</sup></td>
    <td class="EmphTd" colspan="3">Minimum Inhibitory Concentration (mcg/mL)</td>
    <td class="EmphTd" colspan="3">Zone Diameter (mm)</td>
    </tr>
  <tr>
    <td class="EmphTd" width="11%">S</td>
    <td class="EmphTd" width="11%">I</td>
    <td class="EmphTd" width="11%">R</td>
    <td class="EmphTd" width="11%">S</td>
    <td class="EmphTd" width="11%">I</td>
    <td class="EmphTd" width="11%">R</td>
    </tr>
    <tr>
    <td><i>Haemophilus influenzae</i></td>
    <td align="center"> &le;  1</td>
    <td align="center">&mdash;</td>
    <td align="center">&mdash;</td>
    <td align="center"> &ge; 20</td>
    <td align="center">&mdash;</td>
    <td align="center">&mdash;</td>
    </tr>
    <tr>
    <td><i>Haemophilus parainfluenzae</i></td>
    <td align="center"> &le;  1</td>
    <td align="center">&mdash;</td>
    <td align="center">&mdash;</td>
    <td align="center"> &ge; 20</td>
    <td align="center">&mdash;</td>
    <td align="center">&mdash;</td>
    </tr>
    <tr>
    <td><i>Moraxella catarrhalis</i></td>
    <td align="center"> &le;  1</td>
    <td align="center">2</td>
    <td align="center"> &ge;  4</td>
    <td align="center"> &ge; 20</td>
    <td align="center">17 - 19</td>
    <td align="center"> &le;  16</td>
    </tr>
    <tr>
    <td><i>Streptococcus pneumoniae<sup>b</sup></i></td>
    <td align="center"> &le;  0.5</td>
    <td align="center">1</td>
    <td align="center"> &ge;  2</td>
    <td align="center">&mdash;</td>
    <td align="center">&mdash;</td>
    <td align="center">&mdash;</td>
    </tr>
    <tr>
    <td><i>Streptococcus pyogenes</i></td>
    <td align="center"> &le;  1</td>
    <td align="center">2</td>
    <td align="center"> &ge;  4</td>
    <td align="center"> &ge;  20</td>
    <td align="center">17 - 19</td>
    <td align="center"> &le;  16</td>
    </tr>
    <tr>
      <td class="credit" colspan="7"><sup>a</sup>Streptococci other than <i>S. pneumoniae</i> that are
susceptible to penicillin (MIC  &le;  0.12 mcg/mL), can be considered
susceptible to cefdinir. <br />
<sup>b</sup><i>S. pneumoniae</i> that are susceptible to penicillin (MIC
 &le;  0.06 mcg/mL) can be considered susceptible to cefdinir. Isolates of S.
pneumoniae tested against a 1-&mu;g oxacillin disk with oxacillin zone sizes
 &ge;  20 mm are susceptible to penicillin and can be considered susceptible
to cefdinir. Testing of cefdinir against penicillin-intermediate or
penicillin-resistant isolates is not recommended. Reliable interpretive
criteria for cefdinir are not available.</td>
    </tr>
</table>
</center></p>
<p>Susceptibility of staphylococci
to cefdinir may be deduced from testing penicillin and either cefoxitin or
oxacillin. Staphylococci susceptible to oxacillin (cefoxitin) can be considered
susceptible to cefdinir.<sup>3</sup></p>
<p>A report of &ldquo;Susceptible&rdquo;
indicates that antimicrobial is likely to inhibit growth of the pathogen if the
antimicrobial compound reaches the concentrations at the site of infection
necessary to inhibit growth of the pathogen. A report of &ldquo;Intermediate&rdquo;
indicates that the result should be considered equivocal, and, if the
microorganism is not fully susceptible to alternative, clinically feasible
drugs, the test should be repeated. This category implies possible clinical
applicability in body sites where the drug is physiologically concentrated or
in situations where a high dosage of drug can be used. This category also
provides a buffer zone that prevents small uncontrolled technical factors from
causing major discrepancies in interpretation. A report of &ldquo;Resistant&rdquo; indicates
that the antimicrobial is not likely to inhibit growth of the pathogen if the
antimicrobial compound reaches the concentrations usually achievable at the
infection site; other therapy should be selected.</p>
<h5>Quality Control</h5>
<p>Standardized susceptibility test procedures require the
use of laboratory controls to monitor and ensure the accuracy and precision of
supplies and reagents used in the assay, and the techniques of the individual
performing the test.<sup>1,2,3</sup> Standard cefdinir powder should provide
the following range of MIC values as noted in Table 2. For the diffusion
technique using a 5 mcg disk the criteria in Table 2 should be achieved.</p>
<p align="center"><b>Table 2: Acceptable Quality Control Ranges for
Cefdinir</b><br />
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td class="EmphTd" width="50%">QC Strain</td>
    <td class="EmphTd" width="25%">Minimum Inhibitory Concentration (mcg/mL)</td>
    <td class="EmphTd" width="25%">Zone Diameter (mm)</td>
    </tr>
    <tr>
    <td><i>Escherichia coli</i> ATCC 25922</td>
    <td align="center">0.12 - 0.5</td>
    <td align="center">24 - 28</td>
    </tr>
    <tr>
    <td><i>Haemophilus influenzae </i>ATCC 49766</td>
    <td align="center">0.12 - 0.5</td>
    <td align="center">24 - 31</td>
    </tr>
    <tr>
    <td><i>Staphylococcus aureus </i>ATCC 25923</td>
    <td align="center">--</td>
    <td align="center">25 - 32</td>
    </tr>
    <tr>
    <td><i>Staphylococcus aureus</i> ATCC 29213</td>
    <td align="center">0.12 - 0.5</td>
    <td align="center">--</td>
    </tr>
    <tr>
    <td><i>Streptococcus pneumoniae </i>ATCC 49619</td>
    <td align="center">0.03 - 0.25</td>
    <td align="center">26 - 31</td>
    </tr>
</table>
</center></p>
<a name="CS"></a><h4>Clinical Studies</h4>
<h5>Community-Acquired Bacterial Pneumonia</h5>
<p>In a controlled, double-blind study in adults and
adolescents conducted in the US, cefdinir BID was compared with cefaclor 500 mg
 TID. Using strict evaluability and microbiologic/clinical response criteria 6
to 14 days posttherapy, the following clinical cure rates, presumptive
microbiologic eradication rates, and statistical outcomes were obtained:</p>
<p><i>US Community-Acquired Pneumonia Study Cefdinir vs
Cefaclor</i></p>
<p>
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td class="EmphTd" width="25%"></td>
    <td class="EmphTd" width="25%">Cefdinir BID</td>
    <td class="EmphTd" width="25%">Cefaclor TID</td>
    <td class="EmphTd" width="25%">Outcome</td>
    </tr>
    <tr>
    <td>Clinical Cure Rates</td>
    <td align="center">150/187 (80%)</td>
    <td align="center">147/186 (79%)</td>
    <td align="center">Cefdinir equivalent to control</td>
    </tr>
    <tr>
    <td>Eradication Rates&nbsp; Overall</td>
    <td align="center">177/195 (91%)</td>
    <td align="center">184/200 (92%)</td>
    <td align="center">Cefdinir equivalent to control</td>
    </tr>
    <tr>
      <td><i>S. pneumoniae</i></td>
      <td align="center">31/31 (100%) </td>
      <td align="center">35/35 (100%) </td>
      <td>&nbsp;</td>
    </tr>
    <tr>
      <td><i>H. influenzae </i></td>
      <td align="center">55/65 (85%) </td>
      <td align="center">60/72 (83%)</td>
      <td>&nbsp;</td>
    </tr>
    <tr>
      <td><i>M.    catarrhalis </i></td>
      <td align="center">10/10 (100%) </td>
      <td align="center">11/11    (100%)</td>
      <td>&nbsp;</td>
    </tr>
    <tr>
    <td> <i>H. parainfluenzae</i></td>
    <td align="center">81/89 (91%)</td>
    <td align="center">78/82 (95%)</td>
    <td>&nbsp;</td>
    </tr>
</table>
</center></p>
<p>In a second controlled,
investigator-blind study in adults and adolescents conducted primarily in
Europe, cefdinir BID was compared with amoxicillin/clavulanate 500/125 mg TID.
Using strict evaluability and clinical response criteria 6 to 14 days
posttherapy, the following clinical cure rates, presumptive microbiologic
eradication rates, and statistical outcomes were obtained:</p>
<p align="center"><b>European Community-Acquired
Pneumonia Study Cefdinir vs Amoxicillin/Clavulanate</b><br />
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td class="EmphTd" width="25%"></td>
    <td class="EmphTd" width="25%">Cefdinir BID</td>
    <td class="EmphTd" width="25%">Amoxicillin/ Clavulanate TID</td>
    <td class="EmphTd" width="25%">Outcome</td>
    </tr>
    <tr>
    <td>Clinical Cure Rates</td>
    <td align="center">83/104 (80%)</td>
    <td align="center">86/97 (89%)</td>
    <td align="center">Cefdinir not equivalent to control</td>
    </tr>
    <tr>
    <td>Eradication Rates&nbsp; Overall</td>
    <td align="center">85/96 (89%)</td>
    <td align="center">84/90 (93%)</td>
    <td align="center">Cefdinir equivalent to control</td>
    </tr>
    <tr>
      <td><i>S. pneumoniae</i></td>
      <td align="center">42/44 (95%) </td>
      <td align="center">43/44 (98%)</td>
      <td>&nbsp;</td>
    </tr>
    <tr>
      <td><i>H. influenzae </i></td>
      <td align="center">26/35 (74%)</td>
      <td align="center">21/26 (81%)</td>
      <td>&nbsp;</td>
    </tr>
    <tr>
      <td><i>M.    catarrhalis </i></td>
      <td align="center">6/6 (100%) </td>
      <td align="center">8/8 (100%)</td>
      <td>&nbsp;</td>
    </tr>
    <tr>
    <td> <i>H. parainfluenzae</i></td>
    <td align="center">11/11 (100%)</td>
    <td align="center">12/12 (100%)</td>
    <td>&nbsp;</td>
    </tr>
</table>
</center></p>
<h5>Streptococcal
  Pharyngitis/Tonsillitis</h5>
<p>In four controlled studies
conducted in the United States, cefdinir was compared with 10 days of
penicillin in adult, adolescent, and pediatric patients. Two studies (one in
adults and adolescents, the other in pediatric patients) compared 10 days of
cefdinir QD or BID to penicillin 250 mg or 10 mg/kg QID. Using strict
evaluability and microbiologic/ clinical response criteria 5 to 10 days
posttherapy, the following clinical cure rates, microbiologic eradication
rates, and statistical outcomes were obtained:</p>
<p align="center"><b>Pharyngitis/Tonsillitis Studies Cefdinir (10 days) vs
Penicillin (10 days)</b><br />
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td class="EmphTd" width="20%">Study</td>
    <td class="EmphTd" width="20%">Efficacy Parameter</td>
    <td class="EmphTd" width="15%">Cefdinir&nbsp;    QD</td>
    <td class="EmphTd" width="15%">Cefdinir&nbsp;    BID</td>
    <td class="EmphTd" width="15%">Penicillin&nbsp;    QID</td>
    <td class="EmphTd" width="15%">Outcome</td>
    </tr>
    <tr>
    <td>Adults/&nbsp;    Adolescents</td>
    <td>Eradication of <i>S.&nbsp; pyogenes</i></td>
    <td align="center">192/210&nbsp; (91%)</td>
    <td align="center">199/217&nbsp; (92%)</td>
    <td align="center">181/217&nbsp; (83%)</td>
    <td align="center">Cefdinir superior to control</td>
    </tr>
    <tr>
    <td></td>
    <td>Clinical Cure Rates</td>
    <td align="center">199/210&nbsp; (95%)</td>
    <td align="center">209/217&nbsp; (96%)</td>
    <td align="center">193/217&nbsp; (89%)</td>
    <td align="center">Cefdinir superior to control</td>
    </tr>
    <tr>
    <td>Pediatric Patients</td>
    <td>Eradication of <i>S.&nbsp; pyogenes</i></td>
    <td align="center">215/228&nbsp; (94%)</td>
    <td align="center">214/227&nbsp; (94%)</td>
    <td align="center">159/227&nbsp; (70%)</td>
    <td align="center">Cefdinir superior to control</td>
    </tr>
    <tr>
    <td></td>
    <td>Clinical Cure Rates</td>
    <td align="center">222/228&nbsp; (97%)</td>
    <td align="center">218/227&nbsp; (96%)</td>
    <td align="center">196/227&nbsp; (86%)</td>
    <td align="center">Cefdinir superior to control</td>
    </tr>
</table>
</center></p>
<p>Two studies (one in adults and
adolescents, the other in pediatric patients) compared 5 days of cefdinir BID
to 10 days of penicillin 250 mg or 10 mg/kg QID. Using strict evaluability and
microbiologic/clinical response criteria 4 to 10 days posttherapy, the
following clinical cure rates, microbiologic eradication rates, and statistical
outcomes were obtained:</p>
<p align="center"><b>Pharyngitis/Tonsillitis
Studies Cefdinir (5 days) vs Penicillin (10 days)</b><br />
<center>
  <table width="450" cellspacing="0" class="blacktbl">
  <tr>
    <td class="EmphTd" width="20%">Study</td>
    <td class="EmphTd" width="20%">Efficacy Parameter</td>
    <td class="EmphTd" width="20%">Cefdinir&nbsp;    BID</td>
    <td class="EmphTd" width="20%">Penicillin&nbsp;    QID</td>
    <td class="EmphTd" width="20%">Outcome</td>
    </tr>
    <tr>
    <td>Adults/ Adolescents</td>
    <td>Eradication of <i>S. pyogenes</i></td>
    <td align="center">193/218 (89%)</td>
    <td align="center">176/214 (82%)</td>
    <td align="center">Cefdinir equivalent to control</td>
    </tr>
    <tr>
    <td></td>
    <td>Clinical Cure Rates</td>
    <td align="center">194/218 (89%)</td>
    <td align="center">181/214 (85%)</td>
    <td align="center">Cefdinir equivalent to control</td>
    </tr>
    <tr>
    <td>Pediatric Patients</td>
    <td>Eradication of <i>S. pyogenes</i></td>
    <td align="center">176/196 (90%)</td>
    <td align="center">135/193 (70%)</td>
    <td align="center">Cefdinir superior to control</td>
    </tr>
    <tr>
    <td></td>
    <td>Clinical Cure Rates</td>
    <td align="center">179/196 (91%)</td>
    <td align="center">173/193(90%)</td>
    <td align="center">Cefdinir equivalent to control</td>
    </tr>
</table>
</center></p>
<p class="credit"><b>REFERENCES</b></p>
<p class="credit">1. Clinical and Laboratory
  Standards Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility
  Tests for Bacteria That Grow Aerobically; Approved Standard &ndash; Tenth Edition. CLSI
  Document M07-A10 [2015], Clinical and Laboratory Standards Institute, 950 West
Valley Road, Suite 2500, Wayne, Pennsylvania 19087, USA.</p>
<p class="credit">2. Clinical and Laboratory
  Standards Institute (CLSI). Performance Standards for Antimicrobial Disk
  Diffusion Susceptibility Tests; Approved Standard &ndash; Twelfth Edition. CLSI
  Document M02-A12 [2015], Clinical and Laboratory Standards Institute, 950 West
Valley Road, Suite 2500, Wayne, Pennsylvania 19087, USA.</p>
<p class="credit">3. Clinical and Laboratory Standards Institute (CLSI). Performance
  Standards for Antimicrobial Susceptibility Testing; Twenty-fifth Informational
  Supplement, CLSI Document M100-S25 [2015], Clinical and Laboratory Standards
  Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087, USA.</p>
<p class="credit">4. Cockcroft DW, Gault MH. Prediction of creatinine
clearance from serum creatinine. Nephron 1976;16:31-41.</p>
<p class="credit">5. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A. A
  simple estimate of glomerular filtration rate in children derived from body
length and plasma creatinine. <a href="https://www.rxlist.com/pediatrics/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">Pediatrics</a> 1976;58:259-63.</p>
<p class="credit">6. Schwartz GJ, Feld LG, Langford DJ. A simple estimate
  of glomerular filtration rate in full-term infants during the first year of
life. J Pediatrics 1984;104:849-54.</p>
            </div>
            <!--MOD_BOTTOMOFPAGE_10-->
        </div>
    </div>
</section>
<section class="pageSection">
    <div id="apPage" class="apPage">
        <div class="wrapper">
            <a class="bookmark" name="medguide"></a>
            <div class="pgContent">
                <!--MOD_TOPOFPAGE_11-->
                
<a name="PI"></a><h2>Patient Information for Omnicef</h2>
<p>Patients should be counseled that antibacterial drugs
including OMNICEF should only be used to treat bacterial infections. They do
not treat viral infections (e.g., the <a href="https://www.rxlist.com/common_cold/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">common cold</a>). When OMNICEF is prescribed
to treat a bacterial infection, patients should be told that although it is
common to feel better early in the course of therapy, the medication should be
taken exactly as directed. Skipping doses or not completing the full course of
therapy may (1) decrease the effectiveness of the immediate treatment and (2)
increase the likelihood that bacteria will develop resistance and will not be
treatable by OMNICEF or other antibacterial drugs in the future.</p>
<p>Antacids containing magnesium or aluminum interfere with
the absorption of cefdinir. If this type of antacid is required during OMNICEF
therapy, OMNICEF should be taken at least 2 hours before or after the antacid.</p>
<p>Iron supplements, including multivitamins that contain
iron, interfere with the absorption of cefdinir. If iron supplements are
required during OMNICEF therapy, OMNICEF should be taken at least 2 hours
before or after the supplement.</p>
<p>Iron-fortified infant formula does not significantly
interfere with the absorption of cefdinir. Therefore, OMNICEF for Oral
Suspension can be administered with iron-fortified infant formula.</p>
<p>Diabetic patients and caregivers should be aware that the
oral suspension contains 2.86 g of sucrose per teaspoon.</p>
<p>Diarrhea is a common problem caused by antibiotics which
usually ends when the <a href="https://www.rxlist.com/antibiotic/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">antibiotic</a> is discontinued. Sometimes after starting
treatment with antibiotics, patients can develop watery and bloody stools (with
or without <a href="https://www.rxlist.com/stomach_cramps/definition.htm" rel="dict" onclick="wmdTrack('embd-lnk');">stomach cramps</a> and fever) even as late as two or more months after
having taken the last dose of the antibiotic. If this occurs, patients should
contact their physician as soon as possible.</p>
            </div>
            <!--MOD_BOTTOMOFPAGE_11-->
        </div>
    </div>
</section>
<!-- START US ONLY VISITOR RR2 --><div class="from_webmd">
    <h2>From <img class="logoTitle" src="https://images.medicinenet.com/images/promo/logo_webmd.gif" alt="WebMD Logo"></h2>
    <div class="content">
        <div class="wrapper">
    <h5>Infectious Disease Resources</h5>
    <ul>
        <li><a onclick="wmdPageLink('rs-4286-4286_1');" href="https://www.webmd.com/oral-health/guide/sore-throat-cold-strep-throat-tonsillitis" target="_blank" rel="nofollow">Is It a Cold, Strep, or Tonsillitis?</a></li>
    </ul>
</div>
        <div class="wrapper">
    <h5>Featured Centers</h5>
    <ul>
        <li><a onclick="wmdPageLink('fc-3785-1');" href="https://www.webmd.com/skin-problems-and-treatments/psoriasis/psa-22/psa-make-treatment-work
" target="_blank" rel="nofollow">What Are the Best PsA Treatments for You?</a></li><li><a onclick="wmdPageLink('fc-3709-2');" href="https://www.webmd.com/rheumatoid-arthritis/video/ra-biologic-drugs" target="_blank" rel="nofollow">Understanding Biologics
</a></li><li><a onclick="wmdPageLink('fc-5056-3');" href="https://blogs.webmd.com/depression/20220131/what-i-wish-people-knew-about-depression
" target="_blank" rel="nofollow">10 Things People With Depression Wish You Knew
</a></li>
    </ul>
</div>
    </div>
</div>
<!-- END US ONLY VISITOR RR2 -->
<div id="fdaWrapper">
	<img src="https://images.medicinenet.com/images/logo_fda.png" border="0" alt="FDA Logo"/>	
	<h2>Report Problems to the Food and Drug Administration</h2>
	<p>You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the <a href="https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program/reporting-serious-problems-fda" target="_blank" onclick="wmdPageLink('fda-prob');">FDA MedWatch</a> website or call 1-800-FDA-1088.</p>
</div>



                    </div>
                </article>
<scroll-page :max-pages="-1" next-page-uri="/rxl/api/art-rx-sli/120548?num=1" next-type="art-rx-sli" suffix=""></scroll-page>            </section>

                <aside class="stickyColRight">
                    <privacy-button></privacy-button>
                    <div class="sideBox promo">
                        <a onclick="wmdTrack('lr-pid');" href="https://www.rxlist.com/pill-identification-tool/article.htm">
                            <div class="rrpromo pid">
                                <span class="icon-arrow-right2"></span><span class="icon-pill-id"></span><p>Pill Identifier Tool <span>Quick, Easy, Pill Identification</span></p>
                            </div>
                        </a>
                        <a onclick="wmdTrack('lr-dic');" href="https://www.rxlist.com/drug-interaction-checker.htm">
                            <div class="rrpromo dic">
                                <span class="icon-arrow-right2"></span><span class="icon-drug-interaction "></span><p>Drug Interaction Tool <span>Check Potential Drug Interactions</span></p>
                            </div>
                        </a>
                        <a onclick="wmdTrack('lr-lrx');" href="https://www.rxlist.com/pharmacy/local_locations_pharmacies.htm">
                            <div class="rrpromo lrx">
                                <span class="icon-arrow-right2"></span><span class="icon-map"></span><p>Pharmacy Locator Tool <span>Including 24 Hour, Pharmacies</span></p>
                            </div>
                        </a>  
                    </div>
                    <sticky-polyfill top="120">
                        <!-- Start 300x250 Ad Tag -->
<div id="rightAd_rdr">
	<div class="rightAd_top_fmt"></div>
	<div id="rightAd_fmt" class="rightAd_BG_fmt">
        <div id="ads2-pos-121" class="ad_placeholder ad"
    data-is-mobile="false" 
    data-block-codes="_vac_t886_sex3_sex2_sex1_r529_r05_o92_o8_m32_m05_k7_k591_k590_k51_j45_j44_j30_j10_i10_h54_h53_h52_h16_h10_gen2_gen1_g473_g470_g258_g00_food_fit_f65_f50_f43_f1_e1_diet_cust9_cust4_c56_bty21_age234_age133_age132_age123_age122_age121_age11_a6_a5_a49_a403_n952_k21_cust022_supplements_cust031_nn1_cust051_cust056_cust076_cust063_cust091_n898_cust115_a15_" 
    data-pos="121" 
    data-sizes="[[300,250],[300,600],[300,1050]]">
</div>

	</div>
	<div class="rightAd_bottom_fmt"></div>
</div>
<!-- End 300x250 Ad Tag -->

                        
                    </sticky-polyfill>

                </aside>	
        </main>
    
    <footer>
		<ul class="social-section">
        <li class="social fb">
            <offsite-button class="fb_share" theme="fb_share" url="https://www.facebook.com/rxlist" pagelink="soc-fb" icon="icon-facebook" title="Follow us on Facebook. Click Like, and we'll send authoritative health and medical information to your News Feed.">
            </offsite-button>
        </li>
        <li class="social tw">
            <offsite-button class="tw_share" theme="tw_share" url="https://www.twitter.com/rxlist" pagelink="soc-tw" icon="icon-twitter" title="Follow us on Twitter. Be the first to know the latest in health information.">
            </offsite-button>
        </li>
    </ul>
    <nav>
        <div class="col">
            <h4>Drug Categories</h4>
            <ul>
                <li><a href="/drugs/alpha_a.htm">Drugs &amp; Medications</a></li>
                <li><a href="/pill-identification-tool/article.htm">Pill Identification Tool</a></li>
                <li><a href="/supplements/article.htm">Vitamins, Herbs, &amp; Dietary Supplements</a></li>
                <li><a href="/drug-medical-dictionary/article.htm">Dictionary</a></li>
            </ul>
        </div>
        <div class="col">
            <h4>RxList</h4>
            <ul>
                <li><a href="/script/main/art.asp?articlekey=64467">About Us</a></li>
                <li><a href="javascript:void(0);" onclick="window.open('https://data.webmd.com/sdclive/SdcForm.aspx?FormId=rxlistContact','newWin','resizeable=yes,scrollbars=no,width=580,height=600');return false;">Consumer Contact RxList</a></li>
                <li><a href="/script/main/art.asp?articlekey=64473">Terms of Use</a></li>
                <li><a href="/script/main/art.asp?articlekey=64474">Privacy Policy</a></li>
                <li><a href="/script/main/art.asp?articlekey=77768">Sponsor Policy</a></li>                               
            </ul>
        </div>

    </nav>
    <div class="footerCopy">
        <div class="badge">
            <img class="rgb_tag" src="https://images.rxlist.com/images/footer/badges/rgb_tag_registered.png" width="60" height="60" />
            <a href="//privacy.truste.com/privacy-seal/validation?rid=07326333-3522-463d-81bf-f00fd7171fff" target="_blank"><img width="142" height="45" src="//privacy-policy.truste.com/privacy-seal/seal?rid=07326333-3522-463d-81bf-f00fd7171fff" alt="TRUSTe" /></a>
            <a onclick="TRUSTeWidget.Tab.link()"><img src="https://choices.truste.com/get?name=admarker2.png" width="77" height="16" border="0"></a>
        </div>            
        <div class="copyright">
            <a id="ot-sdk-btn1" class="ib-your-choices" onclick="OneTrust.ToggleInfoDisplay();" href="javascript:void(0);">Your Privacy Choices <img src="https://icons.internetbrands.com/ccpa/privacyoptions29x14.png"> </a>
            <p>Copyright &copy; 2024 by RxList Inc. An <a href="https://www.internetbrands.com" rel="nofollow">Internet Brands</a> company. RxList does not provide medical advice, diagnosis or treatment. <a href="https://www.rxlist.com/script/main/art.asp?articlekey=199773">See additional information</a>.</p>
        </div>
    </div>
		</footer>
	</div>
</div>
<!-- start ad 1x1 -->
<div id="ads2-pos-901" class="ad_placeholder ad"
    data-is-mobile="false" 
    data-block-codes="_vac_t886_sex3_sex2_sex1_r529_r05_o92_o8_m32_m05_k7_k591_k590_k51_j45_j44_j30_j10_i10_h54_h53_h52_h16_h10_gen2_gen1_g473_g470_g258_g00_food_fit_f65_f50_f43_f1_e1_diet_cust9_cust4_c56_bty21_age234_age133_age132_age123_age122_age121_age11_a6_a5_a49_a403_n952_k21_cust022_supplements_cust031_nn1_cust051_cust056_cust076_cust063_cust091_n898_cust115_a15_" 
    data-pos="901" 
    data-sizes="[1,1]">
</div>
<script>
  (function(){      
    let adTags = document.querySelectorAll('.ad')
    if (window.ooAdTarget.targets) {
      let adTargets = JSON.stringify(window.ooAdTarget.targets).replaceAll(`"`,`'`)
      for (let adTag of adTags) {
        adTag.setAttribute('data-targets', adTargets)
      }
    }
  })()
</script>

<!-- end ad 1x1 -->


<script src="https://img.wbmdstatic.com/webmd_static_vue/webmd-share-static-files/webmd/PageBuilder_Assets/JS/api/oo_shim_body.min.js"></script>
    <script language="javascript1.2" type="text/javascript" src="https://img.webmd.com/bi_common/bi_oocommon.js"></script>
<script type="text/javascript">    webmd.ads2.adTarget = ['consumer', 'rxlist']; var bIsDFPAdTag = true;</script>
<script>
if(!window.asyncBeacon && typeof _satellite != "undefined"){_satellite.pageBottom();}
if (!window.gdprMatch)
{
try {
    var _comscore = _comscore || [];
    _comscore.push({ c1: "2", c2: "6035829" });
    (function () {
        var s = document.createElement("script"),
            el = document.getElementsByTagName("script")[0];
        s.async = true;
        s.src = "https://sb.scorecardresearch.com/cs/6035829/beacon.js";
        el.parentNode.insertBefore(s, el);
 
        // Dynamic Pageview Tracking
        window.document.addEventListener("onAdobeOmniBeforePv", function () {
            if (self.COMSCORE) {
                COMSCORE.beacon({ c1: "2", c2: "6035829" });
            }
        });
    })();
} catch (err) {}
}
if (window.videoembed) {
    if (globalAsyncAdsCode) {
        webmd.ads.cmd.push(function(){
            webmd.ads.disableInitialLoad();
            webmd.ads.disableAdsInit = true;   
        });
    } else {
        webmd.ads.disableInitialLoad();
        webmd.ads.disableAdsInit = true;   
    }
}
if (!globalAsyncAdsCode){webmd.ads2Consumer.display();}
$(function() {if (window.s_sponsor_program && window.s_sponsor_program!='') $('.medianet').hide();});
function insertWebMDVideo(html) {
return;
    console.info('insertWebMDVideo called');
    if (s_articletype.indexOf("-ap")>0) {
        $(".wrapper .subtitleAP:first").parent().after(html);
    } else {
       $('#artPromoCunk').after(html);
       $('.article-promo').after(html);
    }
}
</script>
<script>if (!window.gdprMatch)
{document.write('<img src="https://bi.medscape.com/pi/global/rxlist-1x1.gif?' + new Date().getTime() + '" alt="" height="1" width="1" border="0" />');
}
</script>
<script src="https://images.rxlist.com/oocommon/js/20190620/legacy-light.js"></script>

</body>
</html> contentType 9 text/html url 43 https://www.rxlist.com:443/omnicef-drug.htm responseCode 3 200 